<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Fetal pulse oximetry for fetal assessment in labour - East, CE - 2014 | Cochrane Library</title> <meta content="Fetal pulse oximetry for fetal assessment in labour - East, CE - 2014 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004075.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Fetal pulse oximetry for fetal assessment in labour - East, CE - 2014 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004075.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD004075.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Fetal pulse oximetry for fetal assessment in labour" name="citation_title"/> <meta content="Christine E East" name="citation_author"/> <meta content="Monash University/Monash Health" name="citation_author_institution"/> <meta content="christine.east@monash.edu" name="citation_author_email"/> <meta content="Lisa Begg" name="citation_author"/> <meta content="Royal Women's Hospital" name="citation_author_institution"/> <meta content="Paul B Colditz" name="citation_author"/> <meta content="The University of Queensland, Royal Brisbane &amp; Women's Hospital" name="citation_author_institution"/> <meta content="Rosalind Lau" name="citation_author"/> <meta content="Monash University" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="10" name="citation_issue"/> <meta content="10.1002/14651858.CD004075.pub4" name="citation_doi"/> <meta content="2014" name="citation_date"/> <meta content="2014/10/07" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004075.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004075.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004075.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Cardiotocography [methods]; Cesarean Section [*statistics &amp; numerical data]; Delivery, Obstetric [statistics &amp; numerical data]; Fetal Monitoring [*methods]; Oximetry [adverse effects, *methods]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004075.pub4&amp;doi=10.1002/14651858.CD004075.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004075.pub4&amp;doi=10.1002/14651858.CD004075.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004075.pub4&amp;doi=10.1002/14651858.CD004075.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004075.pub4&amp;doi=10.1002/14651858.CD004075.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004075.pub4&amp;doi=10.1002/14651858.CD004075.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004075.pub4&amp;doi=10.1002/14651858.CD004075.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004075.pub4&amp;doi=10.1002/14651858.CD004075.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004075.pub4&amp;doi=10.1002/14651858.CD004075.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004075.pub4&amp;doi=10.1002/14651858.CD004075.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004075.pub4&amp;doi=10.1002/14651858.CD004075.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004075.pub4&amp;doi=10.1002/14651858.CD004075.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004075.pub4&amp;doi=10.1002/14651858.CD004075.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004075.pub4&amp;doi=10.1002/14651858.CD004075.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004075.pub4&amp;doi=10.1002/14651858.CD004075.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004075.pub4&amp;doi=10.1002/14651858.CD004075.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004075.pub4&amp;doi=10.1002/14651858.CD004075.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004075.pub4&amp;doi=10.1002/14651858.CD004075.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004075.pub4&amp;doi=10.1002/14651858.CD004075.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004075.pub4&amp;doi=10.1002/14651858.CD004075.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004075.pub4&amp;doi=10.1002/14651858.CD004075.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004075.pub4&amp;doi=10.1002/14651858.CD004075.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004075.pub4&amp;doi=10.1002/14651858.CD004075.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004075.pub4&amp;doi=10.1002/14651858.CD004075.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="7a2tKMcJ";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD004075\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD004075\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004075\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004075\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","hr","fr","ja","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD004075.pub4",title:"Fetal pulse oximetry for fetal assessment in labour",firstPublishedDate:"Oct 7, 2014 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pregnancy and Childbirth Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=7a2tKMcJ&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004075.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004075.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD004075.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD004075.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004075.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD004075.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD004075.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD004075.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD004075.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD004075.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2520 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD004075.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004075.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004075.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004075.pub4/full#CD004075-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004075.pub4/full#CD004075-sec-0088"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004075.pub4/full#CD004075-sec-0022"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004075.pub4/full#CD004075-sec-0027"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004075.pub4/full#CD004075-sec-0028"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004075.pub4/full#CD004075-sec-0065"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004075.pub4/full#CD004075-sec-0082"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004075.pub4/appendices#CD004075-sec-0093"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/table_n/CD004075StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/table_n/CD004075StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004075.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004075.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004075.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004075.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004075.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD004075.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2014 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Fetal pulse oximetry for fetal assessment in labour</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004075.pub4/information#CD004075-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Christine E East</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004075.pub4/information#CD004075-cr-0003">Lisa Begg</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004075.pub4/information#CD004075-cr-0004">Paul B Colditz</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004075.pub4/information#CD004075-cr-0005">Rosalind Lau</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/information/en#CD004075-sec-0103">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 07 October 2014 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD004075.pub4">https://doi.org/10.1002/14651858.CD004075.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD004075-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004075-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004075-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004075-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD004075-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD004075-abs-0001" lang="en"> <section id="CD004075-sec-0001"> <h3 class="title" id="CD004075-sec-0001">Background</h3> <p>The use of conventional cardiotocographic (CTG) monitoring of fetal well‐being during labour is associated with an increased caesarean section rate, compared with intermittent auscultation of the fetal heart rate, resulting in a reduction in neonatal seizures, although no differences in other neonatal outcomes. To improve the sensitivity of this test and therefore reduce the number of caesarean sections performed for nonreassuring fetal status, several additional measures of evaluating fetal well‐being have been considered. These have demonstrated some effect on reducing caesarean section rates, for example, fetal scalp blood sampling for pH estimation/lactate measurement. The adaptation of pulse oximetry for use in the unborn fetus could potentially contribute to improved evaluation during labour and therefore lead to a reduction in caesarean sections for nonreassuring fetal status, without any change in neonatal outcomes. </p> </section> <section id="CD004075-sec-0002"> <h3 class="title" id="CD004075-sec-0002">Objectives</h3> <p>To compare the effectiveness and safety of fetal intrapartum pulse oximetry with other surveillance techniques. </p> </section> <section id="CD004075-sec-0003"> <h3 class="title" id="CD004075-sec-0003">Search methods</h3> <p>We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (31 May 2014), contacted experts in the field and searched reference lists of retrieved studies. In previous versions of this review, we performed additional searches of MEDLINE, Embase and Current Contents. These searches were discontinued for this review update, as they consistently failed to identify any trials that were not shown in the Cochrane Pregnancy and Childbirth Group's Trials Register. </p> </section> <section id="CD004075-sec-0004"> <h3 class="title" id="CD004075-sec-0004">Selection criteria</h3> <p>All published and unpublished randomised controlled trials that compared maternal and fetal outcomes when fetal pulse oximetry was used in labour, (i) with or without concurrent use of conventional fetal surveillance, that is, cardiotocography (CTG), compared with using CTG alone or (ii) with or without concurrent use of both CTG and other method(s) of fetal surveillance, such as fetal electrocardiography (ECG) plus CTG. </p> </section> <section id="CD004075-sec-0005"> <h3 class="title" id="CD004075-sec-0005">Data collection and analysis</h3> <p>At least two independent review authors performed data extraction. We sought additional information from the investigators of three of the reported trials. </p> </section> <section id="CD004075-sec-0006"> <h3 class="title" id="CD004075-sec-0006">Main results</h3> <p>We included seven published trials: six comparing fetal pulse oximetry and CTG with CTG alone (or when fetal pulse oximetry values were blinded) and one comparing fetal pulse oximetry plus CTG with fetal ECG plus CTG. The published trials, with some unpublished data, were at high risk of bias in terms of the impractical nature of blinding participants and clinicians, as well as high risk or unclear risk of bias for outcome assessor for all but one report. Selection bias, attrition bias, reporting bias and other sources of bias were of low or unclear risk. The trials reported on a total of 8013 pregnancies. Differing entry criteria necessitated separate analyses, rather than meta‐analysis of all trials. </p> <p>Systematic review of four trials from 34 weeks not requiring fetal blood sampling (FBS) prior to study entry showed no evidence of differences in the overall caesarean section rate between those monitored with fetal oximetry and those not monitored with fetal pulse oximetry or for whom the fetal pulse oximetry results were masked (average risk ratio (RR) 0.99 using random‐effects, 95% confidence intervals (CI) 0.86 to 1.13, n = 4008, I² = 45%). There was evidence of a higher risk of caesarean section in the group with fetal oximetry plus CTG than in the group with fetal ECG plus CTG (one study, n = 180, RR 1.56, 95% CI 1.06 to 2.29). Neonatal seizures and neonatal encephalopathy were rare in both groups. No studies reported details of long‐term disability. </p> <p>There was evidence of a decrease in caesarean section for nonreassuring fetal status in the fetal pulse oximetry plus CTG group compared to the CTG group, gestation from 34 weeks (average RR (random‐effects) 0.65, 95% CI 0.46 to 0.90, n = 4008, I² = 63%). There was no evidence of differences between groups in caesarean section for dystocia, although the overall incidence rates varied between the trials. </p> </section> <section id="CD004075-sec-0007"> <h3 class="title" id="CD004075-sec-0007">Authors' conclusions</h3> <p>The addition of fetal pulse oximetry does not reduce overall caesarean section rates. One study found a higher caesarean section rate in the group monitored with fetal pulse oximetry plus CTG, compared with fetal ECG plus CTG. The data provide limited support for the use of fetal pulse oximetry when used in the presence of a nonreassuring CTG, to reduce caesarean section for nonreassuring fetal status. A better method than pulse oximetry is required to enhance the overall evaluation of fetal well‐being in labour. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD004075-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004075-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004075-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004075-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD004075-abs-0007">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD004075-abs-0006">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD004075-abs-0009">日本語</a> </li> <li class="section-language"> <a class="" href="full/ru#CD004075-abs-0005">Русский</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD004075-abs-0004" lang="en"> <h3>Fetal pulse oximetry for fetal assessment in labour</h3> <p>Using fetal pulse oximetry to assess the baby's well‐being during labour does not change overall caesarean section rates. </p> <p>During labour, the well‐being of the baby can be assessed intermittently using a Pinard stethoscope or hand‐held monitor to listen to the heart rate, or continuously using cardiotocography (CTG), sometimes called electronic fetal monitoring (EFM). There are also additional tests that can be used if the baby is thought to be getting short of oxygen, like testing the baby's blood in a sample taken from the baby's head or bottom, or through the recording of the electrical activity of the heart using an electrocardiogram (ECG). Fetal pulse oximetry measures how much oxygen the baby's blood is carrying. It uses a probe that sits on the baby's head whilst in the uterus and vagina during labour. The probe is said not to interfere with the woman's mobility during labour. This review looked at fetal pulse oximetry and found trials that used it in conjunction with a CTG. We compared the outcomes for this combined oximetry and CTG, with outcomes where only the CTG had been used, or a combination of CTG and fetal ECG had been used. </p> <p>The review identified seven trials involving 8013 women. Fetal pulse oximetry plus CTG showed no difference in caesarean section rates overall, nor any difference in the mother's or newborn's health, compared with CTG alone. If there was concern about the baby's well‐being before the fetal pulse oximetry probe was placed, the use of fetal pulse oximetry reduced caesarean sections performed for the baby's well‐being. The one trial of oximetry with CTG compared with CTG and fetal ECG showed an increase in the caesarean rate in the oximetry group. In two of the trials, the company making the fetal pulse oximetry machines provided some funding. A better method than fetal pulse oximetry is needed for checking on the well‐being of the baby during labour. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD004075-sec-0088" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD004075-sec-0088"></div> <h3 class="title" id="CD004075-sec-0089">Implications for practice</h3> <section id="CD004075-sec-0089"> <p>This systematic review, comparing fetal intrapartum pulse oximetry with CTG or fetal electrocardiography or masked fetal pulse oximetry, provided evidence of no effect on the overall caesarean section rate between the fetal pulse oximetry group and the CTG group. There was evidence of some effect in reducing caesarean section rates for the indication of nonreassuring CTG when fetal pulse oximetry was added to CTG. Therefore, the evidence suggests that fetal pulse oximetry does not contribute to overall clinical practice. A better method to evaluate fetal well‐being in labour is required. </p> </section> <h3 class="title" id="CD004075-sec-0090">Implications for research</h3> <section id="CD004075-sec-0090"> <p>Further trials could address: entry criteria related to the severity of nonreassuring CTG patterns; action levels for fetal pulse oximetry values, such as a decline by 10% or 20%, rather than an absolute cut‐off value; and the endpoint of long‐term neurodevelopmental outcomes. The ideal study to address the issue of dystocia when a fetal pulse oximetry sensor is placed alongside the fetal head would compare caesarean section for dystocia in three groups: those with fetal oximetry displayed, those with fetal pulse oximetry masked and those without fetal pulse oximetry. Further studies using fetal oximetry sensors attached to the fetal scalp, rather than placed alongside the fetal head, could also be considered. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD004075-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD004075-sec-0022"></div> <section id="CD004075-sec-0023"> <h3 class="title" id="CD004075-sec-0023">Description of the condition</h3> <p>Cardiotocography (CTG) was introduced in the 1960s with the aim of improving neonatal outcomes by improving intrapartum fetal surveillance. The uterine contractions and the fetal heart rate, variability, decelerations and accelerations influence the way these patterns are classified. Terms in use include normal, reassuring, nonreassuring, indeterminate, suspicious, abnormal, pathological and preterminal (<a href="./references#CD004075-bbs2-0010" title="ACOG Committee on Obstetric Practice. Fetal pulse oximetry. ACOG Committee Opinion No 258. Obstetrics &amp; Gynecology2001;98:523‐4. ">ACOG 2001</a>; <a href="./references#CD004075-bbs2-0028" title="FIGO subcommittee on Standards in Perinatal Medicine. Guidelines for the use of fetal monitoring. International Journal of Gynecology and Obstetrics1987;25(2):159‐67. ">FIGO 1987</a>; <a href="./references#CD004075-bbs2-0039" title="National Institute for Health and Clinical Excellence. Intrapartum Care: Care of Healthy Women and their Babies During Childbirth. NICE Clinical Guideline 55. Manchester: National Collaborating Centre for Women's and Children's Health, 2007. ">NICE 2007</a>; <a href="./references#CD004075-bbs2-0046" title="Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Clinical Guidelines. Intrapartum Fetal Surveillance. Third Edition. Melbourne: RANZCOG, 2014. ">RANZCOG 2014</a>). In this review, we refer to the terms reassuring, nonreassuring or abnormal. Reassuring patterns require no specific action. Nonreassuring patterns occur in about 15% to 19% of labours monitored by CTG (<a href="./references#CD004075-bbs2-0003" title="ColditzPB , EastCE . PTO360. Fetal intrapartum pulse oximetry: a multicentre randomised controlled trial. Perinatal Trials Report. www.ctc.usyd.edu.au/6registry/PTO360.htm (accessed 3 Feb 2004). EastC , ChanFY , BrenneckeS , KingJ , ColditzP , the Foremost Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S102. EastC , GascoineM , DoranC , BrenneckeS , KingJ , ColditzP , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomized controlled trial (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S101. EastCE , BrenneckeSP , ChanFY , KingJF , BellerEM , ColditzPB . Clinicians' evaluations of fetal oximetry sensor placement in a multicentre randomised trial (the foremost trial). Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2006;46(3):234‐9. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a nonreassuring fetal heart rate pattern, on operative delivery rates: a multicenter, randomized, controlled trial (the FOREMOST trial). American Journal of Obstetrics and Gynecology2006;194(3):606.e1‐16. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST study group. Fetal pulse oximetry clinical trial (the FOREMOST trial). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:166. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a non‐reassuring fetal heart rate pattern, on operative delivery rates: a multicenter randomized controlled trial (The FOREMOST Trial). American Journal of Obstetrics and Gynecology. 2005; Vol. 193, issue 6 Suppl:S33. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (the FOREMOST trial). Birth2006;33(2):101‐9. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST study group. Childbearing women's experience in the FOREMOST trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:365. EastCE , GascoigneMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomised controlled trial (the FOREMOST trial). BJOG: an international journal of obstetrics and gynaecology2006;113:1080‐7. EastCE , GasgoineMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. Cost‐effectiveness of fetal pulse oximetry (FOREMOST). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:202. ">East 2006</a>; <a href="./references#CD004075-bbs2-0054" title="UmstadMP . The predictive value of abnormal fetal heart rate patterns in early labour. Australian and New Zealand Journal of Obstetrics and Gynaecology1993;33:145‐9. ">Umstad 1993</a>) and may prompt clinical actions ranging from simple manoeuvres, such as a change of maternal position, through to expedited birth of the baby (vacuum, forceps, caesarean section). Abnormal patterns usually prompt expedited birth with the aim of preventing or minimising hypoxia in the fetus. The positive predictive value of CTG for adverse outcome is low and the negative predictive value high (<a href="./references#CD004075-bbs2-0041" title="NonnenmacherA , HoppH , DudenhausenJ . Predictive value of pulse oximetry for the development of fetal acidosis. Journal of Perinatal Medicine2010;38:83‐6. [DOI: 10.1515/JPM.2010.006] ">Nonnenmacher 2010</a>), although this is improving with computerised interpretation of CTGs (<a href="./references#CD004075-bbs2-0017" title="CostaA , SantosC , Ayres‐de‐CamposD , CostaC , BernardesJ . Access to computerised analysis of intrapartum cardiotocographs improves clinicians' prediction of newborn umbilical artery blood pH. BJOG: an international journal of obstetrics and gynaecology2010;117(10):1288‐93. ">Costa 2010</a>). Thus, while a normal CTG usually indicates reassuring fetal status, a nonreassuring or abnormal CTG does not necessarily equate with 'fetal distress'. These features, combined with marked inter‐observer variation in CTG interpretation by midwives (<a href="./references#CD004075-bbs2-0018" title="DevaneD , LalorJ . Midwives' visual interpretation of intrapartum cardiotocographs: intra‐ and inter‐observer agreement. Journal of Advanced Nursing2005;52(2):133‐41. ">Devane 2005</a>) and doctors (<a href="./references#CD004075-bbs2-0042" title="PalomakiO , LuukkaalaT , LuotoR , TuimalR . Intrapartum cardiotocography ‐ the dilemma of interpretational variation. Journal of Perinatal Medicine2006;34(4):298‐302. ">Palomaki 2006</a>), result in variable but inappropriately high operative birth rates for nonreassuring fetal status in many hospitals. Electronic fetal monitoring rapidly gained widespread acceptance for monitoring the fetal heart rate during labour, but it was not until the 1970s that randomised controlled trials were conducted to assess the benefits of this technology. A Cochrane systematic review found that the use of electronic monitoring increased the odds of having a caesarean section, compared to intermittent auscultation of the fetal heart (<a href="./references#CD004075-bbs2-0011" title="AlfirevicZ , DevaneD , GyteGML . Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour. Cochrane Database of Systematic Reviews2013, Issue 5. [DOI: 10.1002/14651858.CD006066.pub2] ">Alfirevic 2013</a>). Despite these shortcomings, cardiotocography remains a widely used means of assessing fetal well‐being during labour. One conclusion of the systematic review of CTG monitoring was to consider how best to convey the uncertainty of the benefits of such monitoring to enable women to make an informed choice, while not compromising labour normality (<a href="./references#CD004075-bbs2-0011" title="AlfirevicZ , DevaneD , GyteGML . Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour. Cochrane Database of Systematic Reviews2013, Issue 5. [DOI: 10.1002/14651858.CD006066.pub2] ">Alfirevic 2013</a>). The National Institute for Health and Clinical Excellence (<a href="./references#CD004075-bbs2-0039" title="National Institute for Health and Clinical Excellence. Intrapartum Care: Care of Healthy Women and their Babies During Childbirth. NICE Clinical Guideline 55. Manchester: National Collaborating Centre for Women's and Children's Health, 2007. ">NICE 2007</a>) suggested that, as for all aspects of care, the woman herself should be involved in decision‐making for choice of fetal monitoring, with adequate access to evidence‐based information; and recommended that electronic monitoring be offered where there is an increased risk of perinatal death, neonatal encephalopathy or cerebral palsy, and during labours induced or augmented by oxytocin. </p> <p>Once a nonreassuring fetal heart rate pattern has been identified, a number of additional assessments of fetal well‐being may be considered. These do not replace the CTG, but are usually used as complementary to it, either intermittently or continuously. One example is fetal scalp blood sampling for pH or lactate analysis. A low pH (for example, less than 7.20) or a high lactate (for example greater than 4.8 mmol/L) may be considered abnormal (<a href="./references#CD004075-bbs2-0033" title="KrugerK , HallbergB , BlennowM , KublickasM , WestgrenM . Predictive value of fetal scalp blood lactate concentration and pH as markers of neurological disability. American Journal of Obstetrics and Gynecology1999;181(5 Pt 1):1072‐8. ">Kruger 1999</a>). The addition of fetal scalp blood sampling to standard electronic monitoring reduces the odds for caesarean section, although the odds are not significantly different compared to intermittent auscultation of the fetal heart (<a href="./references#CD004075-bbs2-0011" title="AlfirevicZ , DevaneD , GyteGML . Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour. Cochrane Database of Systematic Reviews2013, Issue 5. [DOI: 10.1002/14651858.CD006066.pub2] ">Alfirevic 2013</a>). Another example is fetal electrocardiogram (ECG), which measures fetal ST interval and the changes in the T/QRS ratio. An elevation of the ST segment and the ratio between the T wave and QRS amplitudes (T/QRS), identifies fetal anaerobic myocardial metabolism (<a href="./references#CD004075-bbs2-0048" title="RosėnKG , Amer‐WåhlinI , LuziettiR , NorėnH . Fetal ECG waveform analysis. Clinical Obstetrics and Gynaecology2004;18(3):485‐514. ">Rosėn 2004</a>). A Cochrane systematic review of the addition of fetal electrocardiogram monitoring reported no evidence of a difference in overall caesarean section rate when compared to electronic monitoring only (<a href="./references#CD004075-bbs2-0037" title="NeilsonJP . Fetal electrocardiogram (ECG) for fetal monitoring during labour. Cochrane Database of Systematic Reviews2013, Issue 5. [DOI: 10.1002/14651858.CD000116.pub4] ">Neilson 2013</a>). <a href="./references#CD004075-bbs2-0019" title="DokusK , ZuborP , MatasovaK , VisnovskyJ , DankoJ . Impact of fetal pulse oximetry and ST analysis surveillance withdrawal on rates of obstetric surgery and frequency of low birth umbilical artery pH: A cause of rising caesarean rates?. Journal of Obstetrics and Gynaecology2013;33(7):685‐8. ">Dokus 2013</a> considered the potential impact of the declining clinical use of fetal ECG and fetal pulse oximetry (described below), noting that the overall caesarean section rate increased when either fetal ECG or fetal pulse oximetry were no longer available for use (total n = 13,413). Cochrane systematic reviews of vibroacoustic stimulation (VAS) or fetal scalp blood sampling for lactate measurement as additional fetal assessments in labour were unable to identify randomised controlled trials that compared these interventions with no intervention (<a href="./references#CD004075-bbs2-0026" title="EastCE , LeaderLR , SheehanP , HenshallNE , ColditzPB . Intrapartum fetal scalp lactate sampling for fetal assessment in the presence of a non‐reassuring fetal heart rate trace. Cochrane Database of Systematic Reviews2010, Issue 3. [DOI: 10.1002/14651858.CD006174.pub2] ">East 2010</a>; <a href="./references#CD004075-bbs2-0027" title="EastCE , SmythRMD , LeaderLR , HenshallNE , ColditzPB , LauR , et al. Vibroacoustic stimulation for fetal assessment in labour in the presence of a nonreassuring fetal heart rate trace. Cochrane Database of Systematic Reviews2013, Issue 1. [DOI: 10.1002/14651858.CD004664.pub3] ">East 2013</a>). </p> </section> <section id="CD004075-sec-0024"> <h3 class="title" id="CD004075-sec-0024">Description of the intervention</h3> <p>Fetal pulse oximetry aims to improve the accuracy of the evaluation of fetal well‐being during labour (<a href="./references#CD004075-bbs2-0015" title="ColditzPB , BeggLM , EastCE . Fetal pulse oximetry: instrumentation and recent clinical experience. Clinics in Perinatology1999;26:869‐80. ">Colditz 1999</a>; <a href="./references#CD004075-bbs2-0016" title="ColdtizPB , EastCE . Fetal pulse oximetry. In: GinosarY , ReynoldsF , HalpernS , WeinerCP editor(s). Anesthesia and the Fetus. Oxford: Wiley‐Blackwell, 2013:123‐8. [DOI: 10.1002/9781118477076] ">Coldtiz 2013</a>; <a href="./references#CD004075-bbs2-0024" title="EastCE , ColditzPB . Intrapartum oximetry of the fetus. Anesthesia &amp; Analgesia2007;105(6):S59‐S65. ">East 2007a</a>). It is generally reserved for use when a nonreassuring CTG has been recorded, to assist in identifying those fetuses that may benefit from further intervention (<a href="./references#CD004075-bbs2-0022" title="EastCE , ColditzPB , BeggLM , BrenneckeSP . Update on intrapartum fetal pulse oximetry. Australian and New Zealand Journal of Obstetrics and Gynaecology2002;42(2):119‐23. ">East 2002</a>; <a href="./references#CD004075-bbs2-0025" title="EastCE . Fetal pulse oximetry during labor: theory, clinical use and the future. Pediatric Health2008;2(6):787‐95. ">East 2008</a>) and as an adjunct to, rather than replacement of, the CTG monitor. This method has two potential advantages over conventional fetal heart rate monitoring: (i) it directly measures the proportion of haemoglobin that is carrying oxygen: thus, oxygenation, the primary variable underlying the tissue damaging effects of hypoxia/ischaemia is being monitored; and (ii) it relies on an established, safe, noninvasive, widely‐used technology found in every modern intensive care unit and operating theatre. Inaccurate oxygen saturation readings can occur with conditions that decrease arterial blood perfusion, for instance, they can occur with venous pulsations, excessive movement, intravenous pigmented dyes, and abnormal haemoglobin (<a href="./references#CD004075-bbs2-0014" title="ChanED , ChanMM , ChanMM . Pulse oximetry: understanding its basic principles facilitates appreciation of its limitations. Respiratory Medicine2013;107:789‐99. ">Chan 2013</a>). A variety of fetal pulse oximetry sensors has been studied. These are placed during a vaginal examination to attach to the top of the fetal head by suction (<a href="./references#CD004075-bbs2-0013" title="ArikanGM , ScholzHS , HaeuslerMCH , GiulianiA , HaasJ , WeissPAM . Low fetal oxygen saturation at birth and acidosis. Obstetrics &amp; Gynecology2000;95:565‐71. ">Arikan 2000</a>) or clip (<a href="./references#CD004075-bbs2-0032" title="KnitzaR , RallG , SchallerN , KolbenM . First results of a pilot study with the FetalSAT fetal pulse oximetry system [Erste ergebnisse einer pilostudie mit dem FetalSAT pulsoximetriesystem]. Geburtshilfe und Frauenheilkunde2004;64(6):600‐5. ">Knitza 2004</a>), lie against the fetal temple or cheek (<a href="./references#CD004075-bbs2-0036" title="MallinckrodtInc . OxiFirst (TM) Fetal Oxygen Saturation Monitoring System. Operator's Manual. N‐400 Fetal Pulse Oximeter. Pleasanton, CA USA: Mallinckrodt Inc, 2000. ">Mallinckrodt 2000</a>; <a href="./references#CD004075-bbs2-0038" title="Nellcor Puritan Bennett Inc (A division of TYCO Healthcare). OxiFirst® Fetal Pulse Oximetry System. http://www.nellcor.com(accessed 2004). ">Nellcor 2004</a>), or to lie along the fetal back (<a href="./references#CD004075-bbs2-0045" title="OBScientific . OBS‐500 Fetal pulse oximeter. Correspondence from Prothia (accessed April 3 2014). ">Prothia 2014</a>). The sensor remains in situ and fetal pulse oximetry values are recorded for approximately 81% of the monitoring time (<a href="./references#CD004075-bbs2-0021" title="EastCE , DunsterKR , ColditzPB , NathCE , EarlJW . Fetal oxygen saturation monitoring in labour: an analysis of 118 cases. Australian and New Zealand Journal of Obstetrics and Gynaecology1997;37(4):397‐401. ">East 1997</a>). Women have rated their experience with fetal oximetry during observational studies. One survey included questions about the woman's perceived level of comfort during sensor placement, mobility with the sensor in place and ongoing comfort with the sensor in place: these factors were all rated favourably by the women (<a href="./references#CD004075-bbs2-0020" title="EastCE , ColditzPB . Women's evaluations of their experience with fetal intrapartum oxygen saturation monitoring and participation in a research project. Midwifery1996;12:93‐7. ">East 1996</a>). <a href="./references#CD004075-bbs2-0012" title="ArikanGM , HaeuslerMCH , DeutschMR , GreimelER , DorferM . Maternal perceptions of labor with fetal monitoring by pulse oximetry in a research setting. Birth1998;25(3):182‐9. ">Arikan 1998</a> reported that the majority of women did not consider that a fetal oximetry sensor restricted their movement during labour. </p> </section> <section id="CD004075-sec-0025"> <h3 class="title" id="CD004075-sec-0025">How the intervention might work</h3> <p>Results of animal and human research suggest that when using sensors calibrated for the fetal environment, fetal oximetry values greater than or equal to 30% are considered reassuring, even when the CTG is nonreassuring, while values less than 30% warrant consideration of interventions, ranging from maternal position change, through to urgent birth via caesarean section (<a href="./references#CD004075-bbs2-0034" title="KuhnertM , Seelbach‐GoebelB , DiRenzoGC , HowarthE , ButterweggeM , MurayJM . Guidelines for the use of fetal pulse oximetry during labour and delivery. Prenatal and Neonatal Medicine1998;3(4):432‐3. ">Kuhnert 1998</a>; <a href="./references#CD004075-bbs2-0040" title="NijlandR , JongsmaHW , NijhuisJG , van denBergPP , OeseburgB . Arterial oxygen saturation in relation to metabolic acidosis in fetal lambs. American Journal of Obstetrics and Gynecology1995;172:810‐9. ">Nijland 1995</a>; <a href="./references#CD004075-bbs2-0050" title="Seelbach‐GobelB , HeupelM , KuhnertM , ButterweggeM . The prediction of fetal acidosis by means of intrapartum fetal pulse oximetry. American Journal of Obstetrics and Gynecology1999;180:73‐81. ">Seelbach‐Gobel 1999</a>). A prospective, observational cohort study investigating relationship between oxygen saturation using pulse oximetry and umbilical cord arterial pH values in healthy newborns during the first 15 minutes of life found a significant correlation between both preductal and postductal oxygen saturation levels and umbilical arterial blood pH values (<a href="./references#CD004075-bbs2-0055" title="UsluS , BulbulA , CanE , ZubariogluU , SalihogluO , Nuhoglu , A . Relationship between oxygen saturation and umbilical cord pH immediately after birth. Pediatrics and Neonatology2012;53:340‐5. ">Uslu 2012</a>). A prospective observational study found a low pulse oximetry oxygen saturation &lt; 30% for at least 10 minutes correlates highly with fetal acidosis in cases of nonreassuring fetal heart rate (<a href="./references#CD004075-bbs2-0041" title="NonnenmacherA , HoppH , DudenhausenJ . Predictive value of pulse oximetry for the development of fetal acidosis. Journal of Perinatal Medicine2010;38:83‐6. [DOI: 10.1515/JPM.2010.006] ">Nonnenmacher 2010</a>). A novel fetal phantom based on actual fetal parameters showed that the wireless oximeter was capable of identifying 4% and 2% changes in diameter between the diastolic and systolic point in arteries of over 0.2 and 0.4 mm inner diameter, respectively (<a href="./references#CD004075-bbs2-0053" title="StubánN , NiwayamaM . Adjustable fetal phantom for pulse oximetry. Review of Scientific Instruments2009;80(5):054301. [DOI: 10.1063/1.3131632] ">Stubán 2009</a>). One manufacturer recommends this technology for singleton pregnancies only (<a href="./references#CD004075-bbs2-0038" title="Nellcor Puritan Bennett Inc (A division of TYCO Healthcare). OxiFirst® Fetal Pulse Oximetry System. http://www.nellcor.com(accessed 2004). ">Nellcor 2004</a>). Consideration for monitoring multiple pregnancies by monitoring the first fetus during labour, then the second or subsequent fetuses following birth of the preceding fetus may be possible. </p> </section> <section id="CD004075-sec-0026"> <h3 class="title" id="CD004075-sec-0026">Why it is important to do this review</h3> <p>The value of any fetal monitoring system during labour, including the CTG or any additional surveillance, is usually expressed by its ability to predict which fetuses are hypoxic or acidotic. Measures of this may include umbilical cord blood gases (including base excess values less than or equal to 12 mmol/L and pH values less than 7.00 (<a href="./references#CD004075-bbs2-0051" title="SehdevHM , StamilioDM , MaconesGA , GrahamE , MorganMA . Predictive factors for neonatal morbidity in neonates with an umbilical arterial cord pH less than 7.00. American Journal of Obstetrics and Gynecology1997;177(5):1030‐4. ">Sehdev 1997</a>), or less than 7.10 (<a href="./references#CD004075-bbs2-0013" title="ArikanGM , ScholzHS , HaeuslerMCH , GiulianiA , HaasJ , WeissPAM . Low fetal oxygen saturation at birth and acidosis. Obstetrics &amp; Gynecology2000;95:565‐71. ">Arikan 2000</a>) or lactate values &gt; 6.1 mmol/L (<a href="./references#CD004075-bbs2-0057" title="WhiteCRH , DohertyDA , HendersonJJ , KohanR , NewhamJP , PennellCE . Benefits of introducing universal umbilical cord blood gas and lactate analysis into an obstetric unit. Australian and New Zealand Journal of Obstetrics and Gynaecology2010;50:318‐28. ">White 2010</a>); or clinical outcomes including Apgar scores (an assessment of neonatal condition shortly after birth, usually at one and five minutes: Apgar scores of less than seven at five minutes or later are nonspecific but may be associated with hypoxia (<a href="./references#CD004075-bbs2-0035" title="MacLennanA , for the International Cerebral Palsy Task Force. A template for defining a causal relationship between acute intrapartum events and cerebral palsy: an international consensus statement. BMJ1999;319:1054‐9. ">MacLennan 1999</a>; <a href="./references#CD004075-bbs2-0051" title="SehdevHM , StamilioDM , MaconesGA , GrahamE , MorganMA . Predictive factors for neonatal morbidity in neonates with an umbilical arterial cord pH less than 7.00. American Journal of Obstetrics and Gynecology1997;177(5):1030‐4. ">Sehdev 1997</a>)); or abnormal neurological status of the baby, possibly caused by lack of oxygen or blood supply (hypoxic‐ischaemic encephalopathy), or both. Other outcomes of interest may include fetal/maternal infections, for example of the membranes (chorioamnionitis), or the uterine lining (endometritis). Interventions resulting from such tests are also important. For example, it is important to note not only overall modes of birth following different forms of monitoring, but also specific interventions, such as operative birth (vacuum, forceps and caesarean section) for the indication of nonreassuring fetal status, since nonreassuring fetal status is what the monitoring is intended to discern. In the longer term, such interventions may also impact on future pregnancies. For example, the likelihood of a successful vaginal birth after caesarean (VBAC) in a subsequent pregnancy is improved for women whose previous caesarean was performed for the indication of nonreassuring fetal status, compared with those where the previous caesarean was performed for dystocia (<a href="./references#CD004075-bbs2-0029" title="GrinsteadJ , GrobmanWA . Induction of labor after one prior cesarean: predictors of vaginal delivery. Obstetrics &amp; Gynecology2004;103(3):534‐8. ">Grinstead 2004</a>; <a href="./references#CD004075-bbs2-0052" title="ShippTD , ZelopCM , RepkeJT , CohenA , CaugheyA , LiebermanE . Labor after previous cesarean: influence of prior indication and parity. Obstetrics &amp; Gynecology2000;95:913‐6. ">Shipp 2000</a>). Successful VBAC in a subsequent pregnancy will also have economic benefits, with vaginal births costing the health system considerably less than caesarean sections (<a href="./references#CD004075-bbs2-0030" title="HendersonJ , McCandlishR , KumiegaL , PetrouS . Systematic review of economic aspects of alternative modes of delivery. BJOG: an international journal of obstetrics and gynaecology2001;108(2):149. ">Henderson 2001</a>; <a href="./references#CD004075-bbs2-0043" title="PetrouS , GlazenerC . The economic costs of alternative modes of delivery during the first two months postpartum: results from a Scottish observational study. BJOG: an international journal of obstetrics and gynaecology2002;109(2):214‐7. ">Petrou 2002</a>). </p> <p>This review was undertaken to evaluate the clinical effectiveness and safety of fetal pulse oximetry to assess fetal well‐being in labour. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD004075-sec-0027" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD004075-sec-0027"></div> <p>To compare the effectiveness and safety of fetal intrapartum pulse oximetry with conventional fetal surveillance techniques, using the results of randomised controlled trials. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD004075-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD004075-sec-0028"></div> <section id="CD004075-sec-0029"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD004075-sec-0030"> <h4 class="title">Types of studies</h4> <p>All published and unpublished individual‐ or cluster‐randomised and quasi‐randomised trials with reported data that compared maternal and fetal/neonatal/infant outcomes when fetal pulse oximetry was used in labour, with or without concurrent use of conventional fetal surveillance, compared with the use of conventional fetal surveillance techniques alone. </p> <p>Cross‐over studies are unlikely to be appropriate for testing this intervention and therefore would be excluded if identified. We also excluded studies that are only available in abstract form. </p> </section> <section id="CD004075-sec-0031"> <h4 class="title">Types of participants</h4> <p>Women in labour with a live baby where fetal monitoring is clinically indicated.</p> </section> <section id="CD004075-sec-0032"> <h4 class="title">Types of interventions</h4> <p>Use of fetal pulse oximetry compared with not using fetal pulse oximetry, with or without concurrent use of conventional fetal monitoring (fetal heart rate monitoring by intermittent auscultation, intermittent/continuous cardiotocography, fetal electrocardiography [added in this review update], or fetal blood sampling (FBS) for blood gas analysis). </p> </section> <section id="CD004075-sec-0033"> <h4 class="title">Types of outcome measures</h4> <section id="CD004075-sec-0034"> <h5 class="title">Primary outcomes</h5> <p>(1) Caesarean section<br/> (2) Hypoxic‐ischaemic encephalopathy<br/> (3) Neonatal seizures<br/> (4) Long‐term neurodevelopmental outcome </p> </section> <section id="CD004075-sec-0035"> <h5 class="title">Secondary outcomes</h5> <section id="CD004075-sec-0036"> <h6 class="title">Maternal</h6> <p>(5) Caesarean section for nonreassuring fetal status<br/> (6) Caesarean section for dystocia (added since the protocol and original review were first published)<br/> (7) Overall operative birth (caesarean section, forceps, vacuum extraction) for all indications<br/> (8) Overall operative birth (caesarean section, forceps, vacuum extraction) for nonreassuring fetal status<br/> (9) Use of intrapartum antibiotics<br/> (10) Overall antibiotic use<br/> (11) Intrapartum haemorrhage<br/> (12) Postpartum haemorrhage<br/> (13) Chorioamnionitis<br/> (14) Endometritis (added since the protocol was first published)<br/> (15) Uterine rupture<br/> (16) Length of hospital stay<br/> (17) Satisfaction with labour<br/> (18) Satisfaction with fetal monitoring in labour<br/> (19) Death </p> </section> <section id="CD004075-sec-0037"> <h6 class="title">Fetal/neonatal</h6> <p>(20) Skin trauma<br/> (21) Apgar scores less than four at five minutes<br/> (22) Apgar scores less than seven at five minutes<br/> (23) Umbilical arterial pH less than 7.10<br/> (24) Umbilical arterial base excess less than ‐12<br/> (25) Admission to neonatal intensive care unit<br/> (26) Length of hospital stay<br/> (27) Death<br/> (28) Death, hypoxic‐ischaemic encephalopathy, or both<br/> (29) Death, seizures, or both<br/> (30) Death, long‐term neurodevelopmental problem, or both </p> </section> </section> </section> </section> <section id="CD004075-sec-0038"> <h3 class="title">Search methods for identification of studies</h3> <p>The following methods section of this review is based on a standard template used by the Cochrane Pregnancy and Childbirth Group. </p> <section id="CD004075-sec-0039"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Pregnancy and Childbirth Group's Trials Register by contacting the Trials Search Co‐ordinator (31 May 2014). </p> <p>The Cochrane Pregnancy and Childbirth Group’s Trials Register is maintained by the Trials Search Co‐ordinator and contains trials identified from: </p> <p> <ol id="CD004075-list-0001"> <li> <p>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</p> </li> <li> <p>weekly searches of MEDLINE;</p> </li> <li> <p>weekly searches of Embase;</p> </li> <li> <p>handsearches of 30 journals and the proceedings of major conferences;</p> </li> <li> <p>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts. </p> </li> </ol> </p> <p>Details of the search strategies for CENTRAL, MEDLINE and Embase, the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service can be found in the ‘Specialized Register’ section within the editorial information about the <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html" target="_blank">Cochrane Pregnancy and Childbirth Group</a>. </p> <p>Trials identified through the searching activities described above are each assigned to a review topic (or topics). The Trials Search Co‐ordinator searches the register for each review using the topic list rather than keywords. </p> <p>In previous editions of this review, we searched MEDLINE, Embase and Current Contents. The Cochrane Pregnancy and Childbirth Group’s Trials Register reliably records all trials that would have been identified in these additional databases. We have therefore only searched the Cochrane Pregnancy and Childbirth Group’s Trials Register for this update. <i>See:</i><a href="./appendices#CD004075-sec-0094">Appendix 1</a> for the search strategy used in previous editions of this review. </p> </section> <section id="CD004075-sec-0040"> <h4 class="title">Searching other resources</h4> <p>We also sought ongoing and unpublished trials by contacting experts in the field.</p> <p>We did not apply any language restrictions.</p> </section> </section> <section id="CD004075-sec-0041"> <h3 class="title" id="CD004075-sec-0041">Data collection and analysis</h3> <p>For the methods used when assessing the trials identified in the previous version of this review, <i>see</i><a href="./references#CD004075-bbs2-0060" title="EastCE , BeggL , ColditzPB . Fetal pulse oximetry for fetal assessment in labour. Cochrane Database of Systematic Reviews2007, Issue 2. [DOI: 10.1002/14651858.CD004075.pub3] ">East 2007</a>. </p> <p>For this update we used the following methods when assessing the reports identified by the updated search. </p> <p>The following methods section of this review is based on a standard template used by the Cochrane Pregnancy and Childbirth Group. </p> <section id="CD004075-sec-0042"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently assessed for inclusion all the potential studies we identified as a result of the search strategy ‐ all authors participated in these assessments for the range of studies identified, with two allocated per study. We resolved any disagreements through discussion. If it had been required, we would have consulted a third person. </p> </section> <section id="CD004075-sec-0043"> <h4 class="title">Data extraction and management</h4> <p>We designed a form to extract data. For eligible studies, two review authors extracted the data using the agreed form ‐ all authors participated in data extraction for the range of included studies, with two allocated per study. We resolved discrepancies through discussion. If required, we planned to consult a third person. We entered data into Review Manager software (<a href="./references#CD004075-bbs2-0047" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>) and checked for accuracy. </p> <p>When information regarding any of the above was unclear, we attempted to contact authors of the original reports to provide further details. </p> </section> <section id="CD004075-sec-0044"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently assessed risk of bias for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD004075-bbs2-0031" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). All authors participated in assessment of risk of bias of the range of included studies, with two allocated per study. We resolved any disagreement by discussion. Had it been required, we would have involved a third assessor. </p> <section id="CD004075-sec-0045"> <h5 class="title">(1) Random sequence generation (checking for possible selection bias)</h5> <p>We described for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it produced comparable groups. </p> <p>We assessed the method as:</p> <p> <ul id="CD004075-list-0002"> <li> <p>low risk of bias (any truly random process, e.g. random number table; computer random number generator); </p> </li> <li> <p>high risk of bias (any non‐random process, e.g. odd or even date of birth; hospital or clinic record number); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD004075-sec-0046"> <h5 class="title">(2) Allocation concealment (checking for possible selection bias)</h5> <p>We described for each included study the method used to conceal allocation to interventions prior to assignment and assessed whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment. </p> <p>We assessed the methods as:</p> <p> <ul id="CD004075-list-0003"> <li> <p>low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes); </p> </li> <li> <p>high risk of bias (open random allocation; unsealed or non‐opaque envelopes, alternation; date of birth); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD004075-sec-0047"> <h5 class="title">(3.1) Blinding of participants and personnel (checking for possible performance bias)</h5> <p>We described for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We considered that studies were at low risk of bias if they were blinded, or if we judged that the lack of blinding would be unlikely to affect results. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed the methods as:</p> <p> <ul id="CD004075-list-0004"> <li> <p>low, high or unclear risk of bias for participants;</p> </li> <li> <p>low, high or unclear risk of bias for personnel.</p> </li> </ul> </p> </section> <section id="CD004075-sec-0048"> <h5 class="title">(3.2) Blinding of outcome assessment (checking for possible detection bias)</h5> <p>We described for each included study the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed methods used to blind outcome assessment as:</p> <p> <ul id="CD004075-list-0005"> <li> <p>low, high or unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD004075-sec-0049"> <h5 class="title">(4) Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data) </h5> <p>We described for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We stated whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported, or could be supplied by the trial authors, we re‐included missing data in the analyses which we undertook. </p> <p>We assessed methods as:</p> <p> <ul id="CD004075-list-0006"> <li> <p>low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups); </p> </li> <li> <p>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; ‘as treated’ analysis done with substantial departure of intervention received from that assigned at randomisation); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> <p>As per the original protocol, we made an <i>a priori</i> decision to exclude trials where outcome data were unavailable for more than 20% of participants. </p> </section> <section id="CD004075-sec-0050"> <h5 class="title">(5) Selective reporting (checking for reporting bias)</h5> <p>We described for each included study how we investigated the possibility of selective outcome reporting bias and what we found. </p> <p>We assessed the methods as:</p> <p> <ul id="CD004075-list-0007"> <li> <p>low risk of bias (where it is clear that all of the study’s pre‐specified outcomes and all expected outcomes of interest to the review have been reported); </p> </li> <li> <p>high risk of bias (where not all the study’s pre‐specified outcomes have been reported; one or more reported primary outcomes were not pre‐specified; outcomes of interest are reported incompletely and so cannot be used; study fails to include results of a key outcome that would have been expected to have been reported); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD004075-sec-0051"> <h5 class="title">(6) Other bias (checking for bias due to problems not covered by (1) to (5) above)</h5> <p>We described for each included study any important concerns we have about other possible sources of bias. </p> <p>We assessed whether each study was free of other problems that could put it at risk of bias: </p> <p> <ul id="CD004075-list-0008"> <li> <p>low risk of other bias;</p> </li> <li> <p>high risk of other bias;</p> </li> <li> <p>unclear whether there is risk of other bias.</p> </li> </ul> </p> </section> <section id="CD004075-sec-0052"> <h5 class="title">(7) Overall risk of bias</h5> <p>We made explicit judgements about whether studies were at high risk of bias, according to the criteria given in the <i>Handbook</i> (<a href="./references#CD004075-bbs2-0031" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). With reference to (1) to (6) above, we assessed the likely magnitude and direction of the bias and whether we consider it is likely to impact on the findings. We explored the impact of the level of bias through undertaking sensitivity analyses ‐ <i>see</i><a href="#CD004075-sec-0064">Sensitivity analysis</a>. Overall findings from our assessment of risk of bias in the included studies are provided in <a href="#CD004075-fig-0001">Figure 1</a> and <a href="#CD004075-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD004075-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD004075-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD004075-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD004075-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> </section> </section> <section id="CD004075-sec-0053"> <h4 class="title">Measures of treatment effect</h4> <section id="CD004075-sec-0054"> <h5 class="title">Dichotomous data</h5> <p>For dichotomous data, we presented results as summary risk ratio with 95% confidence intervals. </p> </section> <section id="CD004075-sec-0055"> <h5 class="title">Continuous data</h5> <p>For continuous data, we used the mean difference with 95% confidence intervals. If necessary, we planned to use the standardised mean difference to combine trials that measured the same outcome, but used different methods. </p> </section> </section> <section id="CD004075-sec-0056"> <h4 class="title">Unit of analysis issues</h4> <section id="CD004075-sec-0057"> <h5 class="title">Cluster‐randomised trials</h5> <p>We planned to include cluster‐randomised trials identified in the searches in the analyses along with individually‐randomised trials. If cluster‐randomised trials are included in future updates, we will adjust their sample sizes using the methods described in the <i>Handbook</i> using an estimate of the intracluster correlation co‐efficient (ICC) derived from the trial (if possible), from a similar trial or from a study of a similar population. If we use ICCs from other sources, we will report this and conduct sensitivity analyses to investigate the effect of variation in the ICC. If we identify both cluster‐randomised trials and individually‐randomised trials, we will synthesise the relevant information. We will consider it reasonable to combine the results from both if there is little heterogeneity between the study designs and the interaction between the effect of intervention and the choice of randomisation unit is considered to be unlikely. </p> <p>We will also acknowledged heterogeneity in the randomisation unit and perform a sensitivity analysis to investigate the effects of the randomisation unit. </p> </section> <section id="CD004075-sec-0058"> <h5 class="title">Cross‐over trials</h5> <p>It is unlikely that cross‐over designs will be a valid study design for Pregnancy and Childbirth reviews, and so will be excluded if they are identified in future updates of this review. </p> </section> </section> <section id="CD004075-sec-0059"> <h4 class="title">Dealing with missing data</h4> <p>For included studies, we noted levels of attrition. We explored the impact of including studies with high levels of missing data in the overall assessment of treatment effect by considering using sensitivity analysis, although this was not ultimately necessary. </p> <p>For all outcomes, we carried out analyses, as far as possible, on an intention‐to‐treat basis, i.e. we attempted to include all participants randomised to each group in the analyses, and all participants were analysed in the group to which they were allocated, regardless of whether or not they received the allocated intervention. The denominator for each outcome in each trial was the number randomised minus any participants whose outcomes were known to be missing. </p> <p>We made an <i>a priori</i> decision in the original protocol to exclude trials where outcome data were unavailable for more than 20% of participants. </p> </section> <section id="CD004075-sec-0060"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed statistical heterogeneity in each meta‐analysis using the Tau², I² and Chi² statistics. We regarded heterogeneity as substantial if an I² was greater than 30% and either a Tau² was greater than zero, or there was a low P value (less than 0.10) in the Chi² test for heterogeneity. </p> </section> <section id="CD004075-sec-0061"> <h4 class="title">Assessment of reporting biases</h4> <p>Had there been 10 or more studies in the meta‐analysis, we planned to investigate reporting biases (such as publication bias) using funnel plots. In future review updates where 10 or more studies are included, we will assess funnel plot asymmetry visually. If asymmetry is suggested by a visual assessment, we will perform exploratory analyses to investigate it. </p> </section> <section id="CD004075-sec-0062"> <h4 class="title">Data synthesis</h4> <p>We carried out statistical analysis using the Review Manager software (<a href="./references#CD004075-bbs2-0047" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>). We used fixed‐effect meta‐analysis for combining data where it was reasonable to assume that studies were estimating the same underlying treatment effect: i.e. where trials were examining the same intervention, and the trials’ populations and methods were judged sufficiently similar. If there was clinical heterogeneity sufficient to expect that the underlying treatment effects differed between trials, or if substantial statistical heterogeneity was detected, we used random‐effects meta‐analysis to produce an overall summary, if an average treatment effect across trials was considered clinically meaningful. The random‐effects summary was treated as the average of the range of possible treatment effects and we discussed the clinical implications of treatment effects differing between trials. If the average treatment effect was not clinically meaningful, we did not combine trials. </p> <p>Where we used random‐effects analyses, the results were presented as the average treatment effect with 95% confidence intervals, and the estimates of Tau² and I². </p> </section> <section id="CD004075-sec-0063"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>If we identified substantial heterogeneity, we investigated it using subgroup analyses and sensitivity analyses. We considered whether an overall summary was meaningful, and if it was, used random‐effects analysis to produce it. </p> <p>We planned to carry out the following subgroup analyses.</p> <p>1.   Fetal heart rate monitoring by:</p> <p> <ul id="CD004075-list-0009"> <li> <p>intermittent auscultation;</p> </li> <li> <p>intermittent cardiotocography;</p> </li> <li> <p>continuous cardiotocography and fetal scalp stimulation;</p> </li> <li> <p>continuous cardiotocography and fetal ECG analysis (ST segment);</p> </li> <li> <p>continuous cardiotocography and fetal ECG analysis (PR interval).</p> </li> </ul> </p> <p>2.     Fetal scalp blood sampling for blood gas analysis or lactate measurement (performed after randomisation). </p> <p>The primary outcomes were used in subgroup analysis.</p> <p>We planned to assess subgroup differences by interaction tests available within RevMan (<a href="./references#CD004075-bbs2-0047" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>). We reported the results of subgroup analyses quoting the Chi² statistic and P value, and the interaction test I² value. </p> </section> <section id="CD004075-sec-0064"> <h4 class="title">Sensitivity analysis</h4> <p>We performed sensitivity analyses on the primary outcomes where we considered that an aspect of the review, such as risk of bias associated with the quality of some of the included trials, could have affected the results, in particular where there was a high level of statistical heterogeneity. This was applied by creating subgroups based on the different study entry criteria (see <i><b>Data analysis considerations</b> </i> in the <a href="./full#CD004075-sec-0065">Results</a> section). </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD004075-sec-0065" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD004075-sec-0065"></div> <section id="CD004075-sec-0066"> <h3 class="title">Description of studies</h3> <p>The search identified seven published randomised controlled trials (<a href="./references#CD004075-bbs2-0001" title="BloomSL , SpongCY , ThomE , VarnerMW , RouseDJ , WeiningerS , et al. Fetal pulse oximetry and cesarean delivery. New England Journal of Medicine2006;355(21):2195‐202. BloomSL , for the NICHD MFMU Network. The MFMU Network randomized trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2006;196(6 Suppl):S2. Maternal Fetal Medicine Units Network. The FOX trial: a randomized clinical trial of fetal pulse oximetry. http://www.bsc.gwu.edu/mfmu/Projects/fox.cgi (accessed 7 August 2006). RouseD , ShriverEK . Second stage of labour duration: relationship to maternal and perinatal outcomes. American Journal of Obstetrics and Gynecology2008;199(6 Suppl 1):S37. RouseDJ , WeinerSJ , BloomSL , VarnerMW , SpongCY , RaminSM , et al. Second‐stage labor duration in nulliparous women: relationship to maternal and perinatal outcomes. American Journal of Obstetrics and Gynecology2009;201(4):357.e1‐357.e7. ">Bloom 2006</a>; <a href="./references#CD004075-bbs2-0002" title="CaliskanE , CakirogluY , CorakciA , OzerenS . Reduction in caesarean delivery with fetal heart rate monitoring and intermittent pulse oximetry after induction of labour with misoprostol. Journal of Maternal‐Fetal &amp; Neonatal Medicine2009; Vol. 22, issue 5:445‐51. ">Caliskan 2009</a>; <a href="./references#CD004075-bbs2-0003" title="ColditzPB , EastCE . PTO360. Fetal intrapartum pulse oximetry: a multicentre randomised controlled trial. Perinatal Trials Report. www.ctc.usyd.edu.au/6registry/PTO360.htm (accessed 3 Feb 2004). EastC , ChanFY , BrenneckeS , KingJ , ColditzP , the Foremost Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S102. EastC , GascoineM , DoranC , BrenneckeS , KingJ , ColditzP , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomized controlled trial (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S101. EastCE , BrenneckeSP , ChanFY , KingJF , BellerEM , ColditzPB . Clinicians' evaluations of fetal oximetry sensor placement in a multicentre randomised trial (the foremost trial). Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2006;46(3):234‐9. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a nonreassuring fetal heart rate pattern, on operative delivery rates: a multicenter, randomized, controlled trial (the FOREMOST trial). American Journal of Obstetrics and Gynecology2006;194(3):606.e1‐16. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST study group. Fetal pulse oximetry clinical trial (the FOREMOST trial). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:166. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a non‐reassuring fetal heart rate pattern, on operative delivery rates: a multicenter randomized controlled trial (The FOREMOST Trial). American Journal of Obstetrics and Gynecology. 2005; Vol. 193, issue 6 Suppl:S33. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (the FOREMOST trial). Birth2006;33(2):101‐9. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST study group. Childbearing women's experience in the FOREMOST trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:365. EastCE , GascoigneMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomised controlled trial (the FOREMOST trial). BJOG: an international journal of obstetrics and gynaecology2006;113:1080‐7. EastCE , GasgoineMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. Cost‐effectiveness of fetal pulse oximetry (FOREMOST). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:202. ">East 2006</a>; <a href="./references#CD004075-bbs2-0004" title="DildyG , GariteT , McNamaraH , SwedlowD , Mallinckrodt (Nellcor) Fetal Oximetry Research Group. A multicenter randomized trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2000;182(1 Pt 2):S12. DildyGA , ClarkSL , GariteTJ , PorterRF , SwedlowDB , VarnerMW . Current status of the multicenter randomized clinical trial on fetal oxygen saturation monitoring in the United States. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1997;72 Suppl 1:S43‐S50. GariteTJ , DildyGA , McNamaraH , NageotteMP , BoehmFH , DellingerEH , et al. A multicenter controlled trial of fetal pulse oximetry in the intrapartum management of nonreassuring fetal heart rate patterns. American Journal of Obstetrics and Gynecology2000;183(5):1049‐58. GorenbergD , PattilloC , HendiP , RumneyP , GariteT . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S129. GorenbergDM , PattilloC , HendiP , RumneyPJ , GariteTJ . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes. American Journal of Obstetrics and Gynecology2003;189(1):136‐8. HenigsmanS , GariteT , PattilloC , BrewsterW . Fetal pulse oximetry: defining which variable decelerations with slow return to baseline are associated with hypoxia [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. LeeR , MooreM , BrewsterW , HendiP , PattilloC , ZiogasA , et al. All non‐reactive fetal heart rate tracings are not equal [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. Mallinckrodt , Inc . Summary of safety and effectiveness information data. OxiFirst® Fetal Oxygen Saturation Monitoring System2000. MillerH . Differences in cervical dilatation and induction in patients delivered because of dystocia during a multicenter randomized clinical trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S124. PorrecoR , GariteJ , SwedlowD , ThomasS . The occurrence of dystocia among patients monitored in labor with fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S19. ">Garite 2000</a>; <a href="./references#CD004075-bbs2-0005" title="KlauserCK , ChristensenEE , ChauhanSP , BufkinL , MagannEF , BofillJA , et al. Use of fetal pulse oximetry among high‐risk women in labour: a randomized clinical trial. American Journal of Obstetrics and Gynecology2005;192:1810‐7. ">Klauser 2005</a>; <a href="./references#CD004075-bbs2-0006" title="KuhnertM , SchmidtS . Intrapartum management of nonreassuring fetal heart rate patterns: a randomized controlled trial of fetal pulse oximetry. American Journal of Obstetrics and Gynecology2004;191:1989‐95. ">Kuhnert 2004</a>; <a href="./references#CD004075-bbs2-0007" title="ParejaMV , PrietoAP , BadilloMPC , HerrezueloIP , VentosoFM . Comparison of the effectiveness between the fetal pulse oximetry and fetal electrocardiogram during intrapartum fetal well‐being loss risks. Progresos de Obstetricia y Ginecologia2010;53(4):141‐7. PrietoAP , ParejaMV , ZunigaIV , RomeroTA , LeonMDR , VentosoFM . Pulse oximetry compared with fetal electrocardiogram to control intrapartum fetal wellbeing. Journal of Maternal‐Fetal and Neonatal Medicine2008; Vol. 21, issue Suppl 1:141. ValverdeM , PuertasAM , Lopez‐GallegoMF , CarrilloMP , AguilarMT , MontoyaF . Effectiveness of pulse oximetry versus fetal electrocardiography for the intrapartum evaluation of nonreassuring fetal heart rate. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2011;159(2):333‐7. Valverde ParejaM , MartinezMDM , GuadixBR , VentosoFM , PrietoAP , CriadoMSL . Comparison between the pulse oximetry's effectiveness and electrocardiogram's effectiveness; two methods of fetal intrapartum monitoring. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):627. Valverde ParejaM , Romero GuadixB , Moreno MartinezMD , Puertas PrietoAA , Montoya VentosoF . Influence of two methods of fetal intrapartum monitoring; pulse oximetry and fetal electrocardiogram for the duration of the labor, in the presence of alterations in the fetal heart rate. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):243. ">Valverde 2011</a> (the latter added in the 2014 review update)), and two observational studies (<a href="./references#CD004075-bbs2-0008" title="AndresIF , MonteroIM . Fetal pulse oximetry. Intrapartum foetal hypoxia evaluation. Comparative study with invasive techniques concerning foetal welfare [Pulsioximetria fetal. Nuevo metodo de control fetal intraparto. Estudio comparativo con tecnicas invasivas acerca del bienestar fetal]. Anales del Sistema Sanitario de Navarra2004;27(2):179‐89. ">Andres 2004</a>; <a href="./references#CD004075-bbs2-0009" title="GolaszewskiT , FrigoP , UlmM , LeeA , GruberW , RafoltD , et al. Non‐invasive fetal pulse oximetry sub partu. Gynakologisch‐Geburtshilfliche Rundschau1993;33:246‐50. ">Golaszewski 1993</a>). The trial by <a href="./references#CD004075-bbs2-0004" title="DildyG , GariteT , McNamaraH , SwedlowD , Mallinckrodt (Nellcor) Fetal Oximetry Research Group. A multicenter randomized trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2000;182(1 Pt 2):S12. DildyGA , ClarkSL , GariteTJ , PorterRF , SwedlowDB , VarnerMW . Current status of the multicenter randomized clinical trial on fetal oxygen saturation monitoring in the United States. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1997;72 Suppl 1:S43‐S50. GariteTJ , DildyGA , McNamaraH , NageotteMP , BoehmFH , DellingerEH , et al. A multicenter controlled trial of fetal pulse oximetry in the intrapartum management of nonreassuring fetal heart rate patterns. American Journal of Obstetrics and Gynecology2000;183(5):1049‐58. GorenbergD , PattilloC , HendiP , RumneyP , GariteT . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S129. GorenbergDM , PattilloC , HendiP , RumneyPJ , GariteTJ . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes. American Journal of Obstetrics and Gynecology2003;189(1):136‐8. HenigsmanS , GariteT , PattilloC , BrewsterW . Fetal pulse oximetry: defining which variable decelerations with slow return to baseline are associated with hypoxia [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. LeeR , MooreM , BrewsterW , HendiP , PattilloC , ZiogasA , et al. All non‐reactive fetal heart rate tracings are not equal [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. Mallinckrodt , Inc . Summary of safety and effectiveness information data. OxiFirst® Fetal Oxygen Saturation Monitoring System2000. MillerH . Differences in cervical dilatation and induction in patients delivered because of dystocia during a multicenter randomized clinical trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S124. PorrecoR , GariteJ , SwedlowD , ThomasS . The occurrence of dystocia among patients monitored in labor with fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S19. ">Garite 2000</a> had also been published in a number of forms and sub analyses addressing issues that were not considered in this review. Similarly, the trials by <a href="./references#CD004075-bbs2-0003" title="ColditzPB , EastCE . PTO360. Fetal intrapartum pulse oximetry: a multicentre randomised controlled trial. Perinatal Trials Report. www.ctc.usyd.edu.au/6registry/PTO360.htm (accessed 3 Feb 2004). EastC , ChanFY , BrenneckeS , KingJ , ColditzP , the Foremost Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S102. EastC , GascoineM , DoranC , BrenneckeS , KingJ , ColditzP , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomized controlled trial (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S101. EastCE , BrenneckeSP , ChanFY , KingJF , BellerEM , ColditzPB . Clinicians' evaluations of fetal oximetry sensor placement in a multicentre randomised trial (the foremost trial). Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2006;46(3):234‐9. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a nonreassuring fetal heart rate pattern, on operative delivery rates: a multicenter, randomized, controlled trial (the FOREMOST trial). American Journal of Obstetrics and Gynecology2006;194(3):606.e1‐16. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST study group. Fetal pulse oximetry clinical trial (the FOREMOST trial). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:166. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a non‐reassuring fetal heart rate pattern, on operative delivery rates: a multicenter randomized controlled trial (The FOREMOST Trial). American Journal of Obstetrics and Gynecology. 2005; Vol. 193, issue 6 Suppl:S33. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (the FOREMOST trial). Birth2006;33(2):101‐9. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST study group. Childbearing women's experience in the FOREMOST trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:365. EastCE , GascoigneMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomised controlled trial (the FOREMOST trial). BJOG: an international journal of obstetrics and gynaecology2006;113:1080‐7. EastCE , GasgoineMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. Cost‐effectiveness of fetal pulse oximetry (FOREMOST). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:202. ">East 2006</a>, <a href="./references#CD004075-bbs2-0001" title="BloomSL , SpongCY , ThomE , VarnerMW , RouseDJ , WeiningerS , et al. Fetal pulse oximetry and cesarean delivery. New England Journal of Medicine2006;355(21):2195‐202. BloomSL , for the NICHD MFMU Network. The MFMU Network randomized trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2006;196(6 Suppl):S2. Maternal Fetal Medicine Units Network. The FOX trial: a randomized clinical trial of fetal pulse oximetry. http://www.bsc.gwu.edu/mfmu/Projects/fox.cgi (accessed 7 August 2006). RouseD , ShriverEK . Second stage of labour duration: relationship to maternal and perinatal outcomes. American Journal of Obstetrics and Gynecology2008;199(6 Suppl 1):S37. RouseDJ , WeinerSJ , BloomSL , VarnerMW , SpongCY , RaminSM , et al. Second‐stage labor duration in nulliparous women: relationship to maternal and perinatal outcomes. American Journal of Obstetrics and Gynecology2009;201(4):357.e1‐357.e7. ">Bloom 2006</a> and <a href="./references#CD004075-bbs2-0007" title="ParejaMV , PrietoAP , BadilloMPC , HerrezueloIP , VentosoFM . Comparison of the effectiveness between the fetal pulse oximetry and fetal electrocardiogram during intrapartum fetal well‐being loss risks. Progresos de Obstetricia y Ginecologia2010;53(4):141‐7. PrietoAP , ParejaMV , ZunigaIV , RomeroTA , LeonMDR , VentosoFM . Pulse oximetry compared with fetal electrocardiogram to control intrapartum fetal wellbeing. Journal of Maternal‐Fetal and Neonatal Medicine2008; Vol. 21, issue Suppl 1:141. ValverdeM , PuertasAM , Lopez‐GallegoMF , CarrilloMP , AguilarMT , MontoyaF . Effectiveness of pulse oximetry versus fetal electrocardiography for the intrapartum evaluation of nonreassuring fetal heart rate. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2011;159(2):333‐7. Valverde ParejaM , MartinezMDM , GuadixBR , VentosoFM , PrietoAP , CriadoMSL . Comparison between the pulse oximetry's effectiveness and electrocardiogram's effectiveness; two methods of fetal intrapartum monitoring. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):627. Valverde ParejaM , Romero GuadixB , Moreno MartinezMD , Puertas PrietoAA , Montoya VentosoF . Influence of two methods of fetal intrapartum monitoring; pulse oximetry and fetal electrocardiogram for the duration of the labor, in the presence of alterations in the fetal heart rate. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):243. ">Valverde 2011</a> had several related publications (one of which had only been available as a conference abstract in the 2010 update of this review), some of which were considered in this review and were added with this update. </p> <p>We found no unpublished studies.</p> <section id="CD004075-sec-0067"> <h4 class="title">Trials with nonreassuring fetal status not required prior to study entry</h4> <p><a href="./references#CD004075-bbs2-0001" title="BloomSL , SpongCY , ThomE , VarnerMW , RouseDJ , WeiningerS , et al. Fetal pulse oximetry and cesarean delivery. New England Journal of Medicine2006;355(21):2195‐202. BloomSL , for the NICHD MFMU Network. The MFMU Network randomized trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2006;196(6 Suppl):S2. Maternal Fetal Medicine Units Network. The FOX trial: a randomized clinical trial of fetal pulse oximetry. http://www.bsc.gwu.edu/mfmu/Projects/fox.cgi (accessed 7 August 2006). RouseD , ShriverEK . Second stage of labour duration: relationship to maternal and perinatal outcomes. American Journal of Obstetrics and Gynecology2008;199(6 Suppl 1):S37. RouseDJ , WeinerSJ , BloomSL , VarnerMW , SpongCY , RaminSM , et al. Second‐stage labor duration in nulliparous women: relationship to maternal and perinatal outcomes. American Journal of Obstetrics and Gynecology2009;201(4):357.e1‐357.e7. ">Bloom 2006</a> reported a multicentre trial conducted in the USA (n = 5341), which enrolled nulliparous women with CTG monitoring in labour. All participants had a fetal pulse oximetry sensor placed and were then randomly allocated to the 'open' arm with fetal pulse oximetry values displayed or the 'masked' arm with fetal pulse oximetry values stored to computer disk and not displayed to the woman or clinician. These results were analysed separately from the other studies, as the study population, labouring women with a CTG, could not be considered in the same manner as those with a nonreassuring CTG (<i>see belo</i>w). The report included limited outcomes for a separate analysis of those with a nonreassuring CTG prior to study entry.The study reported by <a href="./references#CD004075-bbs2-0002" title="CaliskanE , CakirogluY , CorakciA , OzerenS . Reduction in caesarean delivery with fetal heart rate monitoring and intermittent pulse oximetry after induction of labour with misoprostol. Journal of Maternal‐Fetal &amp; Neonatal Medicine2009; Vol. 22, issue 5:445‐51. ">Caliskan 2009</a> enrolled women from 34 weeks' gestation undergoing induction of labour by oral misoprostol in Turkey. All participants had misoprostol administered and were then randomised to either intermittent fetal pulse oximetry + electronic fetal monitoring, or electronic fetal monitoring only. </p> </section> <section id="CD004075-sec-0068"> <h4 class="title">Trials with nonreassuring fetal status required prior to study entry</h4> <p>The trial published by <a href="./references#CD004075-bbs2-0004" title="DildyG , GariteT , McNamaraH , SwedlowD , Mallinckrodt (Nellcor) Fetal Oximetry Research Group. A multicenter randomized trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2000;182(1 Pt 2):S12. DildyGA , ClarkSL , GariteTJ , PorterRF , SwedlowDB , VarnerMW . Current status of the multicenter randomized clinical trial on fetal oxygen saturation monitoring in the United States. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1997;72 Suppl 1:S43‐S50. GariteTJ , DildyGA , McNamaraH , NageotteMP , BoehmFH , DellingerEH , et al. A multicenter controlled trial of fetal pulse oximetry in the intrapartum management of nonreassuring fetal heart rate patterns. American Journal of Obstetrics and Gynecology2000;183(5):1049‐58. GorenbergD , PattilloC , HendiP , RumneyP , GariteT . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S129. GorenbergDM , PattilloC , HendiP , RumneyPJ , GariteTJ . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes. American Journal of Obstetrics and Gynecology2003;189(1):136‐8. HenigsmanS , GariteT , PattilloC , BrewsterW . Fetal pulse oximetry: defining which variable decelerations with slow return to baseline are associated with hypoxia [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. LeeR , MooreM , BrewsterW , HendiP , PattilloC , ZiogasA , et al. All non‐reactive fetal heart rate tracings are not equal [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. Mallinckrodt , Inc . Summary of safety and effectiveness information data. OxiFirst® Fetal Oxygen Saturation Monitoring System2000. MillerH . Differences in cervical dilatation and induction in patients delivered because of dystocia during a multicenter randomized clinical trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S124. PorrecoR , GariteJ , SwedlowD , ThomasS . The occurrence of dystocia among patients monitored in labor with fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S19. ">Garite 2000</a> was conducted in the United States of America (USA) and compared caesarean section rates for nonreassuring fetal status when conventional fetal monitoring (CTG) was used, versus when fetal pulse oximetry was used in addition to CTG, with reported data on 1010 cases. An unpublished report included some pilot data for a total of 1189 cases. </p> <p><a href="./references#CD004075-bbs2-0006" title="KuhnertM , SchmidtS . Intrapartum management of nonreassuring fetal heart rate patterns: a randomized controlled trial of fetal pulse oximetry. American Journal of Obstetrics and Gynecology2004;191:1989‐95. ">Kuhnert 2004</a> reported a trial from Germany that compared operative birth and fetal scalp blood sampling for nonreassuring fetal status in two groups: those with CTG monitoring and those with fetal pulse oximetry added to the CTG, for a total of 146 cases. Fetal blood sampling (FBS) was required prior to study entry. Whilst not stated in the report, it is appropriate to consider that if the scalp pH was nonreassuring, intervention would have been undertaken to correct this or to deliver the baby prior to enrolment in the study. It can therefore be considered that this represents, at least in part, a different study population to that of the other studies. </p> <p>A single‐centre trial from the USA, reported by <a href="./references#CD004075-bbs2-0005" title="KlauserCK , ChristensenEE , ChauhanSP , BufkinL , MagannEF , BofillJA , et al. Use of fetal pulse oximetry among high‐risk women in labour: a randomized clinical trial. American Journal of Obstetrics and Gynecology2005;192:1810‐7. ">Klauser 2005</a>, included 327 women with gestation from 28 weeks onward. This study compared caesarean birth for nonreassuring fetal status in women with and without fetal pulse oximetry added to CTG monitoring (<a href="./references#CD004075-bbs2-0005" title="KlauserCK , ChristensenEE , ChauhanSP , BufkinL , MagannEF , BofillJA , et al. Use of fetal pulse oximetry among high‐risk women in labour: a randomized clinical trial. American Journal of Obstetrics and Gynecology2005;192:1810‐7. ">Klauser 2005</a>). Interpretation of fetal heart rate monitoring is different in premature babies, compared with term babies. The report did not allow the reader to distinguish outcomes by gestational age. It may therefore be appropriate to consider that this represents a heterogenous population. This would make subsequent combination with other trials inappropriate. We were unable to contact the authors to consider analysis by gestation. </p> <p>An Australian multicentre trial compared operative birth for nonreassuring fetal status in those with and without fetal pulse oximetry added to CTG monitoring (<a href="./references#CD004075-bbs2-0003" title="ColditzPB , EastCE . PTO360. Fetal intrapartum pulse oximetry: a multicentre randomised controlled trial. Perinatal Trials Report. www.ctc.usyd.edu.au/6registry/PTO360.htm (accessed 3 Feb 2004). EastC , ChanFY , BrenneckeS , KingJ , ColditzP , the Foremost Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S102. EastC , GascoineM , DoranC , BrenneckeS , KingJ , ColditzP , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomized controlled trial (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S101. EastCE , BrenneckeSP , ChanFY , KingJF , BellerEM , ColditzPB . Clinicians' evaluations of fetal oximetry sensor placement in a multicentre randomised trial (the foremost trial). Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2006;46(3):234‐9. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a nonreassuring fetal heart rate pattern, on operative delivery rates: a multicenter, randomized, controlled trial (the FOREMOST trial). American Journal of Obstetrics and Gynecology2006;194(3):606.e1‐16. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST study group. Fetal pulse oximetry clinical trial (the FOREMOST trial). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:166. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a non‐reassuring fetal heart rate pattern, on operative delivery rates: a multicenter randomized controlled trial (The FOREMOST Trial). American Journal of Obstetrics and Gynecology. 2005; Vol. 193, issue 6 Suppl:S33. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (the FOREMOST trial). Birth2006;33(2):101‐9. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST study group. Childbearing women's experience in the FOREMOST trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:365. EastCE , GascoigneMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomised controlled trial (the FOREMOST trial). BJOG: an international journal of obstetrics and gynaecology2006;113:1080‐7. EastCE , GasgoineMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. Cost‐effectiveness of fetal pulse oximetry (FOREMOST). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:202. ">East 2006</a>) on 600 pregnancies. </p> <p>The trial reported by <a href="./references#CD004075-bbs2-0001" title="BloomSL , SpongCY , ThomE , VarnerMW , RouseDJ , WeiningerS , et al. Fetal pulse oximetry and cesarean delivery. New England Journal of Medicine2006;355(21):2195‐202. BloomSL , for the NICHD MFMU Network. The MFMU Network randomized trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2006;196(6 Suppl):S2. Maternal Fetal Medicine Units Network. The FOX trial: a randomized clinical trial of fetal pulse oximetry. http://www.bsc.gwu.edu/mfmu/Projects/fox.cgi (accessed 7 August 2006). RouseD , ShriverEK . Second stage of labour duration: relationship to maternal and perinatal outcomes. American Journal of Obstetrics and Gynecology2008;199(6 Suppl 1):S37. RouseDJ , WeinerSJ , BloomSL , VarnerMW , SpongCY , RaminSM , et al. Second‐stage labor duration in nulliparous women: relationship to maternal and perinatal outcomes. American Journal of Obstetrics and Gynecology2009;201(4):357.e1‐357.e7. ">Bloom 2006</a> included 2168 women with a nonreassuring CTG at the time of study entry, of the 5341 enrolled in the study overall (<i>see above</i>). </p> <p><a href="./references#CD004075-bbs2-0007" title="ParejaMV , PrietoAP , BadilloMPC , HerrezueloIP , VentosoFM . Comparison of the effectiveness between the fetal pulse oximetry and fetal electrocardiogram during intrapartum fetal well‐being loss risks. Progresos de Obstetricia y Ginecologia2010;53(4):141‐7. PrietoAP , ParejaMV , ZunigaIV , RomeroTA , LeonMDR , VentosoFM . Pulse oximetry compared with fetal electrocardiogram to control intrapartum fetal wellbeing. Journal of Maternal‐Fetal and Neonatal Medicine2008; Vol. 21, issue Suppl 1:141. ValverdeM , PuertasAM , Lopez‐GallegoMF , CarrilloMP , AguilarMT , MontoyaF . Effectiveness of pulse oximetry versus fetal electrocardiography for the intrapartum evaluation of nonreassuring fetal heart rate. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2011;159(2):333‐7. Valverde ParejaM , MartinezMDM , GuadixBR , VentosoFM , PrietoAP , CriadoMSL . Comparison between the pulse oximetry's effectiveness and electrocardiogram's effectiveness; two methods of fetal intrapartum monitoring. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):627. Valverde ParejaM , Romero GuadixB , Moreno MartinezMD , Puertas PrietoAA , Montoya VentosoF . Influence of two methods of fetal intrapartum monitoring; pulse oximetry and fetal electrocardiogram for the duration of the labor, in the presence of alterations in the fetal heart rate. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):243. ">Valverde 2011</a> reported a single‐centre trial from Spain that compared operative birth and fetal status in 180 women with nonreassuring CTG. Women were randomised to either fetal pulse oximetry plus CTG, or fetal ECG plus CTG. </p> <p><i>See</i><a href="./references#CD004075-sec-0109" title="">Characteristics of included studies</a> table. </p> </section> <section id="CD004075-sec-0069"> <h4 class="title">Data analysis considerations</h4> <p>The trial by <a href="./references#CD004075-bbs2-0001" title="BloomSL , SpongCY , ThomE , VarnerMW , RouseDJ , WeiningerS , et al. Fetal pulse oximetry and cesarean delivery. New England Journal of Medicine2006;355(21):2195‐202. BloomSL , for the NICHD MFMU Network. The MFMU Network randomized trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2006;196(6 Suppl):S2. Maternal Fetal Medicine Units Network. The FOX trial: a randomized clinical trial of fetal pulse oximetry. http://www.bsc.gwu.edu/mfmu/Projects/fox.cgi (accessed 7 August 2006). RouseD , ShriverEK . Second stage of labour duration: relationship to maternal and perinatal outcomes. American Journal of Obstetrics and Gynecology2008;199(6 Suppl 1):S37. RouseDJ , WeinerSJ , BloomSL , VarnerMW , SpongCY , RaminSM , et al. Second‐stage labor duration in nulliparous women: relationship to maternal and perinatal outcomes. American Journal of Obstetrics and Gynecology2009;201(4):357.e1‐357.e7. ">Bloom 2006</a> involved fetal pulse oximetry and cardiotocography in both of the study groups, with one group having the oximetry results displayed for clinical use and the other group having the oximetry results masked. For the purposes of this meta‐analysis, the 'masked' group of this trial has been treated in this review as 'cardiotocography‐only', since the fetal pulse oximetry values did not influence clinical decisions. </p> <p>All trials were included, where outcome data were reported, in the meta‐analysis to allow a comprehensive representation of the findings. The use of a summary measure of effect for some combinations of trials was appropriate. However, we did not use a summary measure of effect for combining all trials, as the appropriateness of combining studies with differing entry criteria and significant heterogeneity if separate analyses were not used, remained uncertain. For example, we created subcategories within analyses based on differing study entry characteristics/requirements: (i) gestation from 34 weeks, FBS not required prior to study entry; (ii) gestation from 36 weeks, FBS prior to study entry; and (iii) gestation from 28 weeks, FBS not required prior to study entry. We then reported the summary effect for each subgroup, rather than a combined summary effect for all studies. The subcategories could have been considered in terms of subgroup analyses, although the different study entry characteristics were not specified as subgroups a priori in the original protocol. The findings as presented in subcategories provide a good measure of clinical realities, although the possibility of converting these to subgroups may be considered in a future update of this review. </p> <p>Inclusion of the trial reported by <a href="./references#CD004075-bbs2-0007" title="ParejaMV , PrietoAP , BadilloMPC , HerrezueloIP , VentosoFM . Comparison of the effectiveness between the fetal pulse oximetry and fetal electrocardiogram during intrapartum fetal well‐being loss risks. Progresos de Obstetricia y Ginecologia2010;53(4):141‐7. PrietoAP , ParejaMV , ZunigaIV , RomeroTA , LeonMDR , VentosoFM . Pulse oximetry compared with fetal electrocardiogram to control intrapartum fetal wellbeing. Journal of Maternal‐Fetal and Neonatal Medicine2008; Vol. 21, issue Suppl 1:141. ValverdeM , PuertasAM , Lopez‐GallegoMF , CarrilloMP , AguilarMT , MontoyaF . Effectiveness of pulse oximetry versus fetal electrocardiography for the intrapartum evaluation of nonreassuring fetal heart rate. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2011;159(2):333‐7. Valverde ParejaM , MartinezMDM , GuadixBR , VentosoFM , PrietoAP , CriadoMSL . Comparison between the pulse oximetry's effectiveness and electrocardiogram's effectiveness; two methods of fetal intrapartum monitoring. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):627. Valverde ParejaM , Romero GuadixB , Moreno MartinezMD , Puertas PrietoAA , Montoya VentosoF . Influence of two methods of fetal intrapartum monitoring; pulse oximetry and fetal electrocardiogram for the duration of the labor, in the presence of alterations in the fetal heart rate. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):243. ">Valverde 2011</a> in the 2014 review update prompted careful deliberations related to whether or not to consider the fetal ECG + CTG group in the same manner as the CTG‐only group used for the remaining studies.The latter may be a reasonable judgement, given that there is a lack of evidence of effect of adding fetal ECG, on caesarean section rates (<a href="./references#CD004075-bbs2-0037" title="NeilsonJP . Fetal electrocardiogram (ECG) for fetal monitoring during labour. Cochrane Database of Systematic Reviews2013, Issue 5. [DOI: 10.1002/14651858.CD000116.pub4] ">Neilson 2013</a>). Adding the <a href="./references#CD004075-bbs2-0007" title="ParejaMV , PrietoAP , BadilloMPC , HerrezueloIP , VentosoFM . Comparison of the effectiveness between the fetal pulse oximetry and fetal electrocardiogram during intrapartum fetal well‐being loss risks. Progresos de Obstetricia y Ginecologia2010;53(4):141‐7. PrietoAP , ParejaMV , ZunigaIV , RomeroTA , LeonMDR , VentosoFM . Pulse oximetry compared with fetal electrocardiogram to control intrapartum fetal wellbeing. Journal of Maternal‐Fetal and Neonatal Medicine2008; Vol. 21, issue Suppl 1:141. ValverdeM , PuertasAM , Lopez‐GallegoMF , CarrilloMP , AguilarMT , MontoyaF . Effectiveness of pulse oximetry versus fetal electrocardiography for the intrapartum evaluation of nonreassuring fetal heart rate. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2011;159(2):333‐7. Valverde ParejaM , MartinezMDM , GuadixBR , VentosoFM , PrietoAP , CriadoMSL . Comparison between the pulse oximetry's effectiveness and electrocardiogram's effectiveness; two methods of fetal intrapartum monitoring. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):627. Valverde ParejaM , Romero GuadixB , Moreno MartinezMD , Puertas PrietoAA , Montoya VentosoF . Influence of two methods of fetal intrapartum monitoring; pulse oximetry and fetal electrocardiogram for the duration of the labor, in the presence of alterations in the fetal heart rate. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):243. ">Valverde 2011</a> findings to the main analysis of the primary outcome, caesarean section, did not change the overall direction of the summary effect, although the I<sup>2</sup> test result did increase from 45% to 61%, making it likely that this heterogeneity was of some importance. In support of treating fetal ECG separately, withdrawal of fetal pulse oximetry and fetal ECG from a clinical service, as compared with their use in a research setting, has been reported to influence a rise in caesarean sections (<a href="./references#CD004075-bbs2-0019" title="DokusK , ZuborP , MatasovaK , VisnovskyJ , DankoJ . Impact of fetal pulse oximetry and ST analysis surveillance withdrawal on rates of obstetric surgery and frequency of low birth umbilical artery pH: A cause of rising caesarean rates?. Journal of Obstetrics and Gynaecology2013;33(7):685‐8. ">Dokus 2013</a>). On the balance of these considerations, a decision was made to create distinct comparison analyses for fetal ECG, rather than include the findings from <a href="./references#CD004075-bbs2-0007" title="ParejaMV , PrietoAP , BadilloMPC , HerrezueloIP , VentosoFM . Comparison of the effectiveness between the fetal pulse oximetry and fetal electrocardiogram during intrapartum fetal well‐being loss risks. Progresos de Obstetricia y Ginecologia2010;53(4):141‐7. PrietoAP , ParejaMV , ZunigaIV , RomeroTA , LeonMDR , VentosoFM . Pulse oximetry compared with fetal electrocardiogram to control intrapartum fetal wellbeing. Journal of Maternal‐Fetal and Neonatal Medicine2008; Vol. 21, issue Suppl 1:141. ValverdeM , PuertasAM , Lopez‐GallegoMF , CarrilloMP , AguilarMT , MontoyaF . Effectiveness of pulse oximetry versus fetal electrocardiography for the intrapartum evaluation of nonreassuring fetal heart rate. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2011;159(2):333‐7. Valverde ParejaM , MartinezMDM , GuadixBR , VentosoFM , PrietoAP , CriadoMSL . Comparison between the pulse oximetry's effectiveness and electrocardiogram's effectiveness; two methods of fetal intrapartum monitoring. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):627. Valverde ParejaM , Romero GuadixB , Moreno MartinezMD , Puertas PrietoAA , Montoya VentosoF . Influence of two methods of fetal intrapartum monitoring; pulse oximetry and fetal electrocardiogram for the duration of the labor, in the presence of alterations in the fetal heart rate. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):243. ">Valverde 2011</a> in the initial meta‐analysis and then attempt subgroup analysis. </p> </section> <section id="CD004075-sec-0070"> <h4 class="title">Excluded studies</h4> <p>The two observational studies identified in the search were excluded (<a href="./references#CD004075-bbs2-0008" title="AndresIF , MonteroIM . Fetal pulse oximetry. Intrapartum foetal hypoxia evaluation. Comparative study with invasive techniques concerning foetal welfare [Pulsioximetria fetal. Nuevo metodo de control fetal intraparto. Estudio comparativo con tecnicas invasivas acerca del bienestar fetal]. Anales del Sistema Sanitario de Navarra2004;27(2):179‐89. ">Andres 2004</a>; <a href="./references#CD004075-bbs2-0009" title="GolaszewskiT , FrigoP , UlmM , LeeA , GruberW , RafoltD , et al. Non‐invasive fetal pulse oximetry sub partu. Gynakologisch‐Geburtshilfliche Rundschau1993;33:246‐50. ">Golaszewski 1993</a>). See <a href="./references#CD004075-sec-0110" title="">Characteristics of excluded studies</a> table. </p> </section> </section> <section id="CD004075-sec-0071"> <h3 class="title">Risk of bias in included studies</h3> <p>In all studies, the fetal oximetry values in the intervention group were used to guide clinical practice, thus making it impractical to blind either the participant or the clinician. Two studies (<a href="./references#CD004075-bbs2-0003" title="ColditzPB , EastCE . PTO360. Fetal intrapartum pulse oximetry: a multicentre randomised controlled trial. Perinatal Trials Report. www.ctc.usyd.edu.au/6registry/PTO360.htm (accessed 3 Feb 2004). EastC , ChanFY , BrenneckeS , KingJ , ColditzP , the Foremost Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S102. EastC , GascoineM , DoranC , BrenneckeS , KingJ , ColditzP , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomized controlled trial (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S101. EastCE , BrenneckeSP , ChanFY , KingJF , BellerEM , ColditzPB . Clinicians' evaluations of fetal oximetry sensor placement in a multicentre randomised trial (the foremost trial). Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2006;46(3):234‐9. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a nonreassuring fetal heart rate pattern, on operative delivery rates: a multicenter, randomized, controlled trial (the FOREMOST trial). American Journal of Obstetrics and Gynecology2006;194(3):606.e1‐16. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST study group. Fetal pulse oximetry clinical trial (the FOREMOST trial). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:166. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a non‐reassuring fetal heart rate pattern, on operative delivery rates: a multicenter randomized controlled trial (The FOREMOST Trial). American Journal of Obstetrics and Gynecology. 2005; Vol. 193, issue 6 Suppl:S33. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (the FOREMOST trial). Birth2006;33(2):101‐9. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST study group. Childbearing women's experience in the FOREMOST trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:365. EastCE , GascoigneMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomised controlled trial (the FOREMOST trial). BJOG: an international journal of obstetrics and gynaecology2006;113:1080‐7. EastCE , GasgoineMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. Cost‐effectiveness of fetal pulse oximetry (FOREMOST). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:202. ">East 2006</a>; <a href="./references#CD004075-bbs2-0004" title="DildyG , GariteT , McNamaraH , SwedlowD , Mallinckrodt (Nellcor) Fetal Oximetry Research Group. A multicenter randomized trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2000;182(1 Pt 2):S12. DildyGA , ClarkSL , GariteTJ , PorterRF , SwedlowDB , VarnerMW . Current status of the multicenter randomized clinical trial on fetal oxygen saturation monitoring in the United States. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1997;72 Suppl 1:S43‐S50. GariteTJ , DildyGA , McNamaraH , NageotteMP , BoehmFH , DellingerEH , et al. A multicenter controlled trial of fetal pulse oximetry in the intrapartum management of nonreassuring fetal heart rate patterns. American Journal of Obstetrics and Gynecology2000;183(5):1049‐58. GorenbergD , PattilloC , HendiP , RumneyP , GariteT . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S129. GorenbergDM , PattilloC , HendiP , RumneyPJ , GariteTJ . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes. American Journal of Obstetrics and Gynecology2003;189(1):136‐8. HenigsmanS , GariteT , PattilloC , BrewsterW . Fetal pulse oximetry: defining which variable decelerations with slow return to baseline are associated with hypoxia [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. LeeR , MooreM , BrewsterW , HendiP , PattilloC , ZiogasA , et al. All non‐reactive fetal heart rate tracings are not equal [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. Mallinckrodt , Inc . Summary of safety and effectiveness information data. OxiFirst® Fetal Oxygen Saturation Monitoring System2000. MillerH . Differences in cervical dilatation and induction in patients delivered because of dystocia during a multicenter randomized clinical trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S124. PorrecoR , GariteJ , SwedlowD , ThomasS . The occurrence of dystocia among patients monitored in labor with fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S19. ">Garite 2000</a>) disclosed funding support from the manufacturers of the fetal oximetry system used in those studies (high risk). Only one study (<a href="./references#CD004075-bbs2-0001" title="BloomSL , SpongCY , ThomE , VarnerMW , RouseDJ , WeiningerS , et al. Fetal pulse oximetry and cesarean delivery. New England Journal of Medicine2006;355(21):2195‐202. BloomSL , for the NICHD MFMU Network. The MFMU Network randomized trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2006;196(6 Suppl):S2. Maternal Fetal Medicine Units Network. The FOX trial: a randomized clinical trial of fetal pulse oximetry. http://www.bsc.gwu.edu/mfmu/Projects/fox.cgi (accessed 7 August 2006). RouseD , ShriverEK . Second stage of labour duration: relationship to maternal and perinatal outcomes. American Journal of Obstetrics and Gynecology2008;199(6 Suppl 1):S37. RouseDJ , WeinerSJ , BloomSL , VarnerMW , SpongCY , RaminSM , et al. Second‐stage labor duration in nulliparous women: relationship to maternal and perinatal outcomes. American Journal of Obstetrics and Gynecology2009;201(4):357.e1‐357.e7. ">Bloom 2006</a>) reported that outcome assessors were blinded to group allocation, while the remainder included sufficient detail to determine that outcome assessment was unblinded (<a href="./references#CD004075-bbs2-0003" title="ColditzPB , EastCE . PTO360. Fetal intrapartum pulse oximetry: a multicentre randomised controlled trial. Perinatal Trials Report. www.ctc.usyd.edu.au/6registry/PTO360.htm (accessed 3 Feb 2004). EastC , ChanFY , BrenneckeS , KingJ , ColditzP , the Foremost Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S102. EastC , GascoineM , DoranC , BrenneckeS , KingJ , ColditzP , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomized controlled trial (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S101. EastCE , BrenneckeSP , ChanFY , KingJF , BellerEM , ColditzPB . Clinicians' evaluations of fetal oximetry sensor placement in a multicentre randomised trial (the foremost trial). Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2006;46(3):234‐9. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a nonreassuring fetal heart rate pattern, on operative delivery rates: a multicenter, randomized, controlled trial (the FOREMOST trial). American Journal of Obstetrics and Gynecology2006;194(3):606.e1‐16. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST study group. Fetal pulse oximetry clinical trial (the FOREMOST trial). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:166. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a non‐reassuring fetal heart rate pattern, on operative delivery rates: a multicenter randomized controlled trial (The FOREMOST Trial). American Journal of Obstetrics and Gynecology. 2005; Vol. 193, issue 6 Suppl:S33. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (the FOREMOST trial). Birth2006;33(2):101‐9. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST study group. Childbearing women's experience in the FOREMOST trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:365. EastCE , GascoigneMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomised controlled trial (the FOREMOST trial). BJOG: an international journal of obstetrics and gynaecology2006;113:1080‐7. EastCE , GasgoineMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. Cost‐effectiveness of fetal pulse oximetry (FOREMOST). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:202. ">East 2006</a>; <a href="./references#CD004075-bbs2-0004" title="DildyG , GariteT , McNamaraH , SwedlowD , Mallinckrodt (Nellcor) Fetal Oximetry Research Group. A multicenter randomized trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2000;182(1 Pt 2):S12. DildyGA , ClarkSL , GariteTJ , PorterRF , SwedlowDB , VarnerMW . Current status of the multicenter randomized clinical trial on fetal oxygen saturation monitoring in the United States. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1997;72 Suppl 1:S43‐S50. GariteTJ , DildyGA , McNamaraH , NageotteMP , BoehmFH , DellingerEH , et al. A multicenter controlled trial of fetal pulse oximetry in the intrapartum management of nonreassuring fetal heart rate patterns. American Journal of Obstetrics and Gynecology2000;183(5):1049‐58. GorenbergD , PattilloC , HendiP , RumneyP , GariteT . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S129. GorenbergDM , PattilloC , HendiP , RumneyPJ , GariteTJ . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes. American Journal of Obstetrics and Gynecology2003;189(1):136‐8. HenigsmanS , GariteT , PattilloC , BrewsterW . Fetal pulse oximetry: defining which variable decelerations with slow return to baseline are associated with hypoxia [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. LeeR , MooreM , BrewsterW , HendiP , PattilloC , ZiogasA , et al. All non‐reactive fetal heart rate tracings are not equal [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. Mallinckrodt , Inc . Summary of safety and effectiveness information data. OxiFirst® Fetal Oxygen Saturation Monitoring System2000. MillerH . Differences in cervical dilatation and induction in patients delivered because of dystocia during a multicenter randomized clinical trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S124. PorrecoR , GariteJ , SwedlowD , ThomasS . The occurrence of dystocia among patients monitored in labor with fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S19. ">Garite 2000</a>) and therefore high risk, or did not specify this information (unclear risk, <a href="./references#CD004075-bbs2-0002" title="CaliskanE , CakirogluY , CorakciA , OzerenS . Reduction in caesarean delivery with fetal heart rate monitoring and intermittent pulse oximetry after induction of labour with misoprostol. Journal of Maternal‐Fetal &amp; Neonatal Medicine2009; Vol. 22, issue 5:445‐51. ">Caliskan 2009</a>; <a href="./references#CD004075-bbs2-0005" title="KlauserCK , ChristensenEE , ChauhanSP , BufkinL , MagannEF , BofillJA , et al. Use of fetal pulse oximetry among high‐risk women in labour: a randomized clinical trial. American Journal of Obstetrics and Gynecology2005;192:1810‐7. ">Klauser 2005</a>; <a href="./references#CD004075-bbs2-0006" title="KuhnertM , SchmidtS . Intrapartum management of nonreassuring fetal heart rate patterns: a randomized controlled trial of fetal pulse oximetry. American Journal of Obstetrics and Gynecology2004;191:1989‐95. ">Kuhnert 2004</a>; <a href="./references#CD004075-bbs2-0007" title="ParejaMV , PrietoAP , BadilloMPC , HerrezueloIP , VentosoFM . Comparison of the effectiveness between the fetal pulse oximetry and fetal electrocardiogram during intrapartum fetal well‐being loss risks. Progresos de Obstetricia y Ginecologia2010;53(4):141‐7. PrietoAP , ParejaMV , ZunigaIV , RomeroTA , LeonMDR , VentosoFM . Pulse oximetry compared with fetal electrocardiogram to control intrapartum fetal wellbeing. Journal of Maternal‐Fetal and Neonatal Medicine2008; Vol. 21, issue Suppl 1:141. ValverdeM , PuertasAM , Lopez‐GallegoMF , CarrilloMP , AguilarMT , MontoyaF . Effectiveness of pulse oximetry versus fetal electrocardiography for the intrapartum evaluation of nonreassuring fetal heart rate. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2011;159(2):333‐7. Valverde ParejaM , MartinezMDM , GuadixBR , VentosoFM , PrietoAP , CriadoMSL . Comparison between the pulse oximetry's effectiveness and electrocardiogram's effectiveness; two methods of fetal intrapartum monitoring. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):627. Valverde ParejaM , Romero GuadixB , Moreno MartinezMD , Puertas PrietoAA , Montoya VentosoF . Influence of two methods of fetal intrapartum monitoring; pulse oximetry and fetal electrocardiogram for the duration of the labor, in the presence of alterations in the fetal heart rate. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):243. ">Valverde 2011</a>). These elements of risk may suggest the need for caution in over‐interpretation of the findings (<a href="#CD004075-fig-0001">Figure 1</a>; <a href="#CD004075-fig-0002">Figure 2</a>). </p> <section id="CD004075-sec-0072"> <h4 class="title">Allocation</h4> <p>Sufficient evidence of random sequence generation and allocation concealment were provided in the reports by <a href="./references#CD004075-bbs2-0001" title="BloomSL , SpongCY , ThomE , VarnerMW , RouseDJ , WeiningerS , et al. Fetal pulse oximetry and cesarean delivery. New England Journal of Medicine2006;355(21):2195‐202. BloomSL , for the NICHD MFMU Network. The MFMU Network randomized trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2006;196(6 Suppl):S2. Maternal Fetal Medicine Units Network. The FOX trial: a randomized clinical trial of fetal pulse oximetry. http://www.bsc.gwu.edu/mfmu/Projects/fox.cgi (accessed 7 August 2006). RouseD , ShriverEK . Second stage of labour duration: relationship to maternal and perinatal outcomes. American Journal of Obstetrics and Gynecology2008;199(6 Suppl 1):S37. RouseDJ , WeinerSJ , BloomSL , VarnerMW , SpongCY , RaminSM , et al. Second‐stage labor duration in nulliparous women: relationship to maternal and perinatal outcomes. American Journal of Obstetrics and Gynecology2009;201(4):357.e1‐357.e7. ">Bloom 2006</a>; <a href="./references#CD004075-bbs2-0002" title="CaliskanE , CakirogluY , CorakciA , OzerenS . Reduction in caesarean delivery with fetal heart rate monitoring and intermittent pulse oximetry after induction of labour with misoprostol. Journal of Maternal‐Fetal &amp; Neonatal Medicine2009; Vol. 22, issue 5:445‐51. ">Caliskan 2009</a>; <a href="./references#CD004075-bbs2-0003" title="ColditzPB , EastCE . PTO360. Fetal intrapartum pulse oximetry: a multicentre randomised controlled trial. Perinatal Trials Report. www.ctc.usyd.edu.au/6registry/PTO360.htm (accessed 3 Feb 2004). EastC , ChanFY , BrenneckeS , KingJ , ColditzP , the Foremost Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S102. EastC , GascoineM , DoranC , BrenneckeS , KingJ , ColditzP , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomized controlled trial (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S101. EastCE , BrenneckeSP , ChanFY , KingJF , BellerEM , ColditzPB . Clinicians' evaluations of fetal oximetry sensor placement in a multicentre randomised trial (the foremost trial). Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2006;46(3):234‐9. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a nonreassuring fetal heart rate pattern, on operative delivery rates: a multicenter, randomized, controlled trial (the FOREMOST trial). American Journal of Obstetrics and Gynecology2006;194(3):606.e1‐16. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST study group. Fetal pulse oximetry clinical trial (the FOREMOST trial). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:166. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a non‐reassuring fetal heart rate pattern, on operative delivery rates: a multicenter randomized controlled trial (The FOREMOST Trial). American Journal of Obstetrics and Gynecology. 2005; Vol. 193, issue 6 Suppl:S33. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (the FOREMOST trial). Birth2006;33(2):101‐9. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST study group. Childbearing women's experience in the FOREMOST trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:365. EastCE , GascoigneMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomised controlled trial (the FOREMOST trial). BJOG: an international journal of obstetrics and gynaecology2006;113:1080‐7. EastCE , GasgoineMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. Cost‐effectiveness of fetal pulse oximetry (FOREMOST). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:202. ">East 2006</a>; and <a href="./references#CD004075-bbs2-0004" title="DildyG , GariteT , McNamaraH , SwedlowD , Mallinckrodt (Nellcor) Fetal Oximetry Research Group. A multicenter randomized trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2000;182(1 Pt 2):S12. DildyGA , ClarkSL , GariteTJ , PorterRF , SwedlowDB , VarnerMW . Current status of the multicenter randomized clinical trial on fetal oxygen saturation monitoring in the United States. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1997;72 Suppl 1:S43‐S50. GariteTJ , DildyGA , McNamaraH , NageotteMP , BoehmFH , DellingerEH , et al. A multicenter controlled trial of fetal pulse oximetry in the intrapartum management of nonreassuring fetal heart rate patterns. American Journal of Obstetrics and Gynecology2000;183(5):1049‐58. GorenbergD , PattilloC , HendiP , RumneyP , GariteT . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S129. GorenbergDM , PattilloC , HendiP , RumneyPJ , GariteTJ . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes. American Journal of Obstetrics and Gynecology2003;189(1):136‐8. HenigsmanS , GariteT , PattilloC , BrewsterW . Fetal pulse oximetry: defining which variable decelerations with slow return to baseline are associated with hypoxia [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. LeeR , MooreM , BrewsterW , HendiP , PattilloC , ZiogasA , et al. All non‐reactive fetal heart rate tracings are not equal [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. Mallinckrodt , Inc . Summary of safety and effectiveness information data. OxiFirst® Fetal Oxygen Saturation Monitoring System2000. MillerH . Differences in cervical dilatation and induction in patients delivered because of dystocia during a multicenter randomized clinical trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S124. PorrecoR , GariteJ , SwedlowD , ThomasS . The occurrence of dystocia among patients monitored in labor with fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S19. ">Garite 2000</a> to rate the risk of bias as low. The report by <a href="./references#CD004075-bbs2-0007" title="ParejaMV , PrietoAP , BadilloMPC , HerrezueloIP , VentosoFM . Comparison of the effectiveness between the fetal pulse oximetry and fetal electrocardiogram during intrapartum fetal well‐being loss risks. Progresos de Obstetricia y Ginecologia2010;53(4):141‐7. PrietoAP , ParejaMV , ZunigaIV , RomeroTA , LeonMDR , VentosoFM . Pulse oximetry compared with fetal electrocardiogram to control intrapartum fetal wellbeing. Journal of Maternal‐Fetal and Neonatal Medicine2008; Vol. 21, issue Suppl 1:141. ValverdeM , PuertasAM , Lopez‐GallegoMF , CarrilloMP , AguilarMT , MontoyaF . Effectiveness of pulse oximetry versus fetal electrocardiography for the intrapartum evaluation of nonreassuring fetal heart rate. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2011;159(2):333‐7. Valverde ParejaM , MartinezMDM , GuadixBR , VentosoFM , PrietoAP , CriadoMSL . Comparison between the pulse oximetry's effectiveness and electrocardiogram's effectiveness; two methods of fetal intrapartum monitoring. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):627. Valverde ParejaM , Romero GuadixB , Moreno MartinezMD , Puertas PrietoAA , Montoya VentosoF . Influence of two methods of fetal intrapartum monitoring; pulse oximetry and fetal electrocardiogram for the duration of the labor, in the presence of alterations in the fetal heart rate. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):243. ">Valverde 2011</a> indicated that sealed, opaque envelopes were used, but we were unable to confirm whether or not these were sequentially numbered, thus rating this as unclear risk of bias. <a href="./references#CD004075-bbs2-0005" title="KlauserCK , ChristensenEE , ChauhanSP , BufkinL , MagannEF , BofillJA , et al. Use of fetal pulse oximetry among high‐risk women in labour: a randomized clinical trial. American Journal of Obstetrics and Gynecology2005;192:1810‐7. ">Klauser 2005</a> and <a href="./references#CD004075-bbs2-0006" title="KuhnertM , SchmidtS . Intrapartum management of nonreassuring fetal heart rate patterns: a randomized controlled trial of fetal pulse oximetry. American Journal of Obstetrics and Gynecology2004;191:1989‐95. ">Kuhnert 2004</a> did not report methods of randomisation and allocation concealment (unclear risk). </p> </section> <section id="CD004075-sec-0073"> <h4 class="title">Blinding</h4> <p>In all studies (<a href="./references#CD004075-bbs2-0001" title="BloomSL , SpongCY , ThomE , VarnerMW , RouseDJ , WeiningerS , et al. Fetal pulse oximetry and cesarean delivery. New England Journal of Medicine2006;355(21):2195‐202. BloomSL , for the NICHD MFMU Network. The MFMU Network randomized trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2006;196(6 Suppl):S2. Maternal Fetal Medicine Units Network. The FOX trial: a randomized clinical trial of fetal pulse oximetry. http://www.bsc.gwu.edu/mfmu/Projects/fox.cgi (accessed 7 August 2006). RouseD , ShriverEK . Second stage of labour duration: relationship to maternal and perinatal outcomes. American Journal of Obstetrics and Gynecology2008;199(6 Suppl 1):S37. RouseDJ , WeinerSJ , BloomSL , VarnerMW , SpongCY , RaminSM , et al. Second‐stage labor duration in nulliparous women: relationship to maternal and perinatal outcomes. American Journal of Obstetrics and Gynecology2009;201(4):357.e1‐357.e7. ">Bloom 2006</a>; <a href="./references#CD004075-bbs2-0002" title="CaliskanE , CakirogluY , CorakciA , OzerenS . Reduction in caesarean delivery with fetal heart rate monitoring and intermittent pulse oximetry after induction of labour with misoprostol. Journal of Maternal‐Fetal &amp; Neonatal Medicine2009; Vol. 22, issue 5:445‐51. ">Caliskan 2009</a>; <a href="./references#CD004075-bbs2-0003" title="ColditzPB , EastCE . PTO360. Fetal intrapartum pulse oximetry: a multicentre randomised controlled trial. Perinatal Trials Report. www.ctc.usyd.edu.au/6registry/PTO360.htm (accessed 3 Feb 2004). EastC , ChanFY , BrenneckeS , KingJ , ColditzP , the Foremost Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S102. EastC , GascoineM , DoranC , BrenneckeS , KingJ , ColditzP , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomized controlled trial (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S101. EastCE , BrenneckeSP , ChanFY , KingJF , BellerEM , ColditzPB . Clinicians' evaluations of fetal oximetry sensor placement in a multicentre randomised trial (the foremost trial). Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2006;46(3):234‐9. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a nonreassuring fetal heart rate pattern, on operative delivery rates: a multicenter, randomized, controlled trial (the FOREMOST trial). American Journal of Obstetrics and Gynecology2006;194(3):606.e1‐16. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST study group. Fetal pulse oximetry clinical trial (the FOREMOST trial). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:166. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a non‐reassuring fetal heart rate pattern, on operative delivery rates: a multicenter randomized controlled trial (The FOREMOST Trial). American Journal of Obstetrics and Gynecology. 2005; Vol. 193, issue 6 Suppl:S33. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (the FOREMOST trial). Birth2006;33(2):101‐9. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST study group. Childbearing women's experience in the FOREMOST trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:365. EastCE , GascoigneMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomised controlled trial (the FOREMOST trial). BJOG: an international journal of obstetrics and gynaecology2006;113:1080‐7. EastCE , GasgoineMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. Cost‐effectiveness of fetal pulse oximetry (FOREMOST). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:202. ">East 2006</a>; <a href="./references#CD004075-bbs2-0004" title="DildyG , GariteT , McNamaraH , SwedlowD , Mallinckrodt (Nellcor) Fetal Oximetry Research Group. A multicenter randomized trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2000;182(1 Pt 2):S12. DildyGA , ClarkSL , GariteTJ , PorterRF , SwedlowDB , VarnerMW . Current status of the multicenter randomized clinical trial on fetal oxygen saturation monitoring in the United States. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1997;72 Suppl 1:S43‐S50. GariteTJ , DildyGA , McNamaraH , NageotteMP , BoehmFH , DellingerEH , et al. A multicenter controlled trial of fetal pulse oximetry in the intrapartum management of nonreassuring fetal heart rate patterns. American Journal of Obstetrics and Gynecology2000;183(5):1049‐58. GorenbergD , PattilloC , HendiP , RumneyP , GariteT . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S129. GorenbergDM , PattilloC , HendiP , RumneyPJ , GariteTJ . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes. American Journal of Obstetrics and Gynecology2003;189(1):136‐8. HenigsmanS , GariteT , PattilloC , BrewsterW . Fetal pulse oximetry: defining which variable decelerations with slow return to baseline are associated with hypoxia [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. LeeR , MooreM , BrewsterW , HendiP , PattilloC , ZiogasA , et al. All non‐reactive fetal heart rate tracings are not equal [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. Mallinckrodt , Inc . Summary of safety and effectiveness information data. OxiFirst® Fetal Oxygen Saturation Monitoring System2000. MillerH . Differences in cervical dilatation and induction in patients delivered because of dystocia during a multicenter randomized clinical trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S124. PorrecoR , GariteJ , SwedlowD , ThomasS . The occurrence of dystocia among patients monitored in labor with fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S19. ">Garite 2000</a>; <a href="./references#CD004075-bbs2-0005" title="KlauserCK , ChristensenEE , ChauhanSP , BufkinL , MagannEF , BofillJA , et al. Use of fetal pulse oximetry among high‐risk women in labour: a randomized clinical trial. American Journal of Obstetrics and Gynecology2005;192:1810‐7. ">Klauser 2005</a>; <a href="./references#CD004075-bbs2-0006" title="KuhnertM , SchmidtS . Intrapartum management of nonreassuring fetal heart rate patterns: a randomized controlled trial of fetal pulse oximetry. American Journal of Obstetrics and Gynecology2004;191:1989‐95. ">Kuhnert 2004</a>; <a href="./references#CD004075-bbs2-0007" title="ParejaMV , PrietoAP , BadilloMPC , HerrezueloIP , VentosoFM . Comparison of the effectiveness between the fetal pulse oximetry and fetal electrocardiogram during intrapartum fetal well‐being loss risks. Progresos de Obstetricia y Ginecologia2010;53(4):141‐7. PrietoAP , ParejaMV , ZunigaIV , RomeroTA , LeonMDR , VentosoFM . Pulse oximetry compared with fetal electrocardiogram to control intrapartum fetal wellbeing. Journal of Maternal‐Fetal and Neonatal Medicine2008; Vol. 21, issue Suppl 1:141. ValverdeM , PuertasAM , Lopez‐GallegoMF , CarrilloMP , AguilarMT , MontoyaF . Effectiveness of pulse oximetry versus fetal electrocardiography for the intrapartum evaluation of nonreassuring fetal heart rate. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2011;159(2):333‐7. Valverde ParejaM , MartinezMDM , GuadixBR , VentosoFM , PrietoAP , CriadoMSL . Comparison between the pulse oximetry's effectiveness and electrocardiogram's effectiveness; two methods of fetal intrapartum monitoring. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):627. Valverde ParejaM , Romero GuadixB , Moreno MartinezMD , Puertas PrietoAA , Montoya VentosoF . Influence of two methods of fetal intrapartum monitoring; pulse oximetry and fetal electrocardiogram for the duration of the labor, in the presence of alterations in the fetal heart rate. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):243. ">Valverde 2011</a>), blinding of the participants or clinicians (performance bias) was not feasible given that FSpO<sub>2</sub> values were used for clinical judgement. The 'masked' group in the study by <a href="./references#CD004075-bbs2-0001" title="BloomSL , SpongCY , ThomE , VarnerMW , RouseDJ , WeiningerS , et al. Fetal pulse oximetry and cesarean delivery. New England Journal of Medicine2006;355(21):2195‐202. BloomSL , for the NICHD MFMU Network. The MFMU Network randomized trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2006;196(6 Suppl):S2. Maternal Fetal Medicine Units Network. The FOX trial: a randomized clinical trial of fetal pulse oximetry. http://www.bsc.gwu.edu/mfmu/Projects/fox.cgi (accessed 7 August 2006). RouseD , ShriverEK . Second stage of labour duration: relationship to maternal and perinatal outcomes. American Journal of Obstetrics and Gynecology2008;199(6 Suppl 1):S37. RouseDJ , WeinerSJ , BloomSL , VarnerMW , SpongCY , RaminSM , et al. Second‐stage labor duration in nulliparous women: relationship to maternal and perinatal outcomes. American Journal of Obstetrics and Gynecology2009;201(4):357.e1‐357.e7. ">Bloom 2006</a> meant that the labouring woman and clinicians were blinded to fetal oximetry values, although both the women and clinicians were aware of group allocation. The overall risk of bias for these studies was therefore high for blinding of participants and clinicians. </p> <p>Outcome assessment (detection bias) of the study reported by <a href="./references#CD004075-bbs2-0001" title="BloomSL , SpongCY , ThomE , VarnerMW , RouseDJ , WeiningerS , et al. Fetal pulse oximetry and cesarean delivery. New England Journal of Medicine2006;355(21):2195‐202. BloomSL , for the NICHD MFMU Network. The MFMU Network randomized trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2006;196(6 Suppl):S2. Maternal Fetal Medicine Units Network. The FOX trial: a randomized clinical trial of fetal pulse oximetry. http://www.bsc.gwu.edu/mfmu/Projects/fox.cgi (accessed 7 August 2006). RouseD , ShriverEK . Second stage of labour duration: relationship to maternal and perinatal outcomes. American Journal of Obstetrics and Gynecology2008;199(6 Suppl 1):S37. RouseDJ , WeinerSJ , BloomSL , VarnerMW , SpongCY , RaminSM , et al. Second‐stage labor duration in nulliparous women: relationship to maternal and perinatal outcomes. American Journal of Obstetrics and Gynecology2009;201(4):357.e1‐357.e7. ">Bloom 2006</a> was conducted by staff who were unaware of group allocation, giving it a rating of low risk. All remaining studies and their outcomes were assessed either unblinded (and therefore high risk, <a href="./references#CD004075-bbs2-0003" title="ColditzPB , EastCE . PTO360. Fetal intrapartum pulse oximetry: a multicentre randomised controlled trial. Perinatal Trials Report. www.ctc.usyd.edu.au/6registry/PTO360.htm (accessed 3 Feb 2004). EastC , ChanFY , BrenneckeS , KingJ , ColditzP , the Foremost Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S102. EastC , GascoineM , DoranC , BrenneckeS , KingJ , ColditzP , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomized controlled trial (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S101. EastCE , BrenneckeSP , ChanFY , KingJF , BellerEM , ColditzPB . Clinicians' evaluations of fetal oximetry sensor placement in a multicentre randomised trial (the foremost trial). Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2006;46(3):234‐9. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a nonreassuring fetal heart rate pattern, on operative delivery rates: a multicenter, randomized, controlled trial (the FOREMOST trial). American Journal of Obstetrics and Gynecology2006;194(3):606.e1‐16. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST study group. Fetal pulse oximetry clinical trial (the FOREMOST trial). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:166. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a non‐reassuring fetal heart rate pattern, on operative delivery rates: a multicenter randomized controlled trial (The FOREMOST Trial). American Journal of Obstetrics and Gynecology. 2005; Vol. 193, issue 6 Suppl:S33. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (the FOREMOST trial). Birth2006;33(2):101‐9. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST study group. Childbearing women's experience in the FOREMOST trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:365. EastCE , GascoigneMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomised controlled trial (the FOREMOST trial). BJOG: an international journal of obstetrics and gynaecology2006;113:1080‐7. EastCE , GasgoineMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. Cost‐effectiveness of fetal pulse oximetry (FOREMOST). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:202. ">East 2006</a>; <a href="./references#CD004075-bbs2-0004" title="DildyG , GariteT , McNamaraH , SwedlowD , Mallinckrodt (Nellcor) Fetal Oximetry Research Group. A multicenter randomized trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2000;182(1 Pt 2):S12. DildyGA , ClarkSL , GariteTJ , PorterRF , SwedlowDB , VarnerMW . Current status of the multicenter randomized clinical trial on fetal oxygen saturation monitoring in the United States. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1997;72 Suppl 1:S43‐S50. GariteTJ , DildyGA , McNamaraH , NageotteMP , BoehmFH , DellingerEH , et al. A multicenter controlled trial of fetal pulse oximetry in the intrapartum management of nonreassuring fetal heart rate patterns. American Journal of Obstetrics and Gynecology2000;183(5):1049‐58. GorenbergD , PattilloC , HendiP , RumneyP , GariteT . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S129. GorenbergDM , PattilloC , HendiP , RumneyPJ , GariteTJ . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes. American Journal of Obstetrics and Gynecology2003;189(1):136‐8. HenigsmanS , GariteT , PattilloC , BrewsterW . Fetal pulse oximetry: defining which variable decelerations with slow return to baseline are associated with hypoxia [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. LeeR , MooreM , BrewsterW , HendiP , PattilloC , ZiogasA , et al. All non‐reactive fetal heart rate tracings are not equal [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. Mallinckrodt , Inc . Summary of safety and effectiveness information data. OxiFirst® Fetal Oxygen Saturation Monitoring System2000. MillerH . Differences in cervical dilatation and induction in patients delivered because of dystocia during a multicenter randomized clinical trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S124. PorrecoR , GariteJ , SwedlowD , ThomasS . The occurrence of dystocia among patients monitored in labor with fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S19. ">Garite 2000</a>) or blinding was not specified (and therefore unclear risk, <a href="./references#CD004075-bbs2-0002" title="CaliskanE , CakirogluY , CorakciA , OzerenS . Reduction in caesarean delivery with fetal heart rate monitoring and intermittent pulse oximetry after induction of labour with misoprostol. Journal of Maternal‐Fetal &amp; Neonatal Medicine2009; Vol. 22, issue 5:445‐51. ">Caliskan 2009</a>; <a href="./references#CD004075-bbs2-0005" title="KlauserCK , ChristensenEE , ChauhanSP , BufkinL , MagannEF , BofillJA , et al. Use of fetal pulse oximetry among high‐risk women in labour: a randomized clinical trial. American Journal of Obstetrics and Gynecology2005;192:1810‐7. ">Klauser 2005</a>; <a href="./references#CD004075-bbs2-0006" title="KuhnertM , SchmidtS . Intrapartum management of nonreassuring fetal heart rate patterns: a randomized controlled trial of fetal pulse oximetry. American Journal of Obstetrics and Gynecology2004;191:1989‐95. ">Kuhnert 2004</a>; <a href="./references#CD004075-bbs2-0007" title="ParejaMV , PrietoAP , BadilloMPC , HerrezueloIP , VentosoFM . Comparison of the effectiveness between the fetal pulse oximetry and fetal electrocardiogram during intrapartum fetal well‐being loss risks. Progresos de Obstetricia y Ginecologia2010;53(4):141‐7. PrietoAP , ParejaMV , ZunigaIV , RomeroTA , LeonMDR , VentosoFM . Pulse oximetry compared with fetal electrocardiogram to control intrapartum fetal wellbeing. Journal of Maternal‐Fetal and Neonatal Medicine2008; Vol. 21, issue Suppl 1:141. ValverdeM , PuertasAM , Lopez‐GallegoMF , CarrilloMP , AguilarMT , MontoyaF . Effectiveness of pulse oximetry versus fetal electrocardiography for the intrapartum evaluation of nonreassuring fetal heart rate. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2011;159(2):333‐7. Valverde ParejaM , MartinezMDM , GuadixBR , VentosoFM , PrietoAP , CriadoMSL . Comparison between the pulse oximetry's effectiveness and electrocardiogram's effectiveness; two methods of fetal intrapartum monitoring. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):627. Valverde ParejaM , Romero GuadixB , Moreno MartinezMD , Puertas PrietoAA , Montoya VentosoF . Influence of two methods of fetal intrapartum monitoring; pulse oximetry and fetal electrocardiogram for the duration of the labor, in the presence of alterations in the fetal heart rate. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):243. ">Valverde 2011</a>). A blinded outcome assessor analysis was performed for a post hoc analysis of partograms in the study by <a href="./references#CD004075-bbs2-0004" title="DildyG , GariteT , McNamaraH , SwedlowD , Mallinckrodt (Nellcor) Fetal Oximetry Research Group. A multicenter randomized trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2000;182(1 Pt 2):S12. DildyGA , ClarkSL , GariteTJ , PorterRF , SwedlowDB , VarnerMW . Current status of the multicenter randomized clinical trial on fetal oxygen saturation monitoring in the United States. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1997;72 Suppl 1:S43‐S50. GariteTJ , DildyGA , McNamaraH , NageotteMP , BoehmFH , DellingerEH , et al. A multicenter controlled trial of fetal pulse oximetry in the intrapartum management of nonreassuring fetal heart rate patterns. American Journal of Obstetrics and Gynecology2000;183(5):1049‐58. GorenbergD , PattilloC , HendiP , RumneyP , GariteT . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S129. GorenbergDM , PattilloC , HendiP , RumneyPJ , GariteTJ . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes. American Journal of Obstetrics and Gynecology2003;189(1):136‐8. HenigsmanS , GariteT , PattilloC , BrewsterW . Fetal pulse oximetry: defining which variable decelerations with slow return to baseline are associated with hypoxia [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. LeeR , MooreM , BrewsterW , HendiP , PattilloC , ZiogasA , et al. All non‐reactive fetal heart rate tracings are not equal [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. Mallinckrodt , Inc . Summary of safety and effectiveness information data. OxiFirst® Fetal Oxygen Saturation Monitoring System2000. MillerH . Differences in cervical dilatation and induction in patients delivered because of dystocia during a multicenter randomized clinical trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S124. PorrecoR , GariteJ , SwedlowD , ThomasS . The occurrence of dystocia among patients monitored in labor with fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S19. ">Garite 2000</a>, conducted to demonstrate progress in labour for all cases of dystocia (defined) and failed induction of labour (defined). </p> </section> <section id="CD004075-sec-0074"> <h4 class="title">Incomplete outcome data</h4> <p>All participants acknowledged to have been enrolled in the seven published studies were accounted for, suggesting that there was a low risk of bias for outcome data. This could be confirmed for three studies that had protocols available prior to or during the trial conduct (<a href="./references#CD004075-bbs2-0001" title="BloomSL , SpongCY , ThomE , VarnerMW , RouseDJ , WeiningerS , et al. Fetal pulse oximetry and cesarean delivery. New England Journal of Medicine2006;355(21):2195‐202. BloomSL , for the NICHD MFMU Network. The MFMU Network randomized trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2006;196(6 Suppl):S2. Maternal Fetal Medicine Units Network. The FOX trial: a randomized clinical trial of fetal pulse oximetry. http://www.bsc.gwu.edu/mfmu/Projects/fox.cgi (accessed 7 August 2006). RouseD , ShriverEK . Second stage of labour duration: relationship to maternal and perinatal outcomes. American Journal of Obstetrics and Gynecology2008;199(6 Suppl 1):S37. RouseDJ , WeinerSJ , BloomSL , VarnerMW , SpongCY , RaminSM , et al. Second‐stage labor duration in nulliparous women: relationship to maternal and perinatal outcomes. American Journal of Obstetrics and Gynecology2009;201(4):357.e1‐357.e7. ">Bloom 2006</a>; <a href="./references#CD004075-bbs2-0003" title="ColditzPB , EastCE . PTO360. Fetal intrapartum pulse oximetry: a multicentre randomised controlled trial. Perinatal Trials Report. www.ctc.usyd.edu.au/6registry/PTO360.htm (accessed 3 Feb 2004). EastC , ChanFY , BrenneckeS , KingJ , ColditzP , the Foremost Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S102. EastC , GascoineM , DoranC , BrenneckeS , KingJ , ColditzP , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomized controlled trial (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S101. EastCE , BrenneckeSP , ChanFY , KingJF , BellerEM , ColditzPB . Clinicians' evaluations of fetal oximetry sensor placement in a multicentre randomised trial (the foremost trial). Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2006;46(3):234‐9. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a nonreassuring fetal heart rate pattern, on operative delivery rates: a multicenter, randomized, controlled trial (the FOREMOST trial). American Journal of Obstetrics and Gynecology2006;194(3):606.e1‐16. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST study group. Fetal pulse oximetry clinical trial (the FOREMOST trial). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:166. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a non‐reassuring fetal heart rate pattern, on operative delivery rates: a multicenter randomized controlled trial (The FOREMOST Trial). American Journal of Obstetrics and Gynecology. 2005; Vol. 193, issue 6 Suppl:S33. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (the FOREMOST trial). Birth2006;33(2):101‐9. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST study group. Childbearing women's experience in the FOREMOST trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:365. EastCE , GascoigneMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomised controlled trial (the FOREMOST trial). BJOG: an international journal of obstetrics and gynaecology2006;113:1080‐7. EastCE , GasgoineMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. Cost‐effectiveness of fetal pulse oximetry (FOREMOST). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:202. ">East 2006</a>; <a href="./references#CD004075-bbs2-0004" title="DildyG , GariteT , McNamaraH , SwedlowD , Mallinckrodt (Nellcor) Fetal Oximetry Research Group. A multicenter randomized trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2000;182(1 Pt 2):S12. DildyGA , ClarkSL , GariteTJ , PorterRF , SwedlowDB , VarnerMW . Current status of the multicenter randomized clinical trial on fetal oxygen saturation monitoring in the United States. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1997;72 Suppl 1:S43‐S50. GariteTJ , DildyGA , McNamaraH , NageotteMP , BoehmFH , DellingerEH , et al. A multicenter controlled trial of fetal pulse oximetry in the intrapartum management of nonreassuring fetal heart rate patterns. American Journal of Obstetrics and Gynecology2000;183(5):1049‐58. GorenbergD , PattilloC , HendiP , RumneyP , GariteT . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S129. GorenbergDM , PattilloC , HendiP , RumneyPJ , GariteTJ . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes. American Journal of Obstetrics and Gynecology2003;189(1):136‐8. HenigsmanS , GariteT , PattilloC , BrewsterW . Fetal pulse oximetry: defining which variable decelerations with slow return to baseline are associated with hypoxia [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. LeeR , MooreM , BrewsterW , HendiP , PattilloC , ZiogasA , et al. All non‐reactive fetal heart rate tracings are not equal [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. Mallinckrodt , Inc . Summary of safety and effectiveness information data. OxiFirst® Fetal Oxygen Saturation Monitoring System2000. MillerH . Differences in cervical dilatation and induction in patients delivered because of dystocia during a multicenter randomized clinical trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S124. PorrecoR , GariteJ , SwedlowD , ThomasS . The occurrence of dystocia among patients monitored in labor with fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S19. ">Garite 2000</a>). </p> </section> <section id="CD004075-sec-0075"> <h4 class="title">Selective reporting</h4> <p>The availability of the trial protocols prior to or during the studies by <a href="./references#CD004075-bbs2-0001" title="BloomSL , SpongCY , ThomE , VarnerMW , RouseDJ , WeiningerS , et al. Fetal pulse oximetry and cesarean delivery. New England Journal of Medicine2006;355(21):2195‐202. BloomSL , for the NICHD MFMU Network. The MFMU Network randomized trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2006;196(6 Suppl):S2. Maternal Fetal Medicine Units Network. The FOX trial: a randomized clinical trial of fetal pulse oximetry. http://www.bsc.gwu.edu/mfmu/Projects/fox.cgi (accessed 7 August 2006). RouseD , ShriverEK . Second stage of labour duration: relationship to maternal and perinatal outcomes. American Journal of Obstetrics and Gynecology2008;199(6 Suppl 1):S37. RouseDJ , WeinerSJ , BloomSL , VarnerMW , SpongCY , RaminSM , et al. Second‐stage labor duration in nulliparous women: relationship to maternal and perinatal outcomes. American Journal of Obstetrics and Gynecology2009;201(4):357.e1‐357.e7. ">Bloom 2006</a>; <a href="./references#CD004075-bbs2-0003" title="ColditzPB , EastCE . PTO360. Fetal intrapartum pulse oximetry: a multicentre randomised controlled trial. Perinatal Trials Report. www.ctc.usyd.edu.au/6registry/PTO360.htm (accessed 3 Feb 2004). EastC , ChanFY , BrenneckeS , KingJ , ColditzP , the Foremost Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S102. EastC , GascoineM , DoranC , BrenneckeS , KingJ , ColditzP , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomized controlled trial (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S101. EastCE , BrenneckeSP , ChanFY , KingJF , BellerEM , ColditzPB . Clinicians' evaluations of fetal oximetry sensor placement in a multicentre randomised trial (the foremost trial). Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2006;46(3):234‐9. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a nonreassuring fetal heart rate pattern, on operative delivery rates: a multicenter, randomized, controlled trial (the FOREMOST trial). American Journal of Obstetrics and Gynecology2006;194(3):606.e1‐16. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST study group. Fetal pulse oximetry clinical trial (the FOREMOST trial). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:166. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a non‐reassuring fetal heart rate pattern, on operative delivery rates: a multicenter randomized controlled trial (The FOREMOST Trial). American Journal of Obstetrics and Gynecology. 2005; Vol. 193, issue 6 Suppl:S33. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (the FOREMOST trial). Birth2006;33(2):101‐9. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST study group. Childbearing women's experience in the FOREMOST trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:365. EastCE , GascoigneMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomised controlled trial (the FOREMOST trial). BJOG: an international journal of obstetrics and gynaecology2006;113:1080‐7. EastCE , GasgoineMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. Cost‐effectiveness of fetal pulse oximetry (FOREMOST). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:202. ">East 2006</a>; <a href="./references#CD004075-bbs2-0004" title="DildyG , GariteT , McNamaraH , SwedlowD , Mallinckrodt (Nellcor) Fetal Oximetry Research Group. A multicenter randomized trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2000;182(1 Pt 2):S12. DildyGA , ClarkSL , GariteTJ , PorterRF , SwedlowDB , VarnerMW . Current status of the multicenter randomized clinical trial on fetal oxygen saturation monitoring in the United States. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1997;72 Suppl 1:S43‐S50. GariteTJ , DildyGA , McNamaraH , NageotteMP , BoehmFH , DellingerEH , et al. A multicenter controlled trial of fetal pulse oximetry in the intrapartum management of nonreassuring fetal heart rate patterns. American Journal of Obstetrics and Gynecology2000;183(5):1049‐58. GorenbergD , PattilloC , HendiP , RumneyP , GariteT . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S129. GorenbergDM , PattilloC , HendiP , RumneyPJ , GariteTJ . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes. American Journal of Obstetrics and Gynecology2003;189(1):136‐8. HenigsmanS , GariteT , PattilloC , BrewsterW . Fetal pulse oximetry: defining which variable decelerations with slow return to baseline are associated with hypoxia [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. LeeR , MooreM , BrewsterW , HendiP , PattilloC , ZiogasA , et al. All non‐reactive fetal heart rate tracings are not equal [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. Mallinckrodt , Inc . Summary of safety and effectiveness information data. OxiFirst® Fetal Oxygen Saturation Monitoring System2000. MillerH . Differences in cervical dilatation and induction in patients delivered because of dystocia during a multicenter randomized clinical trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S124. PorrecoR , GariteJ , SwedlowD , ThomasS . The occurrence of dystocia among patients monitored in labor with fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S19. ">Garite 2000</a> provided evidence of a low risk of bias for selective reporting. There is no evidence to support any concerns of reporting bias in the remainder of the studies (<a href="./references#CD004075-bbs2-0002" title="CaliskanE , CakirogluY , CorakciA , OzerenS . Reduction in caesarean delivery with fetal heart rate monitoring and intermittent pulse oximetry after induction of labour with misoprostol. Journal of Maternal‐Fetal &amp; Neonatal Medicine2009; Vol. 22, issue 5:445‐51. ">Caliskan 2009</a>; <a href="./references#CD004075-bbs2-0005" title="KlauserCK , ChristensenEE , ChauhanSP , BufkinL , MagannEF , BofillJA , et al. Use of fetal pulse oximetry among high‐risk women in labour: a randomized clinical trial. American Journal of Obstetrics and Gynecology2005;192:1810‐7. ">Klauser 2005</a>; <a href="./references#CD004075-bbs2-0006" title="KuhnertM , SchmidtS . Intrapartum management of nonreassuring fetal heart rate patterns: a randomized controlled trial of fetal pulse oximetry. American Journal of Obstetrics and Gynecology2004;191:1989‐95. ">Kuhnert 2004</a>; <a href="./references#CD004075-bbs2-0007" title="ParejaMV , PrietoAP , BadilloMPC , HerrezueloIP , VentosoFM . Comparison of the effectiveness between the fetal pulse oximetry and fetal electrocardiogram during intrapartum fetal well‐being loss risks. Progresos de Obstetricia y Ginecologia2010;53(4):141‐7. PrietoAP , ParejaMV , ZunigaIV , RomeroTA , LeonMDR , VentosoFM . Pulse oximetry compared with fetal electrocardiogram to control intrapartum fetal wellbeing. Journal of Maternal‐Fetal and Neonatal Medicine2008; Vol. 21, issue Suppl 1:141. ValverdeM , PuertasAM , Lopez‐GallegoMF , CarrilloMP , AguilarMT , MontoyaF . Effectiveness of pulse oximetry versus fetal electrocardiography for the intrapartum evaluation of nonreassuring fetal heart rate. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2011;159(2):333‐7. Valverde ParejaM , MartinezMDM , GuadixBR , VentosoFM , PrietoAP , CriadoMSL . Comparison between the pulse oximetry's effectiveness and electrocardiogram's effectiveness; two methods of fetal intrapartum monitoring. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):627. Valverde ParejaM , Romero GuadixB , Moreno MartinezMD , Puertas PrietoAA , Montoya VentosoF . Influence of two methods of fetal intrapartum monitoring; pulse oximetry and fetal electrocardiogram for the duration of the labor, in the presence of alterations in the fetal heart rate. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):243. ">Valverde 2011</a>). </p> </section> <section id="CD004075-sec-0076"> <h4 class="title">Other potential sources of bias</h4> <p>Two studies had elements of high risk of other sources of bias, in so far as the study by <a href="./references#CD004075-bbs2-0004" title="DildyG , GariteT , McNamaraH , SwedlowD , Mallinckrodt (Nellcor) Fetal Oximetry Research Group. A multicenter randomized trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2000;182(1 Pt 2):S12. DildyGA , ClarkSL , GariteTJ , PorterRF , SwedlowDB , VarnerMW . Current status of the multicenter randomized clinical trial on fetal oxygen saturation monitoring in the United States. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1997;72 Suppl 1:S43‐S50. GariteTJ , DildyGA , McNamaraH , NageotteMP , BoehmFH , DellingerEH , et al. A multicenter controlled trial of fetal pulse oximetry in the intrapartum management of nonreassuring fetal heart rate patterns. American Journal of Obstetrics and Gynecology2000;183(5):1049‐58. GorenbergD , PattilloC , HendiP , RumneyP , GariteT . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S129. GorenbergDM , PattilloC , HendiP , RumneyPJ , GariteTJ . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes. American Journal of Obstetrics and Gynecology2003;189(1):136‐8. HenigsmanS , GariteT , PattilloC , BrewsterW . Fetal pulse oximetry: defining which variable decelerations with slow return to baseline are associated with hypoxia [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. LeeR , MooreM , BrewsterW , HendiP , PattilloC , ZiogasA , et al. All non‐reactive fetal heart rate tracings are not equal [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. Mallinckrodt , Inc . Summary of safety and effectiveness information data. OxiFirst® Fetal Oxygen Saturation Monitoring System2000. MillerH . Differences in cervical dilatation and induction in patients delivered because of dystocia during a multicenter randomized clinical trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S124. PorrecoR , GariteJ , SwedlowD , ThomasS . The occurrence of dystocia among patients monitored in labor with fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S19. ">Garite 2000</a> was funded by the manufacturer of the fetal pulse oximetry used in the trial and funding from this manufacturer also contributed to overall funds for the trial reported by <a href="./references#CD004075-bbs2-0003" title="ColditzPB , EastCE . PTO360. Fetal intrapartum pulse oximetry: a multicentre randomised controlled trial. Perinatal Trials Report. www.ctc.usyd.edu.au/6registry/PTO360.htm (accessed 3 Feb 2004). EastC , ChanFY , BrenneckeS , KingJ , ColditzP , the Foremost Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S102. EastC , GascoineM , DoranC , BrenneckeS , KingJ , ColditzP , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomized controlled trial (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S101. EastCE , BrenneckeSP , ChanFY , KingJF , BellerEM , ColditzPB . Clinicians' evaluations of fetal oximetry sensor placement in a multicentre randomised trial (the foremost trial). Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2006;46(3):234‐9. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a nonreassuring fetal heart rate pattern, on operative delivery rates: a multicenter, randomized, controlled trial (the FOREMOST trial). American Journal of Obstetrics and Gynecology2006;194(3):606.e1‐16. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST study group. Fetal pulse oximetry clinical trial (the FOREMOST trial). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:166. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a non‐reassuring fetal heart rate pattern, on operative delivery rates: a multicenter randomized controlled trial (The FOREMOST Trial). American Journal of Obstetrics and Gynecology. 2005; Vol. 193, issue 6 Suppl:S33. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (the FOREMOST trial). Birth2006;33(2):101‐9. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST study group. Childbearing women's experience in the FOREMOST trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:365. EastCE , GascoigneMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomised controlled trial (the FOREMOST trial). BJOG: an international journal of obstetrics and gynaecology2006;113:1080‐7. EastCE , GasgoineMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. Cost‐effectiveness of fetal pulse oximetry (FOREMOST). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:202. ">East 2006</a>. The large difference in findings from the study reported by <a href="./references#CD004075-bbs2-0006" title="KuhnertM , SchmidtS . Intrapartum management of nonreassuring fetal heart rate patterns: a randomized controlled trial of fetal pulse oximetry. American Journal of Obstetrics and Gynecology2004;191:1989‐95. ">Kuhnert 2004</a> to those reported in the remaining studies raises the unconfirmed possibility of unclear risk of bias. There was no evidence to suggest other potential sources of bias in the remaining studies. </p> </section> </section> <section id="CD004075-sec-0077"> <h3 class="title" id="CD004075-sec-0077">Effects of interventions</h3> <p>We included seven trials involving 8013 participants in this review. Findings from one new trial, comparing fetal pulse oximetry plus CTG and fetal ECG plus CTG and involving 180 participants, was included in this 2014 update of the review ( <a href="./references#CD004075-bbs2-0007" title="ParejaMV , PrietoAP , BadilloMPC , HerrezueloIP , VentosoFM . Comparison of the effectiveness between the fetal pulse oximetry and fetal electrocardiogram during intrapartum fetal well‐being loss risks. Progresos de Obstetricia y Ginecologia2010;53(4):141‐7. PrietoAP , ParejaMV , ZunigaIV , RomeroTA , LeonMDR , VentosoFM . Pulse oximetry compared with fetal electrocardiogram to control intrapartum fetal wellbeing. Journal of Maternal‐Fetal and Neonatal Medicine2008; Vol. 21, issue Suppl 1:141. ValverdeM , PuertasAM , Lopez‐GallegoMF , CarrilloMP , AguilarMT , MontoyaF . Effectiveness of pulse oximetry versus fetal electrocardiography for the intrapartum evaluation of nonreassuring fetal heart rate. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2011;159(2):333‐7. Valverde ParejaM , MartinezMDM , GuadixBR , VentosoFM , PrietoAP , CriadoMSL . Comparison between the pulse oximetry's effectiveness and electrocardiogram's effectiveness; two methods of fetal intrapartum monitoring. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):627. Valverde ParejaM , Romero GuadixB , Moreno MartinezMD , Puertas PrietoAA , Montoya VentosoF . Influence of two methods of fetal intrapartum monitoring; pulse oximetry and fetal electrocardiogram for the duration of the labor, in the presence of alterations in the fetal heart rate. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):243. ">Valverde 2011</a>). </p> <section id="CD004075-sec-0078"> <h4 class="title">Primary outcomes</h4> <p>Where meta‐analysis was possible, findings from five of the seven trials resulted in no significant differences in the overall caesarean section rate between those monitored with fetal oximetry and those not monitored with fetal pulse oximetry or for whom the fetal pulse oximetry results were masked (four studies, n = 4008, summary risk ratio (RR) using random‐effects, 0.99, 95% confidence intervals (CI) 0.86 to 1.13, I² = 45, <a href="./references#CD004075-fig-0003" title="">Analysis 1.1</a>). A smaller study for which FBS was required prior to study entry (n = 146) reported a significant decrease in caesarean section in the fetal oximetry group, compared with the control group (<a href="./references#CD004075-fig-0003" title="">Analysis 1.1</a>; <a href="./references#CD004075-bbs2-0006" title="KuhnertM , SchmidtS . Intrapartum management of nonreassuring fetal heart rate patterns: a randomized controlled trial of fetal pulse oximetry. American Journal of Obstetrics and Gynecology2004;191:1989‐95. ">Kuhnert 2004</a>). The risk of overall caesarean section rate for those monitored with fetal pulse oximetry and CTG was higher than for those monitored with fetal ECG and CTG (one study, n = 180, RR 1.56, 95% CI 1.06 to 2.29, <a href="./references#CD004075-fig-0034" title="">Analysis 5.1</a>; <a href="./references#CD004075-bbs2-0007" title="ParejaMV , PrietoAP , BadilloMPC , HerrezueloIP , VentosoFM . Comparison of the effectiveness between the fetal pulse oximetry and fetal electrocardiogram during intrapartum fetal well‐being loss risks. Progresos de Obstetricia y Ginecologia2010;53(4):141‐7. PrietoAP , ParejaMV , ZunigaIV , RomeroTA , LeonMDR , VentosoFM . Pulse oximetry compared with fetal electrocardiogram to control intrapartum fetal wellbeing. Journal of Maternal‐Fetal and Neonatal Medicine2008; Vol. 21, issue Suppl 1:141. ValverdeM , PuertasAM , Lopez‐GallegoMF , CarrilloMP , AguilarMT , MontoyaF . Effectiveness of pulse oximetry versus fetal electrocardiography for the intrapartum evaluation of nonreassuring fetal heart rate. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2011;159(2):333‐7. Valverde ParejaM , MartinezMDM , GuadixBR , VentosoFM , PrietoAP , CriadoMSL . Comparison between the pulse oximetry's effectiveness and electrocardiogram's effectiveness; two methods of fetal intrapartum monitoring. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):627. Valverde ParejaM , Romero GuadixB , Moreno MartinezMD , Puertas PrietoAA , Montoya VentosoF . Influence of two methods of fetal intrapartum monitoring; pulse oximetry and fetal electrocardiogram for the duration of the labor, in the presence of alterations in the fetal heart rate. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):243. ">Valverde 2011</a>). Hypoxic ischaemic encephalopathy was reported in only one case, in the masked group of the study by <a href="./references#CD004075-bbs2-0001" title="BloomSL , SpongCY , ThomE , VarnerMW , RouseDJ , WeiningerS , et al. Fetal pulse oximetry and cesarean delivery. New England Journal of Medicine2006;355(21):2195‐202. BloomSL , for the NICHD MFMU Network. The MFMU Network randomized trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2006;196(6 Suppl):S2. Maternal Fetal Medicine Units Network. The FOX trial: a randomized clinical trial of fetal pulse oximetry. http://www.bsc.gwu.edu/mfmu/Projects/fox.cgi (accessed 7 August 2006). RouseD , ShriverEK . Second stage of labour duration: relationship to maternal and perinatal outcomes. American Journal of Obstetrics and Gynecology2008;199(6 Suppl 1):S37. RouseDJ , WeinerSJ , BloomSL , VarnerMW , SpongCY , RaminSM , et al. Second‐stage labor duration in nulliparous women: relationship to maternal and perinatal outcomes. American Journal of Obstetrics and Gynecology2009;201(4):357.e1‐357.e7. ">Bloom 2006</a> and generally not reported at all in other studies (<a href="./references#CD004075-fig-0004" title="">Analysis 1.2</a>). Few studies reported on neonatal seizures, with only one case reported in the control group of the trial by <a href="./references#CD004075-bbs2-0004" title="DildyG , GariteT , McNamaraH , SwedlowD , Mallinckrodt (Nellcor) Fetal Oximetry Research Group. A multicenter randomized trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2000;182(1 Pt 2):S12. DildyGA , ClarkSL , GariteTJ , PorterRF , SwedlowDB , VarnerMW . Current status of the multicenter randomized clinical trial on fetal oxygen saturation monitoring in the United States. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1997;72 Suppl 1:S43‐S50. GariteTJ , DildyGA , McNamaraH , NageotteMP , BoehmFH , DellingerEH , et al. A multicenter controlled trial of fetal pulse oximetry in the intrapartum management of nonreassuring fetal heart rate patterns. American Journal of Obstetrics and Gynecology2000;183(5):1049‐58. GorenbergD , PattilloC , HendiP , RumneyP , GariteT . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S129. GorenbergDM , PattilloC , HendiP , RumneyPJ , GariteTJ . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes. American Journal of Obstetrics and Gynecology2003;189(1):136‐8. HenigsmanS , GariteT , PattilloC , BrewsterW . Fetal pulse oximetry: defining which variable decelerations with slow return to baseline are associated with hypoxia [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. LeeR , MooreM , BrewsterW , HendiP , PattilloC , ZiogasA , et al. All non‐reactive fetal heart rate tracings are not equal [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. Mallinckrodt , Inc . Summary of safety and effectiveness information data. OxiFirst® Fetal Oxygen Saturation Monitoring System2000. MillerH . Differences in cervical dilatation and induction in patients delivered because of dystocia during a multicenter randomized clinical trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S124. PorrecoR , GariteJ , SwedlowD , ThomasS . The occurrence of dystocia among patients monitored in labor with fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S19. ">Garite 2000</a> and one clinical case in the intervention group of the trial by <a href="./references#CD004075-bbs2-0003" title="ColditzPB , EastCE . PTO360. Fetal intrapartum pulse oximetry: a multicentre randomised controlled trial. Perinatal Trials Report. www.ctc.usyd.edu.au/6registry/PTO360.htm (accessed 3 Feb 2004). EastC , ChanFY , BrenneckeS , KingJ , ColditzP , the Foremost Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S102. EastC , GascoineM , DoranC , BrenneckeS , KingJ , ColditzP , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomized controlled trial (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S101. EastCE , BrenneckeSP , ChanFY , KingJF , BellerEM , ColditzPB . Clinicians' evaluations of fetal oximetry sensor placement in a multicentre randomised trial (the foremost trial). Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2006;46(3):234‐9. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a nonreassuring fetal heart rate pattern, on operative delivery rates: a multicenter, randomized, controlled trial (the FOREMOST trial). American Journal of Obstetrics and Gynecology2006;194(3):606.e1‐16. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST study group. Fetal pulse oximetry clinical trial (the FOREMOST trial). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:166. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a non‐reassuring fetal heart rate pattern, on operative delivery rates: a multicenter randomized controlled trial (The FOREMOST Trial). American Journal of Obstetrics and Gynecology. 2005; Vol. 193, issue 6 Suppl:S33. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (the FOREMOST trial). Birth2006;33(2):101‐9. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST study group. Childbearing women's experience in the FOREMOST trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:365. EastCE , GascoigneMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomised controlled trial (the FOREMOST trial). BJOG: an international journal of obstetrics and gynaecology2006;113:1080‐7. EastCE , GasgoineMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. Cost‐effectiveness of fetal pulse oximetry (FOREMOST). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:202. ">East 2006</a> (<a href="./references#CD004075-fig-0005" title="">Analysis 1.3</a>). No studies reported details of assessment of long‐term disability. </p> </section> <section id="CD004075-sec-0079"> <h4 class="title">Secondary outcomes: maternal</h4> <p>There was evidence of a significant decrease in caesarean section for nonreassuring fetal status in the fetal pulse oximetry plus CTG group compared to the CTG group in two of the four analyses: (i) gestation from 34 weeks with FBS not required prior to study entry (four studies, n = 4008, average RR 0.65 using random‐effects, 95% CI 0.46 to 0.90, I² = 63%); and (ii) when FBS was required prior to study entry (one study, n = 146, average RR 0.03, 95% CI 0.00 to 0.44, <a href="./references#CD004075-fig-0006" title="">Analysis 2.1</a>). There was a statistically significant decrease in operative birth (caesarean section, forceps or vacuum birth) for nonreassuring fetal status when fetal pulse oximetry was added to CTG monitoring, compared with CTG alone (FBS not required prior to study entry, two studies, n = 1610, summary RR 0.74, 95% CI 0.62 to 0.89, (<a href="./references#CD004075-fig-0009" title="">Analysis 2.4</a>). There was a large decrease in the oximetry group for this outcome in the one study (n = 146) where FBS was required prior to study entry (RR 0.05, 95% CI 0.01 to 0.22), (<a href="./references#CD004075-bbs2-0006" title="KuhnertM , SchmidtS . Intrapartum management of nonreassuring fetal heart rate patterns: a randomized controlled trial of fetal pulse oximetry. American Journal of Obstetrics and Gynecology2004;191:1989‐95. ">Kuhnert 2004</a>). </p> <p>There was no evidence of a difference in caesarean section for dystocia when fetal pulse oximetry (fetal pulse oximetry) was added to CTG monitoring, compared with CTG monitoring alone (<a href="./references#CD004075-fig-0007" title="">Analysis 2.2</a>). </p> <p>The addition of fetal pulse oximetry to CTG monitoring resulted in no evidence of differences for overall operative birth rates (with the exception of the smaller study reported by <a href="./references#CD004075-bbs2-0006" title="KuhnertM , SchmidtS . Intrapartum management of nonreassuring fetal heart rate patterns: a randomized controlled trial of fetal pulse oximetry. American Journal of Obstetrics and Gynecology2004;191:1989‐95. ">Kuhnert 2004</a>), endometritis, intrapartum haemorrhage, postpartum haemorrhage, chorioamnionitis, endometritis, uterine rupture, length of hospital stay, satisfaction with labour or satisfaction with fetal monitoring in labour, compared to CTG only. No maternal deaths occurred. The small study by <a href="./references#CD004075-bbs2-0006" title="KuhnertM , SchmidtS . Intrapartum management of nonreassuring fetal heart rate patterns: a randomized controlled trial of fetal pulse oximetry. American Journal of Obstetrics and Gynecology2004;191:1989‐95. ">Kuhnert 2004</a> reported less antibiotic use in the fetal pulse oximetry group, compared with the CTG group. </p> <p>Women reported similar levels of satisfaction with their labour and fetal monitoring when fetal pulse oximetry was added to CTG monitoring, compared to CTG monitoring alone (<a href="./references#CD004075-bbs2-0003" title="ColditzPB , EastCE . PTO360. Fetal intrapartum pulse oximetry: a multicentre randomised controlled trial. Perinatal Trials Report. www.ctc.usyd.edu.au/6registry/PTO360.htm (accessed 3 Feb 2004). EastC , ChanFY , BrenneckeS , KingJ , ColditzP , the Foremost Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S102. EastC , GascoineM , DoranC , BrenneckeS , KingJ , ColditzP , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomized controlled trial (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S101. EastCE , BrenneckeSP , ChanFY , KingJF , BellerEM , ColditzPB . Clinicians' evaluations of fetal oximetry sensor placement in a multicentre randomised trial (the foremost trial). Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2006;46(3):234‐9. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a nonreassuring fetal heart rate pattern, on operative delivery rates: a multicenter, randomized, controlled trial (the FOREMOST trial). American Journal of Obstetrics and Gynecology2006;194(3):606.e1‐16. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST study group. Fetal pulse oximetry clinical trial (the FOREMOST trial). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:166. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a non‐reassuring fetal heart rate pattern, on operative delivery rates: a multicenter randomized controlled trial (The FOREMOST Trial). American Journal of Obstetrics and Gynecology. 2005; Vol. 193, issue 6 Suppl:S33. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (the FOREMOST trial). Birth2006;33(2):101‐9. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST study group. Childbearing women's experience in the FOREMOST trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:365. EastCE , GascoigneMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomised controlled trial (the FOREMOST trial). BJOG: an international journal of obstetrics and gynaecology2006;113:1080‐7. EastCE , GasgoineMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. Cost‐effectiveness of fetal pulse oximetry (FOREMOST). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:202. ">East 2006</a>, <a href="./references#CD004075-fig-0018" title="">Analysis 2.13</a>; <a href="./references#CD004075-fig-0019" title="">Analysis 2.14</a>). </p> <p>The study by <a href="./references#CD004075-bbs2-0007" title="ParejaMV , PrietoAP , BadilloMPC , HerrezueloIP , VentosoFM . Comparison of the effectiveness between the fetal pulse oximetry and fetal electrocardiogram during intrapartum fetal well‐being loss risks. Progresos de Obstetricia y Ginecologia2010;53(4):141‐7. PrietoAP , ParejaMV , ZunigaIV , RomeroTA , LeonMDR , VentosoFM . Pulse oximetry compared with fetal electrocardiogram to control intrapartum fetal wellbeing. Journal of Maternal‐Fetal and Neonatal Medicine2008; Vol. 21, issue Suppl 1:141. ValverdeM , PuertasAM , Lopez‐GallegoMF , CarrilloMP , AguilarMT , MontoyaF . Effectiveness of pulse oximetry versus fetal electrocardiography for the intrapartum evaluation of nonreassuring fetal heart rate. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2011;159(2):333‐7. Valverde ParejaM , MartinezMDM , GuadixBR , VentosoFM , PrietoAP , CriadoMSL . Comparison between the pulse oximetry's effectiveness and electrocardiogram's effectiveness; two methods of fetal intrapartum monitoring. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):627. Valverde ParejaM , Romero GuadixB , Moreno MartinezMD , Puertas PrietoAA , Montoya VentosoF . Influence of two methods of fetal intrapartum monitoring; pulse oximetry and fetal electrocardiogram for the duration of the labor, in the presence of alterations in the fetal heart rate. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):243. ">Valverde 2011</a> (n = 180), demonstrated a statistically significant increase in caesarean section for nonreassuring fetal status comparing fetal pulse oximetry plus CTG with fetal ECG plus CTG (RR 1.71, 95% CI 1.01 to 2.88, <a href="./references#CD004075-fig-0035" title="">Analysis 6.1</a>), but not in caesarean section performed for dystocia (RR 1.30, 95% CI 0.60 to 2.81, <a href="./references#CD004075-fig-0036" title="">Analysis 6.2</a>). There was also a statistically significant increase comparing fetal pulse oximetry plus CTG with fetal ECG plus CTG in overall operative birth (RR 1.20, 95% CI 1.00 to 1.45, <a href="./references#CD004075-fig-0037" title="">Analysis 6.3</a>) but not in overall operative birth for nonreassuring fetal status (RR 1.22, 0.88 to 1.70, <a href="./references#CD004075-fig-0038" title="">Analysis 6.4</a>). </p> </section> <section id="CD004075-sec-0080"> <h4 class="title">Secondary outcomes: fetal/neonatal</h4> <p>No evidence of significant differences was noted for Apgar scores less than four at five minutes or less than seven at five minutes, umbilical arterial pH less than 7.10, umbilical arterial base excess less than ‐12, admission to the neonatal intensive care unit, length of hospital stay, death, or skin trauma. Transient skin markings attributable to the fetal oximetry sensor were noted in 11 of 638 babies (2%) <a href="./references#CD004075-bbs2-0004" title="DildyG , GariteT , McNamaraH , SwedlowD , Mallinckrodt (Nellcor) Fetal Oximetry Research Group. A multicenter randomized trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2000;182(1 Pt 2):S12. DildyGA , ClarkSL , GariteTJ , PorterRF , SwedlowDB , VarnerMW . Current status of the multicenter randomized clinical trial on fetal oxygen saturation monitoring in the United States. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1997;72 Suppl 1:S43‐S50. GariteTJ , DildyGA , McNamaraH , NageotteMP , BoehmFH , DellingerEH , et al. A multicenter controlled trial of fetal pulse oximetry in the intrapartum management of nonreassuring fetal heart rate patterns. American Journal of Obstetrics and Gynecology2000;183(5):1049‐58. GorenbergD , PattilloC , HendiP , RumneyP , GariteT . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S129. GorenbergDM , PattilloC , HendiP , RumneyPJ , GariteTJ . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes. American Journal of Obstetrics and Gynecology2003;189(1):136‐8. HenigsmanS , GariteT , PattilloC , BrewsterW . Fetal pulse oximetry: defining which variable decelerations with slow return to baseline are associated with hypoxia [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. LeeR , MooreM , BrewsterW , HendiP , PattilloC , ZiogasA , et al. All non‐reactive fetal heart rate tracings are not equal [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. Mallinckrodt , Inc . Summary of safety and effectiveness information data. OxiFirst® Fetal Oxygen Saturation Monitoring System2000. MillerH . Differences in cervical dilatation and induction in patients delivered because of dystocia during a multicenter randomized clinical trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S124. PorrecoR , GariteJ , SwedlowD , ThomasS . The occurrence of dystocia among patients monitored in labor with fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S19. ">Garite 2000</a>; in 30 of 305 babies (10%) <a href="./references#CD004075-bbs2-0003" title="ColditzPB , EastCE . PTO360. Fetal intrapartum pulse oximetry: a multicentre randomised controlled trial. Perinatal Trials Report. www.ctc.usyd.edu.au/6registry/PTO360.htm (accessed 3 Feb 2004). EastC , ChanFY , BrenneckeS , KingJ , ColditzP , the Foremost Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S102. EastC , GascoineM , DoranC , BrenneckeS , KingJ , ColditzP , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomized controlled trial (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S101. EastCE , BrenneckeSP , ChanFY , KingJF , BellerEM , ColditzPB . Clinicians' evaluations of fetal oximetry sensor placement in a multicentre randomised trial (the foremost trial). Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2006;46(3):234‐9. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a nonreassuring fetal heart rate pattern, on operative delivery rates: a multicenter, randomized, controlled trial (the FOREMOST trial). American Journal of Obstetrics and Gynecology2006;194(3):606.e1‐16. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST study group. Fetal pulse oximetry clinical trial (the FOREMOST trial). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:166. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a non‐reassuring fetal heart rate pattern, on operative delivery rates: a multicenter randomized controlled trial (The FOREMOST Trial). American Journal of Obstetrics and Gynecology. 2005; Vol. 193, issue 6 Suppl:S33. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (the FOREMOST trial). Birth2006;33(2):101‐9. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST study group. Childbearing women's experience in the FOREMOST trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:365. EastCE , GascoigneMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomised controlled trial (the FOREMOST trial). BJOG: an international journal of obstetrics and gynaecology2006;113:1080‐7. EastCE , GasgoineMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. Cost‐effectiveness of fetal pulse oximetry (FOREMOST). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:202. ">East 2006</a>; and for 152 of 2629 babies (6%) in the open oximetry values group and 155 of 2712 babies (6%) in the masked group <a href="./references#CD004075-bbs2-0001" title="BloomSL , SpongCY , ThomE , VarnerMW , RouseDJ , WeiningerS , et al. Fetal pulse oximetry and cesarean delivery. New England Journal of Medicine2006;355(21):2195‐202. BloomSL , for the NICHD MFMU Network. The MFMU Network randomized trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2006;196(6 Suppl):S2. Maternal Fetal Medicine Units Network. The FOX trial: a randomized clinical trial of fetal pulse oximetry. http://www.bsc.gwu.edu/mfmu/Projects/fox.cgi (accessed 7 August 2006). RouseD , ShriverEK . Second stage of labour duration: relationship to maternal and perinatal outcomes. American Journal of Obstetrics and Gynecology2008;199(6 Suppl 1):S37. RouseDJ , WeinerSJ , BloomSL , VarnerMW , SpongCY , RaminSM , et al. Second‐stage labor duration in nulliparous women: relationship to maternal and perinatal outcomes. American Journal of Obstetrics and Gynecology2009;201(4):357.e1‐357.e7. ">Bloom 2006</a>. </p> <p>The fetal oximetry plus CTG versus fetal ECG plus CTG study by <a href="./references#CD004075-bbs2-0007" title="ParejaMV , PrietoAP , BadilloMPC , HerrezueloIP , VentosoFM . Comparison of the effectiveness between the fetal pulse oximetry and fetal electrocardiogram during intrapartum fetal well‐being loss risks. Progresos de Obstetricia y Ginecologia2010;53(4):141‐7. PrietoAP , ParejaMV , ZunigaIV , RomeroTA , LeonMDR , VentosoFM . Pulse oximetry compared with fetal electrocardiogram to control intrapartum fetal wellbeing. Journal of Maternal‐Fetal and Neonatal Medicine2008; Vol. 21, issue Suppl 1:141. ValverdeM , PuertasAM , Lopez‐GallegoMF , CarrilloMP , AguilarMT , MontoyaF . Effectiveness of pulse oximetry versus fetal electrocardiography for the intrapartum evaluation of nonreassuring fetal heart rate. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2011;159(2):333‐7. Valverde ParejaM , MartinezMDM , GuadixBR , VentosoFM , PrietoAP , CriadoMSL . Comparison between the pulse oximetry's effectiveness and electrocardiogram's effectiveness; two methods of fetal intrapartum monitoring. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):627. Valverde ParejaM , Romero GuadixB , Moreno MartinezMD , Puertas PrietoAA , Montoya VentosoF . Influence of two methods of fetal intrapartum monitoring; pulse oximetry and fetal electrocardiogram for the duration of the labor, in the presence of alterations in the fetal heart rate. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):243. ">Valverde 2011</a> did not demonstrate any evidence of between‐group differences in admission to neonatal intensive care unit (n = 180, RR 1.00, 95% CI 0.06 to 15.74), (<a href="./references#CD004075-fig-0039" title="">Analysis 7.1</a>). Umbilical arterial pH data from one study (<a href="./references#CD004075-bbs2-0007" title="ParejaMV , PrietoAP , BadilloMPC , HerrezueloIP , VentosoFM . Comparison of the effectiveness between the fetal pulse oximetry and fetal electrocardiogram during intrapartum fetal well‐being loss risks. Progresos de Obstetricia y Ginecologia2010;53(4):141‐7. PrietoAP , ParejaMV , ZunigaIV , RomeroTA , LeonMDR , VentosoFM . Pulse oximetry compared with fetal electrocardiogram to control intrapartum fetal wellbeing. Journal of Maternal‐Fetal and Neonatal Medicine2008; Vol. 21, issue Suppl 1:141. ValverdeM , PuertasAM , Lopez‐GallegoMF , CarrilloMP , AguilarMT , MontoyaF . Effectiveness of pulse oximetry versus fetal electrocardiography for the intrapartum evaluation of nonreassuring fetal heart rate. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2011;159(2):333‐7. Valverde ParejaM , MartinezMDM , GuadixBR , VentosoFM , PrietoAP , CriadoMSL . Comparison between the pulse oximetry's effectiveness and electrocardiogram's effectiveness; two methods of fetal intrapartum monitoring. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):627. Valverde ParejaM , Romero GuadixB , Moreno MartinezMD , Puertas PrietoAA , Montoya VentosoF . Influence of two methods of fetal intrapartum monitoring; pulse oximetry and fetal electrocardiogram for the duration of the labor, in the presence of alterations in the fetal heart rate. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):243. ">Valverde 2011</a>) were not in a suitable format for inclusion in the RevMan software: the mean (range) of pH in fetal pulse oximetry group was 7.23 (7.17 to 7.28) and in the fetal ECG group was 7.26 (7.20 to 7.29), which the study authors noted to be a non‐significant difference. </p> </section> <section id="CD004075-sec-0081"> <h4 class="title">Subgroup analyses</h4> <p>Data were available from one trial (<a href="./references#CD004075-bbs2-0003" title="ColditzPB , EastCE . PTO360. Fetal intrapartum pulse oximetry: a multicentre randomised controlled trial. Perinatal Trials Report. www.ctc.usyd.edu.au/6registry/PTO360.htm (accessed 3 Feb 2004). EastC , ChanFY , BrenneckeS , KingJ , ColditzP , the Foremost Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S102. EastC , GascoineM , DoranC , BrenneckeS , KingJ , ColditzP , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomized controlled trial (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S101. EastCE , BrenneckeSP , ChanFY , KingJF , BellerEM , ColditzPB . Clinicians' evaluations of fetal oximetry sensor placement in a multicentre randomised trial (the foremost trial). Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2006;46(3):234‐9. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a nonreassuring fetal heart rate pattern, on operative delivery rates: a multicenter, randomized, controlled trial (the FOREMOST trial). American Journal of Obstetrics and Gynecology2006;194(3):606.e1‐16. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST study group. Fetal pulse oximetry clinical trial (the FOREMOST trial). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:166. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a non‐reassuring fetal heart rate pattern, on operative delivery rates: a multicenter randomized controlled trial (The FOREMOST Trial). American Journal of Obstetrics and Gynecology. 2005; Vol. 193, issue 6 Suppl:S33. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (the FOREMOST trial). Birth2006;33(2):101‐9. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST study group. Childbearing women's experience in the FOREMOST trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:365. EastCE , GascoigneMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomised controlled trial (the FOREMOST trial). BJOG: an international journal of obstetrics and gynaecology2006;113:1080‐7. EastCE , GasgoineMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. Cost‐effectiveness of fetal pulse oximetry (FOREMOST). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:202. ">East 2006</a>) to allow the planned subgroup analyses of fetal scalp blood sampling post randomisation. There were no significant differences in the primary outcome of caesarean section and no seizures were reported for any of the babies in this subgroup. Data were not available to allow the remaining subgroup analyses to be conducted. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD004075-sec-0082" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD004075-sec-0082"></div> <section id="CD004075-sec-0083"> <h3 class="title" id="CD004075-sec-0083">Summary of main results</h3> <p>When systematically reviewed, five of the seven published trials (with some unpublished data available), comparing fetal intrapartum pulse oximetry with CTG or fetal electrocardiography or masked fetal pulse oximetry, reported no difference in the overall caesarean section rate between the fetal pulse oximetry group and the CTG group. One smaller study did note a significant difference in favour of the fetal pulse oximetry plus CTG group. A study comparing fetal pulse oximetry plus CTG and fetal electrocardiography plus CTG reported less caesarean section births in the fetal electrocardiography plus CTG group. </p> <p>Meta‐analysis of the four studies with nonreassuring fetal status from 34 weeks' gestation prior to randomisation demonstrated a reduction in caesarean section for nonreassuring fetal status, with no differences in neonatal outcomes. That is, a decision not to perform a caesarean section for nonreassuring fetal status in the fetal pulse oximetry group did not result in worse outcomes for those babies (but a larger sample would be required to demonstrate a difference in such low‐prevalence outcomes). There were no between‐group differences in caesarean section for nonreassuring fetal status when all participants in the largest study were considered, when analysed without consideration of fetal status at study entry. </p> <p>The findings from more than 8000 participants provide substantial evidence to suggest that knowledge of fetal pulse oximetry values does not reduce overall caesarean section rates. However, several issues warrant consideration. Firstly, does the indication for caesarean section matter if the overall incidence of caesarean section is the same, given than there is limited support from the findings of this review, for the use of fetal pulse oximetry when used in the presence of a nonreassuring CTG, to reduce caesarean section for nonreassuring fetal status? An additional area of importance is whether or not the presence of a fetal oximetry sensor contributes to dystocia. </p> </section> <section id="CD004075-sec-0084"> <h3 class="title" id="CD004075-sec-0084">Overall completeness and applicability of evidence</h3> <p>The decision pathway leading to performing a caesarean section may be important. The additional information that fetal pulse oximetry can provide, when a nonreassuring fetal heart rate trace has been identified, may translate to avoidance of a caesarean section for nonreassuring fetal status, with its associated stress levels for the mother and resource implications for the health service providers. An 'inevitable' caesarean section may still be performed for other indications, when the woman has had more time to consider her options. Staffing levels can also be adjusted over a number of hours, rather than the immediate and potentially costly provision of staff for an emergency operation. One trial reported that the addition of fetal pulse oximetry to CTG monitoring was cost effective in reducing operative birth for nonreassuring fetal status (<a href="./references#CD004075-bbs2-0003" title="ColditzPB , EastCE . PTO360. Fetal intrapartum pulse oximetry: a multicentre randomised controlled trial. Perinatal Trials Report. www.ctc.usyd.edu.au/6registry/PTO360.htm (accessed 3 Feb 2004). EastC , ChanFY , BrenneckeS , KingJ , ColditzP , the Foremost Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S102. EastC , GascoineM , DoranC , BrenneckeS , KingJ , ColditzP , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomized controlled trial (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S101. EastCE , BrenneckeSP , ChanFY , KingJF , BellerEM , ColditzPB . Clinicians' evaluations of fetal oximetry sensor placement in a multicentre randomised trial (the foremost trial). Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2006;46(3):234‐9. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a nonreassuring fetal heart rate pattern, on operative delivery rates: a multicenter, randomized, controlled trial (the FOREMOST trial). American Journal of Obstetrics and Gynecology2006;194(3):606.e1‐16. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST study group. Fetal pulse oximetry clinical trial (the FOREMOST trial). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:166. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a non‐reassuring fetal heart rate pattern, on operative delivery rates: a multicenter randomized controlled trial (The FOREMOST Trial). American Journal of Obstetrics and Gynecology. 2005; Vol. 193, issue 6 Suppl:S33. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (the FOREMOST trial). Birth2006;33(2):101‐9. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST study group. Childbearing women's experience in the FOREMOST trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:365. EastCE , GascoigneMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomised controlled trial (the FOREMOST trial). BJOG: an international journal of obstetrics and gynaecology2006;113:1080‐7. EastCE , GasgoineMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. Cost‐effectiveness of fetal pulse oximetry (FOREMOST). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:202. ">East 2006</a>). </p> <p>Women's reports of satisfaction with their labour and with fetal monitoring were similar when fetal pulse oximetry was added to CTG monitoring, compared to CTG monitoring alone. This is an important consideration, given that the use of technology may impact on women's perceived control over their labour experience (<a href="./references#CD004075-bbs2-0056" title="WagnerM . Fish can't see water: the need to humanize birth. International Journal of Gynecology &amp; Obstetrics2001;75 Suppl 1:S25‐S37. ">Wagner 2001</a>). Although an ideal study would compare women's satisfaction with fetal pulse oximetry and without any technology, such a study is not feasible. It can be considered, however, that once continuous CTG monitoring is in use during labour, the addition of fetal pulse oximetry technology does not adversely affect women's perceptions of their labour experience or of fetal monitoring overall. Long‐term neurodevelopmental outcome has not been measured. </p> </section> <section id="CD004075-sec-0085"> <h3 class="title" id="CD004075-sec-0085">Quality of the evidence</h3> <p>Overall, the evidence (for the primary outcomes) was of moderate to high quality. The impractical nature of blinding participants and clinicians in the intervention arm of each study was not viewed as something that could be overcome and was consistent across studies, meaning that any impact of this potential bias was essentially the same for each study. The findings from the smallest of the included studies (n = 146, <a href="./references#CD004075-bbs2-0006" title="KuhnertM , SchmidtS . Intrapartum management of nonreassuring fetal heart rate patterns: a randomized controlled trial of fetal pulse oximetry. American Journal of Obstetrics and Gynecology2004;191:1989‐95. ">Kuhnert 2004</a>) were considerably more positive for the primary outcome of caesarean section than was noted in any of the remaining studies. This inconsistency in findings is worthy of consideration when interpreting overall results. The addition in this update of another small study (n = 180, <a href="./references#CD004075-bbs2-0007" title="ParejaMV , PrietoAP , BadilloMPC , HerrezueloIP , VentosoFM . Comparison of the effectiveness between the fetal pulse oximetry and fetal electrocardiogram during intrapartum fetal well‐being loss risks. Progresos de Obstetricia y Ginecologia2010;53(4):141‐7. PrietoAP , ParejaMV , ZunigaIV , RomeroTA , LeonMDR , VentosoFM . Pulse oximetry compared with fetal electrocardiogram to control intrapartum fetal wellbeing. Journal of Maternal‐Fetal and Neonatal Medicine2008; Vol. 21, issue Suppl 1:141. ValverdeM , PuertasAM , Lopez‐GallegoMF , CarrilloMP , AguilarMT , MontoyaF . Effectiveness of pulse oximetry versus fetal electrocardiography for the intrapartum evaluation of nonreassuring fetal heart rate. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2011;159(2):333‐7. Valverde ParejaM , MartinezMDM , GuadixBR , VentosoFM , PrietoAP , CriadoMSL . Comparison between the pulse oximetry's effectiveness and electrocardiogram's effectiveness; two methods of fetal intrapartum monitoring. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):627. Valverde ParejaM , Romero GuadixB , Moreno MartinezMD , Puertas PrietoAA , Montoya VentosoF . Influence of two methods of fetal intrapartum monitoring; pulse oximetry and fetal electrocardiogram for the duration of the labor, in the presence of alterations in the fetal heart rate. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):243. ">Valverde 2011</a>) resulted in an increase in caesarean section rates for those in the fetal pulse oximetry group, compared with CTG plus fetal ECG. Where meta‐analysis was appropriate, there was considerable heterogeneity, even when using random‐effects, meaning that larger sample sizes may be necessary to address the outcomes of interest. </p> </section> <section id="CD004075-sec-0086"> <h3 class="title" id="CD004075-sec-0086">Potential biases in the review process</h3> <p>The authors are not aware of potential biases that have not already been addressed through the rigorous methods adopted in this review in line with those of the Cochrane Pregnancy and Childbirth Group. The search strategy is believed to be robust in its ability to identify all trials. The evaluation of the study that two of the review authors had conducted (CE and PB: <a href="./references#CD004075-bbs2-0003" title="ColditzPB , EastCE . PTO360. Fetal intrapartum pulse oximetry: a multicentre randomised controlled trial. Perinatal Trials Report. www.ctc.usyd.edu.au/6registry/PTO360.htm (accessed 3 Feb 2004). EastC , ChanFY , BrenneckeS , KingJ , ColditzP , the Foremost Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S102. EastC , GascoineM , DoranC , BrenneckeS , KingJ , ColditzP , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomized controlled trial (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S101. EastCE , BrenneckeSP , ChanFY , KingJF , BellerEM , ColditzPB . Clinicians' evaluations of fetal oximetry sensor placement in a multicentre randomised trial (the foremost trial). Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2006;46(3):234‐9. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a nonreassuring fetal heart rate pattern, on operative delivery rates: a multicenter, randomized, controlled trial (the FOREMOST trial). American Journal of Obstetrics and Gynecology2006;194(3):606.e1‐16. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST study group. Fetal pulse oximetry clinical trial (the FOREMOST trial). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:166. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a non‐reassuring fetal heart rate pattern, on operative delivery rates: a multicenter randomized controlled trial (The FOREMOST Trial). American Journal of Obstetrics and Gynecology. 2005; Vol. 193, issue 6 Suppl:S33. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (the FOREMOST trial). Birth2006;33(2):101‐9. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST study group. Childbearing women's experience in the FOREMOST trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:365. EastCE , GascoigneMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomised controlled trial (the FOREMOST trial). BJOG: an international journal of obstetrics and gynaecology2006;113:1080‐7. EastCE , GasgoineMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. Cost‐effectiveness of fetal pulse oximetry (FOREMOST). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:202. ">East 2006</a>) by an independent author (LB) in the 2007 update of this review aimed to minimise any potential reporting bias for that trial. </p> </section> <section id="CD004075-sec-0087"> <h3 class="title" id="CD004075-sec-0087">Agreements and disagreements with other studies or reviews</h3> <p>European clinicians published guidelines for fetal pulse oximetry use (<a href="./references#CD004075-bbs2-0034" title="KuhnertM , Seelbach‐GoebelB , DiRenzoGC , HowarthE , ButterweggeM , MurayJM . Guidelines for the use of fetal pulse oximetry during labour and delivery. Prenatal and Neonatal Medicine1998;3(4):432‐3. ">Kuhnert 1998</a>; <a href="./references#CD004075-bbs2-0049" title="SalingE . Fetal pulse oximetry during labor: issues and recommendations for clinical use. Journal of Perinatal Medicine1996;24:467‐78. ">Saling 1996</a>) that were consistent with the management of fetal pulse oximetry in <a href="./references#CD004075-bbs2-0004" title="DildyG , GariteT , McNamaraH , SwedlowD , Mallinckrodt (Nellcor) Fetal Oximetry Research Group. A multicenter randomized trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2000;182(1 Pt 2):S12. DildyGA , ClarkSL , GariteTJ , PorterRF , SwedlowDB , VarnerMW . Current status of the multicenter randomized clinical trial on fetal oxygen saturation monitoring in the United States. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1997;72 Suppl 1:S43‐S50. GariteTJ , DildyGA , McNamaraH , NageotteMP , BoehmFH , DellingerEH , et al. A multicenter controlled trial of fetal pulse oximetry in the intrapartum management of nonreassuring fetal heart rate patterns. American Journal of Obstetrics and Gynecology2000;183(5):1049‐58. GorenbergD , PattilloC , HendiP , RumneyP , GariteT . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S129. GorenbergDM , PattilloC , HendiP , RumneyPJ , GariteTJ . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes. American Journal of Obstetrics and Gynecology2003;189(1):136‐8. HenigsmanS , GariteT , PattilloC , BrewsterW . Fetal pulse oximetry: defining which variable decelerations with slow return to baseline are associated with hypoxia [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. LeeR , MooreM , BrewsterW , HendiP , PattilloC , ZiogasA , et al. All non‐reactive fetal heart rate tracings are not equal [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. Mallinckrodt , Inc . Summary of safety and effectiveness information data. OxiFirst® Fetal Oxygen Saturation Monitoring System2000. MillerH . Differences in cervical dilatation and induction in patients delivered because of dystocia during a multicenter randomized clinical trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S124. PorrecoR , GariteJ , SwedlowD , ThomasS . The occurrence of dystocia among patients monitored in labor with fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S19. ">Garite 2000</a> and prior to its results being known. Only two small randomised controlled trials of fetal pulse oximetry have since been reported from Europe to test these guidelines (<a href="./references#CD004075-bbs2-0006" title="KuhnertM , SchmidtS . Intrapartum management of nonreassuring fetal heart rate patterns: a randomized controlled trial of fetal pulse oximetry. American Journal of Obstetrics and Gynecology2004;191:1989‐95. ">Kuhnert 2004</a>; <a href="./references#CD004075-bbs2-0007" title="ParejaMV , PrietoAP , BadilloMPC , HerrezueloIP , VentosoFM . Comparison of the effectiveness between the fetal pulse oximetry and fetal electrocardiogram during intrapartum fetal well‐being loss risks. Progresos de Obstetricia y Ginecologia2010;53(4):141‐7. PrietoAP , ParejaMV , ZunigaIV , RomeroTA , LeonMDR , VentosoFM . Pulse oximetry compared with fetal electrocardiogram to control intrapartum fetal wellbeing. Journal of Maternal‐Fetal and Neonatal Medicine2008; Vol. 21, issue Suppl 1:141. ValverdeM , PuertasAM , Lopez‐GallegoMF , CarrilloMP , AguilarMT , MontoyaF . Effectiveness of pulse oximetry versus fetal electrocardiography for the intrapartum evaluation of nonreassuring fetal heart rate. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2011;159(2):333‐7. Valverde ParejaM , MartinezMDM , GuadixBR , VentosoFM , PrietoAP , CriadoMSL . Comparison between the pulse oximetry's effectiveness and electrocardiogram's effectiveness; two methods of fetal intrapartum monitoring. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):627. Valverde ParejaM , Romero GuadixB , Moreno MartinezMD , Puertas PrietoAA , Montoya VentosoF . Influence of two methods of fetal intrapartum monitoring; pulse oximetry and fetal electrocardiogram for the duration of the labor, in the presence of alterations in the fetal heart rate. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):243. ">Valverde 2011</a>). These trials reported divergent findings (an increase in one and decrease in the other) for overall caesarean section rates. </p> <p>The American College of Obstetrics and Gynecology (ACOG) reviewed the results of the trial reported by <a href="./references#CD004075-bbs2-0004" title="DildyG , GariteT , McNamaraH , SwedlowD , Mallinckrodt (Nellcor) Fetal Oximetry Research Group. A multicenter randomized trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2000;182(1 Pt 2):S12. DildyGA , ClarkSL , GariteTJ , PorterRF , SwedlowDB , VarnerMW . Current status of the multicenter randomized clinical trial on fetal oxygen saturation monitoring in the United States. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1997;72 Suppl 1:S43‐S50. GariteTJ , DildyGA , McNamaraH , NageotteMP , BoehmFH , DellingerEH , et al. A multicenter controlled trial of fetal pulse oximetry in the intrapartum management of nonreassuring fetal heart rate patterns. American Journal of Obstetrics and Gynecology2000;183(5):1049‐58. GorenbergD , PattilloC , HendiP , RumneyP , GariteT . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S129. GorenbergDM , PattilloC , HendiP , RumneyPJ , GariteTJ . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes. American Journal of Obstetrics and Gynecology2003;189(1):136‐8. HenigsmanS , GariteT , PattilloC , BrewsterW . Fetal pulse oximetry: defining which variable decelerations with slow return to baseline are associated with hypoxia [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. LeeR , MooreM , BrewsterW , HendiP , PattilloC , ZiogasA , et al. All non‐reactive fetal heart rate tracings are not equal [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. Mallinckrodt , Inc . Summary of safety and effectiveness information data. OxiFirst® Fetal Oxygen Saturation Monitoring System2000. MillerH . Differences in cervical dilatation and induction in patients delivered because of dystocia during a multicenter randomized clinical trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S124. PorrecoR , GariteJ , SwedlowD , ThomasS . The occurrence of dystocia among patients monitored in labor with fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S19. ">Garite 2000</a> and recommended further trials before the introduction of fetal pulse oximetry into clinical practice (<a href="./references#CD004075-bbs2-0010" title="ACOG Committee on Obstetric Practice. Fetal pulse oximetry. ACOG Committee Opinion No 258. Obstetrics &amp; Gynecology2001;98:523‐4. ">ACOG 2001</a>). Their recommendation was based mainly on the increase in dystocia reported with the use of fetal pulse oximetry and the potential to increase fetal monitoring costs without improving clinical outcomes (<a href="./references#CD004075-bbs2-0010" title="ACOG Committee on Obstetric Practice. Fetal pulse oximetry. ACOG Committee Opinion No 258. Obstetrics &amp; Gynecology2001;98:523‐4. ">ACOG 2001</a>). One trial reported that the addition of fetal pulse oximetry to cardiotocography was cost effective in reducing operative birth for nonreassuring fetal status (<a href="./references#CD004075-bbs2-0003" title="ColditzPB , EastCE . PTO360. Fetal intrapartum pulse oximetry: a multicentre randomised controlled trial. Perinatal Trials Report. www.ctc.usyd.edu.au/6registry/PTO360.htm (accessed 3 Feb 2004). EastC , ChanFY , BrenneckeS , KingJ , ColditzP , the Foremost Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S102. EastC , GascoineM , DoranC , BrenneckeS , KingJ , ColditzP , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomized controlled trial (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S101. EastCE , BrenneckeSP , ChanFY , KingJF , BellerEM , ColditzPB . Clinicians' evaluations of fetal oximetry sensor placement in a multicentre randomised trial (the foremost trial). Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2006;46(3):234‐9. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a nonreassuring fetal heart rate pattern, on operative delivery rates: a multicenter, randomized, controlled trial (the FOREMOST trial). American Journal of Obstetrics and Gynecology2006;194(3):606.e1‐16. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST study group. Fetal pulse oximetry clinical trial (the FOREMOST trial). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:166. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a non‐reassuring fetal heart rate pattern, on operative delivery rates: a multicenter randomized controlled trial (The FOREMOST Trial). American Journal of Obstetrics and Gynecology. 2005; Vol. 193, issue 6 Suppl:S33. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (the FOREMOST trial). Birth2006;33(2):101‐9. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST study group. Childbearing women's experience in the FOREMOST trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:365. EastCE , GascoigneMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomised controlled trial (the FOREMOST trial). BJOG: an international journal of obstetrics and gynaecology2006;113:1080‐7. EastCE , GasgoineMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. Cost‐effectiveness of fetal pulse oximetry (FOREMOST). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:202. ">East 2006</a>). </p> <p>When the findings of the first trials of fetal pulse oximetry became available, there was debate about why the incidence of caesarean section for dystocia more than doubled from 9% in the CTG‐only group to 19% when fetal pulse oximetry was added. The investigators explored several possible causes for the increase in dystocia in the fetal pulse oximetry group, including potential mislabelling of dystocia and the presence of the oximetry sensor slowing the labour (<a href="./references#CD004075-bbs2-0004" title="DildyG , GariteT , McNamaraH , SwedlowD , Mallinckrodt (Nellcor) Fetal Oximetry Research Group. A multicenter randomized trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2000;182(1 Pt 2):S12. DildyGA , ClarkSL , GariteTJ , PorterRF , SwedlowDB , VarnerMW . Current status of the multicenter randomized clinical trial on fetal oxygen saturation monitoring in the United States. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1997;72 Suppl 1:S43‐S50. GariteTJ , DildyGA , McNamaraH , NageotteMP , BoehmFH , DellingerEH , et al. A multicenter controlled trial of fetal pulse oximetry in the intrapartum management of nonreassuring fetal heart rate patterns. American Journal of Obstetrics and Gynecology2000;183(5):1049‐58. GorenbergD , PattilloC , HendiP , RumneyP , GariteT . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S129. GorenbergDM , PattilloC , HendiP , RumneyPJ , GariteTJ . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes. American Journal of Obstetrics and Gynecology2003;189(1):136‐8. HenigsmanS , GariteT , PattilloC , BrewsterW . Fetal pulse oximetry: defining which variable decelerations with slow return to baseline are associated with hypoxia [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. LeeR , MooreM , BrewsterW , HendiP , PattilloC , ZiogasA , et al. All non‐reactive fetal heart rate tracings are not equal [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. Mallinckrodt , Inc . Summary of safety and effectiveness information data. OxiFirst® Fetal Oxygen Saturation Monitoring System2000. MillerH . Differences in cervical dilatation and induction in patients delivered because of dystocia during a multicenter randomized clinical trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S124. PorrecoR , GariteJ , SwedlowD , ThomasS . The occurrence of dystocia among patients monitored in labor with fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S19. ">Garite 2000</a>). The authors concluded that mislabelling of the indication for caesarean section had not occurred and the presence of the sensor did not result in a longer labour. They suggested that the nonreassuring CTG may indicate an underlying risk for dystocia (<a href="./references#CD004075-bbs2-0004" title="DildyG , GariteT , McNamaraH , SwedlowD , Mallinckrodt (Nellcor) Fetal Oximetry Research Group. A multicenter randomized trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2000;182(1 Pt 2):S12. DildyGA , ClarkSL , GariteTJ , PorterRF , SwedlowDB , VarnerMW . Current status of the multicenter randomized clinical trial on fetal oxygen saturation monitoring in the United States. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1997;72 Suppl 1:S43‐S50. GariteTJ , DildyGA , McNamaraH , NageotteMP , BoehmFH , DellingerEH , et al. A multicenter controlled trial of fetal pulse oximetry in the intrapartum management of nonreassuring fetal heart rate patterns. American Journal of Obstetrics and Gynecology2000;183(5):1049‐58. GorenbergD , PattilloC , HendiP , RumneyP , GariteT . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S129. GorenbergDM , PattilloC , HendiP , RumneyPJ , GariteTJ . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes. American Journal of Obstetrics and Gynecology2003;189(1):136‐8. HenigsmanS , GariteT , PattilloC , BrewsterW . Fetal pulse oximetry: defining which variable decelerations with slow return to baseline are associated with hypoxia [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. LeeR , MooreM , BrewsterW , HendiP , PattilloC , ZiogasA , et al. All non‐reactive fetal heart rate tracings are not equal [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. Mallinckrodt , Inc . Summary of safety and effectiveness information data. OxiFirst® Fetal Oxygen Saturation Monitoring System2000. MillerH . Differences in cervical dilatation and induction in patients delivered because of dystocia during a multicenter randomized clinical trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S124. PorrecoR , GariteJ , SwedlowD , ThomasS . The occurrence of dystocia among patients monitored in labor with fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S19. ">Garite 2000</a>). To test this hypothesis, <a href="./references#CD004075-bbs2-0044" title="PorrecoRP , BoehmFH , DildyGA , MillerHS , WickstromEA , GariteTJ , et al. Dystocia in nulliparous patients monitored with fetal pulse oximetry. American Journal of Obstetrics and Gynecology2004;190(1):113‐7. ">Porreco 2004</a> conducted a multicentre, prospective, observational cohort study of fetal pulse oximetry in nulliparous labouring women, with a standardised labour management protocol and a specific focus on the management of dystocia (defined). The investigators concluded that the presence of persistent, progressive and moderate to severely nonreassuring CTGs may predict the need for birth by caesarean section for dystocia, despite adequate fetal oxygenation (<a href="./references#CD004075-bbs2-0044" title="PorrecoRP , BoehmFH , DildyGA , MillerHS , WickstromEA , GariteTJ , et al. Dystocia in nulliparous patients monitored with fetal pulse oximetry. American Journal of Obstetrics and Gynecology2004;190(1):113‐7. ">Porreco 2004</a>). No other trials in this systematic review demonstrated a difference in caesarean section for dystocia. However, the incidence of dystocia in each trial varied: from 11% in the fetal pulse oximetry group and 14% in the CTG‐only group (<a href="./references#CD004075-bbs2-0003" title="ColditzPB , EastCE . PTO360. Fetal intrapartum pulse oximetry: a multicentre randomised controlled trial. Perinatal Trials Report. www.ctc.usyd.edu.au/6registry/PTO360.htm (accessed 3 Feb 2004). EastC , ChanFY , BrenneckeS , KingJ , ColditzP , the Foremost Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S102. EastC , GascoineM , DoranC , BrenneckeS , KingJ , ColditzP , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomized controlled trial (The Foremost Trial). American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S101. EastCE , BrenneckeSP , ChanFY , KingJF , BellerEM , ColditzPB . Clinicians' evaluations of fetal oximetry sensor placement in a multicentre randomised trial (the foremost trial). Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2006;46(3):234‐9. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a nonreassuring fetal heart rate pattern, on operative delivery rates: a multicenter, randomized, controlled trial (the FOREMOST trial). American Journal of Obstetrics and Gynecology2006;194(3):606.e1‐16. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , on behalf of the FOREMOST study group. Fetal pulse oximetry clinical trial (the FOREMOST trial). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:166. EastCE , BrenneckeSP , KingJF , ChanFY , ColditzPB , the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a non‐reassuring fetal heart rate pattern, on operative delivery rates: a multicenter randomized controlled trial (The FOREMOST Trial). American Journal of Obstetrics and Gynecology. 2005; Vol. 193, issue 6 Suppl:S33. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (the FOREMOST trial). Birth2006;33(2):101‐9. EastCE , ChanFY , BrenneckeSP , KingJF , ColditzPB , on behalf of the FOREMOST study group. Childbearing women's experience in the FOREMOST trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:365. EastCE , GascoigneMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. A cost‐effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomised controlled trial (the FOREMOST trial). BJOG: an international journal of obstetrics and gynaecology2006;113:1080‐7. EastCE , GasgoineMB , DoranCM , BrenneckeSP , KingJF , ColditzPB , et al. Cost‐effectiveness of fetal pulse oximetry (FOREMOST). Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:202. ">East 2006</a>) to 19% for all women in both the open and masked groups, where all participants had a fetal oximetry sensor placed (<a href="./references#CD004075-bbs2-0001" title="BloomSL , SpongCY , ThomE , VarnerMW , RouseDJ , WeiningerS , et al. Fetal pulse oximetry and cesarean delivery. New England Journal of Medicine2006;355(21):2195‐202. BloomSL , for the NICHD MFMU Network. The MFMU Network randomized trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2006;196(6 Suppl):S2. Maternal Fetal Medicine Units Network. The FOX trial: a randomized clinical trial of fetal pulse oximetry. http://www.bsc.gwu.edu/mfmu/Projects/fox.cgi (accessed 7 August 2006). RouseD , ShriverEK . Second stage of labour duration: relationship to maternal and perinatal outcomes. American Journal of Obstetrics and Gynecology2008;199(6 Suppl 1):S37. RouseDJ , WeinerSJ , BloomSL , VarnerMW , SpongCY , RaminSM , et al. Second‐stage labor duration in nulliparous women: relationship to maternal and perinatal outcomes. American Journal of Obstetrics and Gynecology2009;201(4):357.e1‐357.e7. ">Bloom 2006</a>), which was similar to that of the fetal pulse oximetry group of <a href="./references#CD004075-bbs2-0004" title="DildyG , GariteT , McNamaraH , SwedlowD , Mallinckrodt (Nellcor) Fetal Oximetry Research Group. A multicenter randomized trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2000;182(1 Pt 2):S12. DildyGA , ClarkSL , GariteTJ , PorterRF , SwedlowDB , VarnerMW . Current status of the multicenter randomized clinical trial on fetal oxygen saturation monitoring in the United States. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1997;72 Suppl 1:S43‐S50. GariteTJ , DildyGA , McNamaraH , NageotteMP , BoehmFH , DellingerEH , et al. A multicenter controlled trial of fetal pulse oximetry in the intrapartum management of nonreassuring fetal heart rate patterns. American Journal of Obstetrics and Gynecology2000;183(5):1049‐58. GorenbergD , PattilloC , HendiP , RumneyP , GariteT . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S129. GorenbergDM , PattilloC , HendiP , RumneyPJ , GariteTJ . Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes. American Journal of Obstetrics and Gynecology2003;189(1):136‐8. HenigsmanS , GariteT , PattilloC , BrewsterW . Fetal pulse oximetry: defining which variable decelerations with slow return to baseline are associated with hypoxia [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. LeeR , MooreM , BrewsterW , HendiP , PattilloC , ZiogasA , et al. All non‐reactive fetal heart rate tracings are not equal [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S131. Mallinckrodt , Inc . Summary of safety and effectiveness information data. OxiFirst® Fetal Oxygen Saturation Monitoring System2000. MillerH . Differences in cervical dilatation and induction in patients delivered because of dystocia during a multicenter randomized clinical trial of fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S124. PorrecoR , GariteJ , SwedlowD , ThomasS . The occurrence of dystocia among patients monitored in labor with fetal pulse oximetry [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S19. ">Garite 2000</a>.The incidence of dystocia was much lower in the study reported by <a href="./references#CD004075-bbs2-0002" title="CaliskanE , CakirogluY , CorakciA , OzerenS . Reduction in caesarean delivery with fetal heart rate monitoring and intermittent pulse oximetry after induction of labour with misoprostol. Journal of Maternal‐Fetal &amp; Neonatal Medicine2009; Vol. 22, issue 5:445‐51. ">Caliskan 2009</a> (2.6% in the fetal oximetry group and 3.4% in the CTG‐only group). These researchers considered that the intermittent use of the fetal oximetry probe may have avoided an over representation of dystocia in the oximetry group. It remains possible that the presence of a fetal oximetry sensor alongside the fetal head contributes to dystocia. </p> <p>The use of CTG has some parallels. Current clinical practice recommendations are that the clinician and the individual woman should consider the appropriateness of CTG to enable an informed choice for each case (<a href="./references#CD004075-bbs2-0011" title="AlfirevicZ , DevaneD , GyteGML . Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour. Cochrane Database of Systematic Reviews2013, Issue 5. [DOI: 10.1002/14651858.CD006066.pub2] ">Alfirevic 2013</a>; <a href="./references#CD004075-bbs2-0039" title="National Institute for Health and Clinical Excellence. Intrapartum Care: Care of Healthy Women and their Babies During Childbirth. NICE Clinical Guideline 55. Manchester: National Collaborating Centre for Women's and Children's Health, 2007. ">NICE 2007</a>). Given the high quality of evidence from several of the reported fetal pulse oximetry trials and the reduction in caesarean section for nonreassuring fetal status (but not for overall caesarean section rates) in those for which a nonreassuring CTG was required prior to study entry, it may be prudent when developing recommendations to encourage the individual woman and her clinicians to make the decision to use or not use fetal pulse oximetry. Unlike CTG, however, the randomised controlled trials of fetal pulse oximetry have been conducted prior to widespread clinical acceptance and medico‐legal expectation of fetal pulse oximetry usage where there is concern about fetal well‐being. </p> <p>Commercial availability of the fetal pulse oximetry system used in the studies was discontinued during 2006. Other systems that have not yet been subject to trials may still remain available commercially. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD004075-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD004075-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/full#CD004075-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD004075-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/full#CD004075-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Primary outcomes: FPO + CTG versus CTG only, Outcome 1 Caesarean section." data-id="CD004075-fig-0003" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Primary outcomes: FPO + CTG versus CTG only, Outcome 1 Caesarean section.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Primary outcomes: FPO + CTG versus CTG only, Outcome 2 Hypoxic‐ischaemic encephalopathy." data-id="CD004075-fig-0004" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Primary outcomes: FPO + CTG versus CTG only, Outcome 2 Hypoxic‐ischaemic encephalopathy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Primary outcomes: FPO + CTG versus CTG only, Outcome 3 Neonatal seizures." data-id="CD004075-fig-0005" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Primary outcomes: FPO + CTG versus CTG only, Outcome 3 Neonatal seizures.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 1 Caesarean section for nonreassuring fetal status." data-id="CD004075-fig-0006" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 1 Caesarean section for nonreassuring fetal status. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 2 Caesarean section for dystocia." data-id="CD004075-fig-0007" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 2 Caesarean section for dystocia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 3 Operative birth (caesarean section, forceps, vacuum extraction) for all indications." data-id="CD004075-fig-0008" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 3 Operative birth (caesarean section, forceps, vacuum extraction) for all indications. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 4 Operative birth (caesarean section, forceps, vacuum) for nonreassuring fetal status." data-id="CD004075-fig-0009" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 4 Operative birth (caesarean section, forceps, vacuum) for nonreassuring fetal status. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 5 Use of intrapartum antibiotics." data-id="CD004075-fig-0010" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 5 Use of intrapartum antibiotics. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 6 Overall antibiotic use." data-id="CD004075-fig-0011" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 6 Overall antibiotic use. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 7 Intrapartum haemorrhage." data-id="CD004075-fig-0012" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 7 Intrapartum haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-002-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-002-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 8 Postpartum haemorrhage." data-id="CD004075-fig-0013" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-002-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 8 Postpartum haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-002-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-002-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-002-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 9 Chorioamnionitis." data-id="CD004075-fig-0014" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-002-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 9 Chorioamnionitis.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-002-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-002-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-002-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 10 Endometritis." data-id="CD004075-fig-0015" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-002-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.10</div> <div class="figure-caption"> <p>Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 10 Endometritis.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-002-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-002-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-002-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 11 Uterine rupture." data-id="CD004075-fig-0016" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-002-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.11</div> <div class="figure-caption"> <p>Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 11 Uterine rupture. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-002-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-002-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-002-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 12 Length of hospital stay (days)." data-id="CD004075-fig-0017" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-002-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.12</div> <div class="figure-caption"> <p>Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 12 Length of hospital stay (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-002-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-002-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-002-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 13 Satisfaction with labour." data-id="CD004075-fig-0018" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-002-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.13</div> <div class="figure-caption"> <p>Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 13 Satisfaction with labour. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-002-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-002-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-002-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 14 Satisfaction with fetal monitoring in labour." data-id="CD004075-fig-0019" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-002-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.14</div> <div class="figure-caption"> <p>Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 14 Satisfaction with fetal monitoring in labour. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-002-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-002-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-002-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 15 Death." data-id="CD004075-fig-0020" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-002-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.15</div> <div class="figure-caption"> <p>Comparison 2 Secondary outcomes: maternal: FPO + CTG versus CTG only, Outcome 15 Death.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-002-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only, Outcome 1 Apgar score less than 4 at 5 minutes." data-id="CD004075-fig-0021" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only, Outcome 1 Apgar score less than 4 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only, Outcome 2 Apgar score less than 7 at 5 minutes." data-id="CD004075-fig-0022" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only, Outcome 2 Apgar score less than 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only, Outcome 3 Length of hospital stay (days)." data-id="CD004075-fig-0023" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only, Outcome 3 Length of hospital stay (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only, Outcome 4 Umbilical arterial pH less than 7.10." data-id="CD004075-fig-0024" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only, Outcome 4 Umbilical arterial pH less than 7.10. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only, Outcome 5 Umbilical arterial base excess less than ‐12." data-id="CD004075-fig-0025" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only, Outcome 5 Umbilical arterial base excess less than ‐12. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only, Outcome 6 Admission to neonatal intensive care unit." data-id="CD004075-fig-0026" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only, Outcome 6 Admission to neonatal intensive care unit. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-003-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-003-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only, Outcome 7 Death." data-id="CD004075-fig-0027" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-003-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only, Outcome 7 Death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-003-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-003-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-003-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only, Outcome 8 Death, hypoxic‐ischaemic encephalopathy, or both." data-id="CD004075-fig-0028" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-003-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only, Outcome 8 Death, hypoxic‐ischaemic encephalopathy, or both. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-003-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-003-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-003-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only, Outcome 9 Death, seizures, or both." data-id="CD004075-fig-0029" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-003-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.9</div> <div class="figure-caption"> <p>Comparison 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only, Outcome 9 Death, seizures, or both. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-003-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-003-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-003-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only, Outcome 10 Death, long‐term neurodevelopmental problem, or both." data-id="CD004075-fig-0030" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-003-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.10</div> <div class="figure-caption"> <p>Comparison 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only, Outcome 10 Death, long‐term neurodevelopmental problem, or both. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-003-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-003-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-003-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only, Outcome 11 Skin trauma." data-id="CD004075-fig-0031" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-003-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.11</div> <div class="figure-caption"> <p>Comparison 3 Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only, Outcome 11 Skin trauma. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-003-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Subgroup: fetal blood sampling: primary outcomes, Outcome 1 Caesarean section." data-id="CD004075-fig-0032" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Subgroup: fetal blood sampling: primary outcomes, Outcome 1 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Subgroup: fetal blood sampling: primary outcomes, Outcome 2 Neonatal seizures." data-id="CD004075-fig-0033" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Subgroup: fetal blood sampling: primary outcomes, Outcome 2 Neonatal seizures. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Primary outcomes: FPO + CTG versus fetal ECG + CTG, Outcome 1 Caesarean section." data-id="CD004075-fig-0034" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Primary outcomes: FPO + CTG versus fetal ECG + CTG, Outcome 1 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Secondary outcomes: maternal: FPO + CTG versus fetal ECG + CTG, Outcome 1 Caesarean section for nonreassuring fetal status." data-id="CD004075-fig-0035" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Secondary outcomes: maternal: FPO + CTG versus fetal ECG + CTG, Outcome 1 Caesarean section for nonreassuring fetal status. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Secondary outcomes: maternal: FPO + CTG versus fetal ECG + CTG, Outcome 2 Caesarean section for dystocia." data-id="CD004075-fig-0036" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Secondary outcomes: maternal: FPO + CTG versus fetal ECG + CTG, Outcome 2 Caesarean section for dystocia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Secondary outcomes: maternal: FPO + CTG versus fetal ECG + CTG, Outcome 3 Operative birth (caesarean section, forceps, vacuum)." data-id="CD004075-fig-0037" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 Secondary outcomes: maternal: FPO + CTG versus fetal ECG + CTG, Outcome 3 Operative birth (caesarean section, forceps, vacuum). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-006-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-006-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Secondary outcomes: maternal: FPO + CTG versus fetal ECG + CTG, Outcome 4 Operative birth (caesarean section, forceps, vacuum) for nonreassuring fetal status." data-id="CD004075-fig-0038" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-006-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6 Secondary outcomes: maternal: FPO + CTG versus fetal ECG + CTG, Outcome 4 Operative birth (caesarean section, forceps, vacuum) for nonreassuring fetal status. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-006-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004075-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/urn:x-wiley:14651858:media:CD004075:CD004075-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_t/tCD004075-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Secondary outcomes: fetal/neonatal: FPO + CTG versus fetal ECG + CTG, Outcome 1 Admission to neonatal intensive care unit." data-id="CD004075-fig-0039" src="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Secondary outcomes: fetal/neonatal: FPO + CTG versus fetal ECG + CTG, Outcome 1 Admission to neonatal intensive care unit. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/media/CDSR/CD004075/image_n/nCD004075-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="comparison" data-id="CD004075-tbl-0001"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Primary outcomes: FPO + CTG versus CTG only</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Gestation from 34 weeks, FBS not required prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.86, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Gestation from 36 weeks, FBS prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.24, 0.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Gestation from 28 weeks, FBS not required prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>327</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.76, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Gestation from 36 weeks, nonreassuring fetal status not required prior to study entry </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5341</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.87, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Hypoxic‐ischaemic encephalopathy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Gestation from 36 weeks, FBS not required prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>600</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Gestation from 36 weeks, FBS prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Gestation from 36 weeks, nonreassuring fetal status not required prior to study entry </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5341</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.01, 8.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Neonatal seizures <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Gestation from 36 weeks, FBS not required prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1789</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.10, 8.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Gestation from 36 weeks, FBS prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Gestation from 36 weeks, nonreassuring fetal status not required prior to study entry </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5341</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.15, 2.59]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Primary outcomes: FPO + CTG versus CTG only</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004075-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Secondary outcomes: maternal: FPO + CTG versus CTG only</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Caesarean section for nonreassuring fetal status <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Gestation from 34 weeks, FBS not required prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.46, 0.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Gestation from 36 weeks, FBS prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [0.00, 0.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Gestation from 28 weeks, FBS not required prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>327</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.64, 1.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Gestation from 36 weeks, nonreassuring fetal status not required prior to study entry </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5341</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.75, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section for dystocia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Gestation from 34 weeks, FBS not required prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.38 [0.91, 2.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Gestation from 36 weeks, FBS prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.4 [0.47, 4.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Gestation from 28 weeks, FBS not required prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>327</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.66, 1.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 Gestation from 36 weeks, nonreassuring fetal status not required prior to study entry </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5341</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.87, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Operative birth (caesarean section, forceps, vacuum extraction) for all indications <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Gestation from 34 weeks, FBS not required prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1840</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.92, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Gestation from 36 weeks, FBS prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.36, 0.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Gestation from 36 weeks, nonreassuring fetal status not required prior to study entry </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5341</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.90, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Operative birth (caesarean section, forceps, vacuum) for nonreassuring fetal status <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Gestation from 36 weeks, FBS not required prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1610</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.62, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Gestation from 36 weeks, FBS prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [0.01, 0.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Use of intrapartum antibiotics <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Gestation from 36 weeks, FBS not required prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>600</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.87, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Gestation from 36 weeks, FBS required prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.30, 0.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Overall antibiotic use <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Gestation from 36 weeks, FBS prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.30, 0.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Intrapartum haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Gestation from 36 weeks, FBS not required prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1610</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.50 [0.52, 4.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Gestation from 36 weeks, FBS prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.06, 15.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Postpartum haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Gestation from 36 weeks, FBS not required prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1789</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.52 [0.53, 4.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Gestation from 36 weeks, FBS prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Chorioamnionitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Gestation from 36 weeks, FBS prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.11, 3.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Gestation from 36 weeks, nonreassuring fetal status not required prior to study entry </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5341</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.86, 1.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Endometritis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7276</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.79, 1.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Gestation from 36 weeks, FBS not required prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1789</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.61, 2.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 Gestation from 36 weeks, FBS prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.3 Gestation from 36 weeks, nonreassuring fetal status not required prior to study entry </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5341</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.76, 1.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Uterine rupture <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 Gestation from 36 weeks, FBS not required prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1789</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.12, 6.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 Gestation from 36 weeks, FBS prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Length of hospital stay (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 Gestation from 36 weeks, FBS not required prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>600</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.06 [‐0.36, 0.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 Gestation from 36 weeks, FBS prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.65, 0.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Satisfaction with labour <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 Gestation from 36 weeks, FBS not required prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>448</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [‐0.16, 0.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Satisfaction with fetal monitoring in labour <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 Gestation from 36 weeks, FBS not required prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>448</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [‐0.05, 0.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 Gestation from 36 weeks, FBS not required prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1789</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2 Gestation from 36 weeks, FBS prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Secondary outcomes: maternal: FPO + CTG versus CTG only</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004075-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Apgar score less than 4 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Gestation from 36 weeks, FBS not required prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1789</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.60 [0.11, 63.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Gestation from 36 weeks, FBS prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Gestation from 36 weeks, nonreassuring fetal status not required prior to study entry </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5341</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.06 [0.52, 8.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Apgar score less than 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Gestation from 34 weeks, FBS not required prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2019</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.38, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Gestation from 36 weeks, FBS required prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.12, 72.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Gestation from 28 weeks, FBS not required prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>327</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.17, 2.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Length of hospital stay (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Gestation from 36 weeks, FBS not required prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>600</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.33, 0.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Gestation from 36 weeks, FBS prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.32, 0.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Umbilical arterial pH less than 7.10 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Gestation from 36 weeks, FBS not required prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1701</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.66, 1.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Gestation from 36 weeks, FBS prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.02, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Gestation from 28 weeks, FBS not required prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>327</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.17, 1.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Umbilical arterial base excess less than ‐12 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Gestation from 36 weeks, FBS not required prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1670</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.58, 1.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Gestation from 36 weeks, FBS prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.14, 6.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Admission to neonatal intensive care unit <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Gestation from 34 weeks, FBS not required prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2019</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.84, 1.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Gestation from 36 weeks, FBS prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.30, 3.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 Gestation from 28 weeks, FBS not required prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>327</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.55, 1.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4 Gestation from 36 weeks, nonreassuring fetal status not required prior to study entry </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5341</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.70, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Gestation from 36 weeks, FBS not required prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1789</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.20, 3.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Gestation from 36 weeks, FBS prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 Gestation from 36 weeks, nonreassuring fetal status not required prior to study entry </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5341</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.01, 8.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Death, hypoxic‐ischaemic encephalopathy, or both <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Gestation from 36 weeks, FBS not required prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1789</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.20, 4.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Gestation from 36 weeks, FBS required prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 Gestation from 36 weeks, nonreassuring fetal status not required prior to study entry </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5341</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.01, 4.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Death, seizures, or both <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Gestation from 36 weeks, FBS not required prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1789</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.22, 3.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Gestation from 36 weeks, FBS prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Death, long‐term neurodevelopmental problem, or both <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Gestation from 36 weeks, FBS not required prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1789</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.20, 4.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 Gestation from 36 weeks, FBS prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Skin trauma <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 Gestation from 36 weeks, FBS not required prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>600</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.16, 3.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 Gestation from 36 weeks, FBS prior to study entry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Secondary outcomes: fetal/neonatal: FPO + CTG versus CTG only</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004075-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Subgroup: fetal blood sampling: primary outcomes</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Neonatal seizures <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Subgroup: fetal blood sampling: primary outcomes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004075-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Primary outcomes: FPO + CTG versus fetal ECG + CTG</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.56 [1.06, 2.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Primary outcomes: FPO + CTG versus fetal ECG + CTG</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004075-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Secondary outcomes: maternal: FPO + CTG versus fetal ECG + CTG</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Caesarean section for nonreassuring fetal status <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.71 [1.01, 2.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section for dystocia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.3 [0.60, 2.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Operative birth (caesarean section, forceps, vacuum) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [1.00, 1.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Operative birth (caesarean section, forceps, vacuum) for nonreassuring fetal status <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.22 [0.88, 1.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Secondary outcomes: maternal: FPO + CTG versus fetal ECG + CTG</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004075-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Secondary outcomes: fetal/neonatal: FPO + CTG versus fetal ECG + CTG</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Admission to neonatal intensive care unit <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.06, 15.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Secondary outcomes: fetal/neonatal: FPO + CTG versus fetal ECG + CTG</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004075.pub4/references#CD004075-tbl-0007">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD004075.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD004075-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD004075-note-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD004075-note-0003">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD004075-note-0002">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD004075-note-0005">日本語</a> </li> <li class="section-language"> <a class="" href="ru#CD004075-note-0001">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004075\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004075\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004075\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004075\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004075\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004075\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004075\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004075\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004075\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004075\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004075\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004075\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004075\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004075\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004075\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004075\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004075\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004075\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=7a2tKMcJ&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004075.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004075.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD004075.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD004075.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004075.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740715615317"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004075.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740715615320"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004075.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d8b6e5a7c9371',t:'MTc0MDcxNTYxNS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 